Clinical Notes

DateTypeAuthorContentSource
2026-01-15Progress NotesBenjamin Tan, MD - 01/15/2026 11:30 AM CSTFormatting of this note is different fepic_ihe_xdm
2026-01-15Progress NotesEllen S - 01/15/2026 9:42 AM CSTFormatting of this note might be different fromepic_ihe_xdm
2025-12-29Progress NotesSarah Matson, PA - 12/29/2025 9:30 AM CSTFormatting of this note is different fepic_ihe_xdm
2025-12-18Miscellaneous NotesPlan of Care - Nurse Jayla W - 12/19/2025 9:09 AM CSTFormatting of this note miepic_ihe_xdm
2025-12-18Discharge SummariesMichael Bryant, NP - 12/19/2025 9:36 AM CSTFormatting of this note is differentepic_ihe_xdm
2025-12-18H&P NotesCaroline Godfrey, MD - 12/18/2025 11:45 AM CSTFormatting of this note might be depic_ihe_xdm
2025-12-18Progress NotesReshma Mulla, MD - 12/19/2025 6:25 AM CSTFormatting of this note is different fepic_ihe_xdm
2025-12-18Anesthesia RecordProcedure SummaryProcedure NameResponsible AnesthesiologistAnesthesia Start Timeepic_ihe_xdm
2025-12-18OR NotesAnesthesia Postprocedure Evaluation - Samuel Erlinger, MD - 12/18/2025 4:41 PMepic_ihe_xdm
2025-12-16Progress NotesJeannette K - 12/16/2025 7:43 AM CSTFormatting of this note might be differentepic_ihe_xdm
2025-12-01Progress NotesJeannette K - 12/01/2025 4:07 PM CSTFormatting of this note might be differentepic_ihe_xdm
2025-11-26Progress NotesMorgen Rockel, PA - 11/26/2025 9:00 AM CSTFormatting of this note is differentepic_ihe_xdm
2025-11-21Miscellaneous NotesTelephone Encounter - Jeannette K - 11/21/2025 9:55 AM CSTFormatting of this noepic_ihe_xdm
2025-11-20Progress NotesBenjamin Tan, MD - 11/20/2025 8:15 AM CSTFormatting of this note is different fepic_ihe_xdm
2025-11-12Progress NotesAmy Ngo, NP - 11/12/2025 5:20 PM CSTFormatting of this note might be differentepic_ihe_xdm
2025-11-06Progress NotesAmy Ngo, NP - 11/06/2025 11:20 AM CSTFormatting of this note is different from tepic_ihe_xdm
2025-10-09Progress NotesBenjamin Tan, MD - 10/09/2025 8:15 AM CDTFormatting of this note is different fepic_ihe_xdm
2025-09-11Progress NotesAmy Ngo, NP - 09/11/2025 8:15 AM CDTFormatting of this note is different from tepic_ihe_xdm
2025-08-14Progress NotesBenjamin Tan, MD - 08/14/2025 11:00 AM CDTFormatting of this note is different fepic_ihe_xdm
2025-07-31Progress NotesCrystal Wolf, PA - 07/31/2025 10:20 AM CDTFormatting of this note is different fepic_ihe_xdm
2025-07-08Progress NotesBenjamin Tan, MD - 07/08/2025 11:45 AM CDTFormatting of this note is different fepic_ihe_xdm
2025-05-28Progress NotesMaureen Mercier, NP - 05/28/2025 9:15 AM CDTFormatting of this note is differenepic_ihe_xdm
2025-05-14Miscellaneous NotesInitial Assessments - Nurse Kelli M - 05/15/2025 7:31 AM CDTFormatting of thisepic_ihe_xdm
2025-05-14Discharge SummariesMallory Hubbard, PA - 05/15/2025 8:55 AM CDTFormatting of this note is differenepic_ihe_xdm
2025-05-14H&P NotesDeshka Foster, MD - 05/14/2025 10:37 AM CDTFormatting of this note might be diffepic_ihe_xdm
2025-05-14Progress NotesNurse Kelli M - 05/15/2025 9:18 AM CDTFormatting of this note is different fromepic_ihe_xdm
2025-05-14Anesthesia RecordProcedure SummaryProcedure NameResponsible AnesthesiologistAnesthesia Start Timeepic_ihe_xdm
2025-05-14OR NotesAnesthesia Postprocedure Evaluation - Archana Bharadwaj, MD - 05/14/2025 3:06 Pepic_ihe_xdm
2025-04-30Progress NotesMallory Hubbard, PA - 04/30/2025 9:30 AM CDTFormatting of this note might be diepic_ihe_xdm
2025-01-06Miscellaneous NotesTelephone Encounter - Elizabeth N - 01/06/2025 2:11 PM CSTFormatting of this noepic_ihe_xdm
2024-12-30Progress NotesMaureen Mercier, NP - 12/30/2024 1:04 PM CSTFormatting of this note might be diepic_ihe_xdm
2024-12-10Progress NotesMaureen Mercier, NP - 12/10/2024 10:25 AM CSTFormatting of this note might be diepic_ihe_xdm
2024-11-14Progress NotesWilliam Chapman, MD - 11/14/2024 1:00 PM CSTFormatting of this note is differenepic_ihe_xdm
2024-11-14Miscellaneous NotesTelephone Encounter - Matthew H - 11/14/2024 8:30 AM CSTFormatting of this noteepic_ihe_xdm
2024-11-01Miscellaneous NotesTelephone Encounter - Matthew H - 11/01/2024 1:23 PM CDTFormatting of this noteepic_ihe_xdm
2024-10-23Progress NotesLauren Lutz, NP - 10/23/2024 10:30 AM CDTFormatting of this note is different frepic_ihe_xdm
2024-10-03Miscellaneous NotesTelephone Encounter - Matthew H - 10/03/2024 11:24 AM CDTFormatting of this noteepic_ihe_xdm
2024-09-17Miscellaneous NotesTelephone Encounter - Benjamin Tan, MD - 09/17/2024 11:58 AM CDTFormatting of thepic_ihe_xdm
2024-09-12Progress NotesEllen S - 09/12/2024 10:47 AM CDTFormatting of this note might be different fromepic_ihe_xdm
2024-09-11Miscellaneous NotesTelephone Encounter - Ciaran M - 09/11/2024 2:53 PM CDTFormatting of this noteepic_ihe_xdm
2024-09-11Progress NotesEllen S - 09/11/2024 3:06 PM CDTFormatting of this note might be different fromepic_ihe_xdm
2024-09-06Miscellaneous NotesTelephone Encounter - Benjamin Tan, MD - 09/06/2024 11:35 AM CDTFormatting of thepic_ihe_xdm
2024-08-15Progress NotesBenjamin Tan, MD - 08/15/2024 3:15 PM CDTFormatting of this note is different fepic_ihe_xdm
2024-08-12Miscellaneous NotesTelephone Encounter - Nurse Kimberly B - 08/12/2024 4:17 PM CDTFormatting of thepic_ihe_xdm
2024-07-22AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2024-07-22Chief Complaint and Reason for VisitChief Complaint SBO, Hx colon CA s/p partial colectomyMalignanmeditech_anderson
2024-07-22Plan of TreatmentAuthorHannah MorrisonAnderson HealthcareAuthoredJune 12th, 2024 10:08amI have remeditech_anderson
2024-07-22Hospital Discharge InstructionsAdditional Instructions Discharge Instruction Sheet for Portacath Placement Dr.meditech_anderson
2024-07-22Progress NoteAuthor James PowellAnderson HealthcareJuly 22nd, 2024 1:23pmmeditech_anderson
2024-07-22History & Physical NoteAuthor Pei ChungAnderson HealthcareJuly 22nd, 2024 12:21pmmeditech_anderson
2024-07-01AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2024-07-01Chief Complaint and Reason for VisitChief Complaint Port-A-Cath no longer neededSBO, Hx colon CA smeditech_anderson
2024-07-01Plan of TreatmentAuthorHannah MorrisonAnderson HealthcareAuthoredJune 12th, 2024 10:08amI have remeditech_anderson
2024-07-01Hospital Discharge InstructionsAdditional Instructions DISCHARGE INSTRUCTION SHEET FOR DR. CHUNG 1. May showemeditech_anderson
2024-07-01Discharge Summary NoteAuthor Kelsy WasmuthAnderson HealthcareJuly 3rd, 2024 4:37pmmeditech_anderson
2024-07-01Progress NoteAuthor Pei ChungAnderson HealthcareJuly 2nd, 2024 2:47pmmeditech_anderson
2024-07-01History & Physical NoteAuthor Pei ChungAnderson HealthcareJuly 1st, 2024 11:33ammeditech_anderson
2024-05-08AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2024-05-08Chief Complaint and Reason for VisitChief Complaint Malignant neoplasm of sigmoid colonPort-A-Cathmeditech_anderson
2024-05-08Plan of TreatmentFuture Tests Future scheduled test information is unavailable Pending Tests Penmeditech_anderson
2024-05-08Consultation NoteAuthor Pei ChungAnderson HealthcareMay 9th, 2024 9:58ammeditech_anderson
2024-05-08Discharge Summary NoteAuthor Pei ChungAnderson HealthcareMay 9th, 2024 9:57ammeditech_anderson
2024-05-08Progress NoteAuthor Anthony ZychAnderson HealthcareMay 8th, 2024 7:04pmmeditech_anderson
2024-05-08History & Physical NoteAuthor Pei ChungAnderson HealthcareMay 8th, 2024 12:20pmmeditech_anderson
2023-08-23Progress NotesMary Stuart, PA - 08/23/2023 9:00 AM CDTFormatting of this note is different frepic_ihe_xdm
2023-08-09Miscellaneous NotesTelephone Encounter - Brittni C - 08/09/2023 10:49 AM CDTFormatting of this noteepic_ihe_xdm
2022-05-16AssessmentsNo assessment information availablemeditech_anderson
2022-05-16Chief Complaint and Reason for VisitChief Complaint oncologist sent - diarrhea since mondaytreatmemeditech_anderson
2022-05-16Plan of TreatmentFuture Tests Future scheduled test information is unavailable Pending Tests Penmeditech_anderson
2022-03-16AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2022-03-16Chief Complaint and Reason for VisitChief Complaint left colon mass 12-29left colon massRoutinemeditech_anderson
2022-03-16Plan of TreatmentFuture Tests Future scheduled test information is unavailable Pending Tests Penmeditech_anderson
2022-02-09AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2022-02-09Chief Complaint and Reason for VisitChief Complaint Occult blood in stooloccult GI bleed, Anemiad5meditech_anderson
2022-02-09Plan of Treatment? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3,meditech_anderson
2022-02-09Hospital Discharge InstructionsAdditional Instructions Discharge Instruction Sheet for Portacath Placement Dr.meditech_anderson
2022-02-08AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2022-02-08Chief Complaint and Reason for VisitChief Complaint Occult blood in stooloccult GI bleed, Anemiad5meditech_anderson
2022-02-08Plan of Treatment? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3,meditech_anderson
2022-02-01AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2022-02-01Chief Complaint and Reason for VisitChief Complaint Occult blood in stooloccult GI bleed, Anemiad5meditech_anderson
2022-02-01Plan of Treatment? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3,meditech_anderson
2021-12-29AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
2021-12-29Chief Complaint and Reason for VisitChief Complaint Occult blood in stooloccult GI bleed, Anemiad5meditech_anderson
2021-12-29Plan of Treatment? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3,meditech_anderson
AssessmentsDiagnosis Onset Date Resolutionmeditech_anderson
Plan of TreatmentI have reviewed Dr. Arshad’s office note, colonoscopy report and pathology priormeditech_anderson
Reason for ReferralReason for Referral Date Referral was Provided Provider Office Contact Locationmeditech_anderson
Chief Complaint and Reason for VisitChief Complaint SBO, Hx colon CA s/p partial colectomyMalignanmeditech_anderson
Plan of CareInstructions Antibiotic Form Hydrocodone/Acetaminophen (By mouth) Colectomymeditech_anderson
Hospital Discharge InstructionsAdditional Discharge Instructions DISCHARGE INSTRUCTION SHEET FOR LAPAROSCOPICmeditech_anderson
Reason for ReferralSleep Medicine Referral for Sleep apneaathena_sihf
NotesDate Note Typeathena_sihf
Plan of TreatmentRemindersathena_sihf
AssessmentEncounter Date Assessment Dateathena_sihf
Anesthesia Record — 2025-05-14

Date: 2025-05-14

Type: Anesthesia Record

Source: epic_ihe_xdm

Procedure SummaryProcedure NameResponsible AnesthesiologistAnesthesia Start TimeAnesthesia Stop TimeXI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED, TAP Block (Abdomen)Zoller, Jonathan Kramer, MD05/14/25 122105/14/25 1439EventsDateTimeEventComment05/14/20251005In Preop1220In Room1221An Start1221An Start Data1227An InductionThe patient was reevaluated immediately before moderate or deep sedation use and before anesthesia induction.1230An Intubation1238Anesthesia Ready1248Arterial Line sampling artifact1308Proc Start1308Incision Start1403Local injected by surgeon1417Proc Fin1424An Extubation1427Out of Room1439Handoff to RNI completed my handoff to the receiving nurse during which we: 1. Patient identified 2. Responsible provider identified 3. Pertinent medical history reviewed 4. Procedure type and surgical course discussed 5. Intraoperative anesthetic management and any significant issues discussed 6. Expectations and concerns for postop period discussed 7. Questions solicited from receiving nurse 8. Patient disposition at the time of handoff: No value filed.1439An StopMedsNameTotallidocaine (cardiac) syringe 2 %100 mgpropofol200 mgfentaNYL100 mcgHYDROmorphone 2 mg/mL0.8 mgrocuronium150 mgphenylephrine 100 mcg/mL1.11 mgondansetron PF (ZOFRAN) 2 mg/mL injection4 mgglycopyrrolate0.4 mgcefOXitin (MEFOXITIN) 2,000 mg/20 mL in sterile water (premix) 2,000 mg2,000 mgmagnesium sulfate 2 g/50 mL2 gsugammadex200 mgLactated Ringer’s (LR) infusion700 mLAgentsNameO2% ExpiredN2O ExpiredO2N2OAirExpired SevofluraneInspired SevofluraneBloodNo blood administrations on file.Lines, Drains, and AirwaysTypeDetailsPlacementRemovalImplanted PortExisting LDA Placed by: Other hospital (Placed at Anderson); Type: Non-power (Per patient); Orientation: Left; Location: Chest05/01/25 0739 by Peripheral IVPlacement Date: 05/14/25; Placement Time: 1020; Catheter Size: 20 G; Orientation: Right; Location: Forearm; Removal Date: 05/15/25; Removal Time: 0911; Removal Reason: Discharge05/14/25 1020 by Estes, Sydney, RN05/15/25 0911 by Evjen, Sofia Amanda, RNUrethral CatheterPlacement Date: 05/14/25; Placement Time: 1235; Inserted by: G. St. Pierre, RN; Type: Double-lumen, Non-latex, Straight-tip, Temperature probe; Balloon Size: 10 mL; Urine Returned: Yes; Removal Date: 05/15/25; Removal Time: 0011; Removal Reason: Therapy complete05/14/25 1235 by St. Pierre, Grace Marguerite, RN05/15/25 0011 by Chesnut, Caden Riley, RNETTPlacement Date: 05/14/25; Placement Time: 1249 (created via procedure documentation); Mask Ventilation: 1; Technique: Direct laryngoscopy; Type: ETT - single; Single Lumen Tube Size: 8 mm; Cuffed: Yes; Laryngoscope: Macintosh; Blade Size: 4; Grade View: Grade I; Insertion Attempts: 1; Placement Verification: Auscultation, Capnometry; Removal Date: 05/14/25; Removal Time: 142405/14/25 1249 by Lewis, Bradley Mitchell, DO05/14/25 1424 by Lewis, Bradley Mitchell, DOArterial LinePlacement Date: 05/14/25; Placemnt Time: 1254 (created via procedure documentation); Size: 20 G; Orientation: Left; Location: Radial; Removal Date: 05/14/25; Removal Time: 1458; Removal Reason: Per order05/14/25 1254 by Lewis, Bradley Mitchell, DO05/14/25 1458 by Price, Austin Matthew, RNPeripheral IVPlacement Date: 05/14/25; Placement Time: 1254 (created via procedure documentation); Catheter Size: 18 G; Orientation: Left; Location: Wrist; Site Prep: Chlorhexidine; Insertion Attempts: 1; Removal Date: 05/15/25; Removal Time: 0911; Removal Reason: Discharge05/14/25 1254 by Lewis, Bradley Mitchell, DO05/15/25 0911 by Evjen, Sofia Amanda, RNWound05/14/25; 1406; Incision; Abdomen; 5 port sites; 11/26/25; Unknown05/14/25 1406 by St. Pierre, Grace Marguerite, RN11/26/25 0000 by Miller, Dawn K., RNdocumented in this encounter

Anesthesia Record — 2025-12-18

Date: 2025-12-18

Type: Anesthesia Record

Source: epic_ihe_xdm

Procedure SummaryProcedure NameResponsible AnesthesiologistAnesthesia Start TimeAnesthesia Stop TimeXI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED SEGMENT 5 8 and 4B, INTRAOPERATIVE ULTRASOUND and TAP BLOCK (Abdomen)King, Christopher R., MD PhD12/18/25 130912/18/25 1608EventsDateTimeEventComment12/18/20250949In Preop10561308In Room1309An Start1309An Start Data1319An InductionThe patient was reevaluated immediately before moderate or deep sedation use and before anesthesia induction.1324An Intubation1336Anesthesia Ready1405Proc Start1405Incision Start1544An Extubation1547Incision Close1547Proc Fin1551an stop data1553Out of Room1608Handoff to RNI completed my handoff to the receiving nurse during which we: 1. Patient identified 2. Responsible provider identified 3. Pertinent medical history reviewed 4. Procedure type and surgical course discussed 5. Intraoperative anesthetic management and any significant issues discussed 6. Expectations and concerns for postop period discussed 7. Questions solicited from receiving nurse 8. Patient disposition at the time of handoff: PACU1608An StopMedsNameTotalmidazolam PF2 mglidocaine (cardiac) syringe 2 %100 mgpropofol130 mgfentaNYL200 mcgHYDROmorphone 2 mg/mL1.2 mgrocuronium180 mgphenylephrine 100 mcg/mL100 mcgePHEDrine5 mgondansetron PF (ZOFRAN) 2 mg/mL injection4 mgglycopyrrolate0.2 mgcefOXitin (MEFOXITIN) 2,000 mg/20 mL in sterile water (premix) 2,000 mg4,000 mgmannitol 25 %12.5 gphenylephrine 5,000 mcg/50 mL (100 mcg/mL) SYR1.27 mgfamotidine20 mgsugammadex400 mgLactated Ringer’s (LR) infusion1,300 mLAgentsNameO2% ExpiredN2O ExpiredO2N2OAirExpired SevofluraneInspired SevofluraneBloodNo blood administrations on file.Lines, Drains, and AirwaysTypeDetailsPlacementRemovalImplanted PortExisting LDA Placed by: Other hospital (Placed at Anderson); Type: Non-power (Per patient); Orientation: Left; Location: Chest05/01/25 0739 by Wound12/18/25; 1454; N; Incision; Abdomen; 5 port sites12/18/25 1454 by Boehmer, Natalie Nicole, RNPeripheral IVPlacement Date: 12/18/25; Placement Time: 1008; Catheter Size: 18 G; Orientation: Left; Location: Wrist; Removal Date: 12/19/25; Removal Time: 1001; Removal Reason: Discharge12/18/25 1008 by Estes, Sydney, RN12/19/25 1001 by Evjen, Sofia Amanda, RNUrethral CatheterPlacement Date: 12/18/25; Placement Time: 1336; Inserted by: Andy RN; Type: Non-latex, Straight-tip, Temperature probe; Balloon Size: 10 mL; Urine Returned: Yes; Removal Date: 12/18/25; Removal Time: 1543; Removal Reason: Discontinued in OR12/18/25 1336 by Boehmer, Natalie Nicole, RN12/18/25 1543 by Boehmer, Natalie Nicole, RNETTPlacement Date: 12/18/25; Placement Time: 1405 (created via procedure documentation); Mask Ventilation: 1; Technique: Video laryngoscopy; Type: ETT - single; Single Lumen Tube Size: 7.5 mm; Cuffed: Yes; Laryngoscope: Macintosh; Blade Size: 4; Location: Oral; Insertion Attempts: 1; Placement Verification: Auscultation; Removal Date: 12/18/25; Removal Time: 155112/18/25 1405 by Maxey, Lucas Aaron, CRNA12/18/25 1551 by Maxey, Lucas Aaron, CRNAArterial LinePlacement Date: 12/18/25; Placemnt Time: 1405 (created via procedure documentation); Size: 20 G; Orientation: Left; Location: Radial; Removal Date: 12/18/25; Removal Time: 170912/18/25 1405 by Maxey, Lucas Aaron, CRNA12/18/25 1709 by Tabor, Caroline Eleanore, RNPeripheral IVPlacement Date: 12/18/25; Placement Time: 1405 (created via procedure documentation); Catheter Size: 14 G ; Orientation: Right; Location: Forearm; Site Prep: Alcohol; Insertion Attempts: 1; Removal Date: 12/19/25; Removal Time: 1001; Removal Reason: Discharge12/18/25 1405 by Maxey, Lucas Aaron, CRNA12/19/25 1001 by Evjen, Sofia Amanda, RNdocumented in this encounter

Assessment

Type: Assessment

Source: athena_sihf

Encounter Date Assessment Date Assessment LastModified by Organization Details LastModified Time

10/27/2025 10/27/2025

MEDICAL HISTORY: Colon cancer - stave 4. Anemia. Hypothyroidism. Renal impairment.

CURRENT ASSESSMENT:

On intake, patient presents with established treatment and no mood complaints, although does endorse some anxiety when he considers mortality. States he was given 1 year to live 1.5 years ago.

Patient currently completing PhD in computer science. Denies history of hospitalization or adverse life events.

RISK/SAFETY:

Denies SIHISIB, endorses having many things to accomplish, AVH, new or increased use of substance of abuse.

Endorses history of alcohol use in remission since 2015.

MEDICATION MANAGEMENT:

  • continue Lorazepam 0.5mg PO daily PRN for breakthrough anxiety.

Zolpidem 5mg tablet PO daily PRN for sleep.

VITALS: UTA

LABS: 4/2025

  • UDS: 10/28/25

REFERRALS: none

PLAN/DISCUSSION: continue current treatment plan

Discussed with patient plan to take over medications once UDS complete. Patient will present to clinic for UDS. Will continue treatment

Patient is encouraged to adhere to prescribed medication regimen to ensure optimal efficacy. Patient advised to contact provider before discontinuing any medication, particularly if adverse symptoms occur.

Psychoeducation and brief supportive counseling were provided.

Encouraged engagement with therapy; referrals will be made if necessary

Encouraged to follow up with medical provider if necessary

Discussed importance of nutrition, exercise, and sleep hygiene.

Discussed r/b, side effects, alternatives of _____, or choice to forgo pharmacological treatment with patient. Patient agreed to start trial.

CONSENT: Patient was given opportunity to ask questions and has verbally consented to the current treatment plan and any recommended changes.

Encouraged to seek care at ED if SI/HI with plan/intent develops or to call office if symptoms worsen


RELEVANT HISTORY:

nbennett54 Not available 10/29/2025 22:52:17

11/25/2025 11/25/2025

MEDICAL HISTORY: Colon cancer - stave 4. Anemia. Hypothyroidism. Renal impairment.

CURRENT ASSESSMENT:

11/25/25 - Patient presents with no pervasive mood concern.

RELEVANT HISTORY

On intake, patient presents with established treatment and no mood complaints, although does endorse some anxiety when he considers mortality. States he was given 1 year to live 1.5 years ago.

Patient currently completing PhD in computer science. Denies history of hospitalization or adverse life events. Discussed with patient plan to take over medications once UDS complete. Patient will present to clinic for UDS. Will continue treatment

Assessments

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Anemia

acute

History of colon cancer

acute

Small bowel obstruction

acute

Status post partial resection of colon

acute

History of colon cancer

acute

Iron deficiency anemia

acute

Status post partial resection of colon

acute

History of colon cancer

acute

Ileum ulcer

acute

Iron deficiency anemia

acute

Adenocarcinoma of small bowel

acute

Anemia

acute

History of colon cancer

acute

Status post partial resection of colon

acute

Adenocarcinoma of small bowel

acute

Anemia

acute

Colon cancer

acute

History of colon cancer

acute

Status post partial resection of colon

acute

Adenocarcinoma of small bowel

acute

Assessments — 2021-12-29

Date: 2021-12-29

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Anemia

acute

Anemia

acute

BMI 31.0-31.9,adult

acute

Dysplasia of colon

acute

Mass of colon

acute

Mass of colon

acute

Assessments — 2022-02-01

Date: 2022-02-01

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Anemia

acute

Anemia

acute

BMI 31.0-31.9,adult

acute

Dysplasia of colon

acute

Mass of colon 2021

acute

BMI 31.0-31.9,adult

acute

Iron deficiency anemia

acute

Mass of colon 2021

acute

BMI 31.0-31.9,adult

acute

Colon cancer metastasized to intra-abdominal lymph node

acute

Encounter for surgical aftercare following surgery on the digestive system

acute

Assessments — 2022-02-08

Date: 2022-02-08

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Anemia

acute

Anemia

acute

BMI 31.0-31.9,adult

acute

Dysplasia of colon

acute

Mass of colon 2021

acute

BMI 31.0-31.9,adult

acute

Iron deficiency anemia

acute

Mass of colon 2021

acute

BMI 31.0-31.9,adult

acute

Colon cancer metastasized to intra-abdominal lymph node

acute

Encounter for surgical aftercare following surgery on the digestive system

acute

Assessments — 2022-02-09

Date: 2022-02-09

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Anemia

acute

Anemia

acute

BMI 31.0-31.9,adult

acute

Dysplasia of colon

acute

Mass of colon 2021

acute

BMI 31.0-31.9,adult

acute

Iron deficiency anemia

acute

Mass of colon 2021

acute

BMI 31.0-31.9,adult

acute

Colon cancer metastasized to intra-abdominal lymph node

acute

Encounter for surgical aftercare following surgery on the digestive system

acute

Assessments — 2022-03-16

Date: 2022-03-16

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

BMI 31.0-31.9,adult

acute

Iron deficiency anemia

acute

Mass of colon 2021

acute

BMI 31.0-31.9,adult

acute

Colon cancer metastasized to intra-abdominal lymph node

acute

Encounter for surgical aftercare following surgery on the digestive system

acute

Assessments — 2022-05-16

Date: 2022-05-16

Type: Assessments

Source: meditech_anderson

No assessment information available

Assessments — 2024-05-08

Date: 2024-05-08

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Encounter for removal of vascular catheter

acute

Colon cancer metastasized to intra-abdominal lymph node

chronic

Anemia

acute

History of colon cancer

acute

Small bowel obstruction

acute

Status post partial resection of colon

acute

Assessments — 2024-07-01

Date: 2024-07-01

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Encounter for removal of vascular catheter

acute

Colon cancer metastasized to intra-abdominal lymph node

chronic

Anemia

acute

History of colon cancer

acute

Small bowel obstruction

acute

Status post partial resection of colon

acute

History of colon cancer

acute

Iron deficiency anemia

acute

Status post partial resection of colon

acute

History of colon cancer

acute

Ileum ulcer

acute

Iron deficiency anemia

acute

Adenocarcinoma of small bowel

acute

Anemia

acute

History of colon cancer

acute

Status post partial resection of colon

acute

Adenocarcinoma of small bowel

acute

Anemia

acute

Colon cancer

acute

History of colon cancer

acute

Status post partial resection of colon

acute

Assessments — 2024-07-22

Date: 2024-07-22

Type: Assessments

Source: meditech_anderson

Diagnosis Onset Date Resolution Status

Anemia

acute

History of colon cancer

acute

Small bowel obstruction

acute

Status post partial resection of colon

acute

History of colon cancer

acute

Iron deficiency anemia

acute

Status post partial resection of colon

acute

History of colon cancer

acute

Ileum ulcer

acute

Iron deficiency anemia

acute

Adenocarcinoma of small bowel

acute

Anemia

acute

History of colon cancer

acute

Status post partial resection of colon

acute

Adenocarcinoma of small bowel

acute

Anemia

acute

Colon cancer

acute

History of colon cancer

acute

Status post partial resection of colon

acute

Adenocarcinoma of small bowel

acute

Chief Complaint and Reason for Visit

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint SBO, Hx colon CA s/p partial colectomyMalignant neoplasm of colon, unspecifiedAbnormal Imaging of abdomen, Pers.Hx. Col CASmall bowel obstructionColorectal cancerSm Bowel Ca / Surg 7-01small bowel catreatmentTesting 07-22-2024malig neoplasm of colon

Reason for Visit AnemiaHistory of colon cancerSmall bowel obstructionStatus post partial resection of colonHistory of colon cancerIron deficiency anemiaStatus post partial resection of colonHistory of colon cancerIleum ulcerIron deficiency anemiaAdenocarcinoma of small bowelAnemiaHistory of colon cancerStatus post partial resection of colonAdenocarcinoma of small bowelAnemiaColon cancerHistory of colon cancerStatus post partial resection of colonAdenocarcinoma of small bowel

Chief Complaint and Reason for Visit — 2021-12-29

Date: 2021-12-29

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint Occult blood in stooloccult GI bleed, Anemiad50.9/k63.89Abdominal complaintsIron defincy anemialeft colon mass 12-29left colon mass

Reason for Visit AnemiaAnemiaBMI 31.0-31.9,adultDysplasia of colonMass of colonMass of colon

Chief Complaint and Reason for Visit — 2022-02-01

Date: 2022-02-01

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint Occult blood in stooloccult GI bleed, Anemiad50.9/k63.89Abdominal complaintsIron defincy anemialeft colon mass 12-29left colon massRoutine post-operative visitMalignant neoplasm of sigmoid colon

Reason for Visit AnemiaAnemiaBMI 31.0-31.9,adultDysplasia of colonMass of colonBMI 31.0-31.9,adultIron deficiency anemiaMass of colonBMI 31.0-31.9,adultColon cancer metastasized to intra-abdominal lymph nodeEncounter for surgical aftercare following surgery on the digestive system

Chief Complaint and Reason for Visit — 2022-02-08

Date: 2022-02-08

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint Occult blood in stooloccult GI bleed, Anemiad50.9/k63.89Abdominal complaintsIron defincy anemialeft colon mass 12-29left colon massRoutine post-operative visitMalignant neoplasm of sigmoid colonPRE-OP TESTING 2/9

Reason for Visit AnemiaAnemiaBMI 31.0-31.9,adultDysplasia of colonMass of colonBMI 31.0-31.9,adultIron deficiency anemiaMass of colonBMI 31.0-31.9,adultColon cancer metastasized to intra-abdominal lymph nodeEncounter for surgical aftercare following surgery on the digestive system

Chief Complaint and Reason for Visit — 2022-02-09

Date: 2022-02-09

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint Occult blood in stooloccult GI bleed, Anemiad50.9/k63.89Abdominal complaintsIron defincy anemialeft colon mass 12-29left colon massRoutine post-operative visitMalignant neoplasm of sigmoid colonPRE-OP TESTING 2/9Malignant neoplasm of sigmoid colon

Reason for Visit AnemiaAnemiaBMI 31.0-31.9,adultDysplasia of colonMass of colonBMI 31.0-31.9,adultIron deficiency anemiaMass of colonBMI 31.0-31.9,adultColon cancer metastasized to intra-abdominal lymph nodeEncounter for surgical aftercare following surgery on the digestive system

Chief Complaint and Reason for Visit — 2022-03-16

Date: 2022-03-16

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint left colon mass 12-29left colon massRoutine post-operative visitMalignant neoplasm of sigmoid colonPRE-OP TESTING 2/9Malignant neoplasm of sigmoid colontreatment

Reason for Visit BMI 31.0-31.9,adultIron deficiency anemiaMass of colonBMI 31.0-31.9,adultColon cancer metastasized to intra-abdominal lymph nodeEncounter for surgical aftercare following surgery on the digestive system

Chief Complaint and Reason for Visit — 2022-05-16

Date: 2022-05-16

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint oncologist sent - diarrhea since mondaytreatment

Chief Complaint and Reason for Visit — 2024-05-08

Date: 2024-05-08

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint Malignant neoplasm of sigmoid colonPort-A-Cath no longer neededtreatmentSBO, Hx colon CA s/p partial colectomy

Reason for Visit Encounter for removal of vascular catheterColon cancer metastasized to intra-abdominal lymph nodeAnemiaHistory of colon cancerSmall bowel obstructionStatus post partial resection of colon

Chief Complaint and Reason for Visit — 2024-07-01

Date: 2024-07-01

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint Port-A-Cath no longer neededSBO, Hx colon CA s/p partial colectomyMalignant neoplasm of colon, unspecifiedtreatmentAbnormal Imaging of abdomen, Pers.Hx. Col CASmall bowel obstructionColorectal cancerSm Bowel Ca / Surg 7-01small bowel ca

Reason for Visit Encounter for removal of vascular catheterColon cancer metastasized to intra-abdominal lymph nodeAnemiaHistory of colon cancerSmall bowel obstructionStatus post partial resection of colonHistory of colon cancerIron deficiency anemiaStatus post partial resection of colonHistory of colon cancerIleum ulcerIron deficiency anemiaAdenocarcinoma of small bowelAnemiaHistory of colon cancerStatus post partial resection of colonAdenocarcinoma of small bowelAnemiaColon cancerHistory of colon cancerStatus post partial resection of colon

Chief Complaint and Reason for Visit — 2024-07-22

Date: 2024-07-22

Type: Chief Complaint and Reason for Visit

Source: meditech_anderson

Chief Complaint SBO, Hx colon CA s/p partial colectomyMalignant neoplasm of colon, unspecifiedAbnormal Imaging of abdomen, Pers.Hx. Col CASmall bowel obstructionColorectal cancerSm Bowel Ca / Surg 7-01small bowel catreatmentTesting 07-22-2024malig neoplasm of colon

Reason for Visit AnemiaHistory of colon cancerSmall bowel obstructionStatus post partial resection of colonHistory of colon cancerIron deficiency anemiaStatus post partial resection of colonHistory of colon cancerIleum ulcerIron deficiency anemiaAdenocarcinoma of small bowelAnemiaHistory of colon cancerStatus post partial resection of colonAdenocarcinoma of small bowelAnemiaColon cancerHistory of colon cancerStatus post partial resection of colonAdenocarcinoma of small bowel

Consultation Note — 2024-05-08

Date: 2024-05-08

Type: Consultation Note

Source: meditech_anderson

Author Pei ChungAnderson HealthcareMay 9th, 2024 9:58am

Note Date/Time May 8th, 2024 12:12pm

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 General Surgery Consult Note SignedPatient: Towell,Alexander R MR#: M000499848 DOB: 08/04/1975 Acct:V00003663948Age: 48 ADM Date: 05/08/24 Loc: ANH3MEDSUR 327-01 Attending Dr: Pei Chang Chung M.D.cc: Chung, Pei Chang MD; Gaudreault, Rachel N. PA-C; Suthan***, Nanthini MD~this was entered in error, as I already completed a history and physicalHistory of Present IllnessConsult detailsConsult date: 05/08/24Reason for consult: abdominal painPMFSHPast Medical HistoryMedical History (Reviewed 05/07/24 @ 21:08 by Rachel N. Gaudreault, PA-C)Colon cancerIron deficiency anemia (Unknown)Mass of colon (~12/2021)ObesitySurgical HistorySurgical History (Reviewed 05/07/24 @ 21:08 by Rachel N. Gaudreault, PA-C)History of colon resection 12/29/2021 - hand assisted laparoscopic sigmoid colectomy with mobilization of the splenic flexureHistory of partial thyroidectomyFamily HistoryFamily History (Updated 05/08/24 @ 02:31 by Abby E. Scanzoni, RN)Father Hypertension Malignant neoplasm of prostateMother Deceased COPD (chronic obstructive pulmonary disease)Social HistorySocial History (Reviewed 05/07/24 @ 21:08 by Rachel N. Gaudreault, PA-C)Smoking status: Never smoker Second hand tobacco smoke exposure: No Alcohol intake: never Drinks per week: 1 Alcohol use details: LAST DRINK 2015 Substance use: never Substance use type: does not use Do You Feel Safe in your Home?: Yes Lack of Transportation: No Lack of Food: Never True Current Housing: I Have Housing Concerned About Future Housing: No Difficulty Paying Gas/Electric Bills: No Difficulty Paying for Meds: No Currently Unemployed: No Education: Master’s Degree or Higher Difficulty w/ Childcare or Family Care: No Living arrangements: with family Additional living arrangements comments: LIVES WITH SIGNIFICANT OTHER Spiritual care concerns: No MedsHome Medications and Allergies Home Medications Medication Instructions Recorded Confirmed Typecholecalciferol (vitamin D3) 25 25 mcg PO DAILY 01/12/24 05/08/24 Historymcg (1,000 unit) tablet (Vitamin D3) levothyroxine 100 mcg tablet 100 mcg PO DAILY 01/12/24 05/08/24 Historymultivitamin with minerals-folic 1 tablet PO DAILY 01/12/24 05/08/24 Historyacid 200 mcg chewable tablet (Adult Multivitamin Gummies) AllergiesAllergy/AdvReac Type Severity Reaction Status Date / TimeNo Known Allergies Allergy Verified 05/08/24 02:36Vital Signs Vital Signs - 24 hr 05/07/2420:12 05/07/2420:12 05/07/2422:58Temperature 37.1 C 37.1 C Pulse Rate 72 76 61Respiratory Rate 17 19 18Blood Pressure 143/76 H 143/76 H 123/68Pulse Oximetry 100 100 98Oxygen Delivery Room Air 05/08/2401:00 05/08/2402:26 05/08/2406:00Temperature 36.4 C 36.4 CPulse Rate 66 62 70Respiratory Rate 18 16 16Blood Pressure 137/76 149/80 H 132/72Pulse Oximetry 100 98 100Oxygen Delivery 05/08/2408:25Temperature Pulse Rate Respiratory Rate Blood Pressure Pulse Oximetry Oxygen Delivery Room AirResultsLabs 05/07/24 21:05 05/07/24 21:05 Labs: Abnormal lab results 05/07/24 Range/Units 21:05 RBC 4.38 L (4.6-6.20) M/mm3Hgb 11.5 L (14.0-18.0) g/dLHct 35.5 L (42.0-52.0) %MPV 10.8 H (7.4-10.4) flCarbon Dioxide 20 L (22-30) mmol/LBUN 25 H (9-20) mg/dLUr Specific Gravity 1.092 H (1.001-1.035) Urine Ketones 1+ H (Negative) mg/dL Diabetes panel 05/07/24 Range/Units 21:05 Sodium 139 (137-145) mmol/LPotassium 3.6 (3.4-5.0) mmol/LChloride 107 (98-107) mmol/LCarbon Dioxide 20 L (22-30) mmol/LBUN 25 H (9-20) mg/dLCreatinine 1.30 (0.7-1.3) mg/dLGlucose 93 (65-110) mg/dLCalcium 9.2 (8.4-10.2) mg/dLAST 24 (17-59) U/LALT 15 (6-50) U/LAlkaline Phosphatase 85 (38-126) U/LTotal Protein 8.0 (6.3-8.2) g/dLAlbumin 4.7 (3.5-5.1) g/dL Calcium panel 05/07/24 Range/Units 21:05 Calcium 9.2 (8.4-10.2) mg/dLAlbumin 4.7 (3.5-5.1) g/dL Pituitary panel 05/07/24 Range/Units 21:05 Sodium 139 (137-145) mmol/LPotassium 3.6 (3.4-5.0) mmol/LChloride 107 (98-107) mmol/LCarbon Dioxide 20 L (22-30) mmol/LBUN 25 H (9-20) mg/dLCreatinine 1.30 (0.7-1.3) mg/dLGlucose 93 (65-110) mg/dLCalcium 9.2 (8.4-10.2) mg/dL Adrenal panel 05/07/24 Range/Units 21:05 Sodium 139 (137-145) mmol/LPotassium 3.6 (3.4-5.0) mmol/LChloride 107 (98-107) mmol/LCarbon Dioxide 20 L (22-30) mmol/LBUN 25 H (9-20) mg/dLCreatinine 1.30 (0.7-1.3) mg/dLGlucose 93 (65-110) mg/dLCalcium 9.2 (8.4-10.2) mg/dLTotal Bilirubin 0.5 (0.2-1.3) mg/dLAST 24 (17-59) U/LALT 15 (6-50) U/LAlkaline Phosphatase 85 (38-126) U/LTotal Protein 8.0 (6.3-8.2) g/dLAlbumin 4.7 (3.5-5.1) g/dLAll other labs normal.This report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical,spelling, and recognition errors present.Report Initialized date/time: Chung, Pei Chang MD 05/08/24 / 1212Electronically signed by: Chung, Pei Chang MD 05/09/24 0958

Discharge Summaries — 2025-05-14

Date: 2025-05-14

Type: Discharge Summaries

Source: epic_ihe_xdm

Mallory Hubbard, PA - 05/15/2025 8:55 AM CDTFormatting of this note is different from the original.Inpatient Discharge SummaryBRIEF OVERVIEWAdmitting Provider: William Cavanaugh Chapman, MDDischarge Provider: Chapman, William Cavanaugh, MDPrimary Care Physician at Discharge: Beard, Kelsey Michelle, NP 618-463-0689 Admission Date: 5/14/2025 Discharge Date: 5/15/2025Admission Location: Barnes Jewish HospitalHospital Problems/Diagnoses:Principal Problem: Metastatic colon cancer to liver (HCC)Active Problems: Metastasis to liver (HCC)Resolved Problems:No resolved hospital problems.DETAILS OF HOSPITAL STAYPresenting Problem/History of Present Illness:Mr. Alexander R Towell is a 49 y.o. male with history of metastatic colorectal cancer the liver. Presenting for surgical consultation accompanied by his girlfriend, Kimberly. He was diagnosed with sigmoid colon cancer status post laparoscopic sigmoid colectomy in 12/29/2021. He was recurrence free until three years later, his recurrence was in the terminal ileum status post right hemicolectomy in 7/1/2024, pathology notable for ileal adenocarcinoma. Last colonoscopy was 2 months ago which was normal. He was first seen in our clinic and reviewed at liver multidisciplinary conference in 10/2024. > Findings: PET (july)- 4 areas of FDG uptake in the liver, very focal. 2 in left hemiliver 1 near segment 7 + 1 near the dome. MRI (aug)- treatment response with smaller lesions, only see 3 lesions. Pelvic disease is treated. >

Plan: Consider left lateral resection versus ablationHospital Course:The patient was taken to the OR on 5/14 for a robotic segment 2 resection (small wedge). For details of the operation, please see the OP note in Epic.Surgeons and Role: * Chapman, William Cavanaugh, MD - Primary>Post operative pain controlled with PO pain mediations.>Foley catheter was removed without incident.>No surgical drain utilized. PT/OT evaluated while inpatient and recommend home.The patient was discharged home in stable condition on 5/15.Scripts: Oxycodone 5mg #15, robaxinFollow-up:No future appointments. > surgical follow up in 2 weeks, appointment has been requestedTest Results Pending at Discharge:Pending Labs Order Current Status Surgical pathology In process Operative Procedures Performed:Procedure(s):XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED, TAP BlockDischarge DetailsPhysical Exam at Discharge:Discharge Condition: goodPulse: 60Resp: 17BP: 121/80Temp: 36.5 °C (97.7 °F)Weight: 97.9 kg (215 lb 14.4 oz)Pertinent Exam Findings at Discharge: dermabond CDIDischarge Disposition:Patient will be discharged to:home Code Status at Discharge: FULLDischarge Instructions:Instructions For Hepatobiliary Surgery Patients: Call 911 or go to your local emergency room if: You have bleeding from your incision that worries you. You have chest pain. You feel like you can’t catch your breath. You faint or pass out. Call Your Doctor If: You have a fever of 101.5 F degrees or higher. It is hard for you to urinate. You have nausea, vomiting or diarrhea. If you have bright red blood or bad smelling drainage from your incision sites. You have any questions about your medications. You have belly pain that is getting worse. Your incision is red or swollen. Your eyes appear yellow; you have clay-colored stool, dark urine, and/or persistent itching. These can be a signs of a problem with your liver. If you are sent home with a drain, call if there is a sudden change in your abdominal drain output or color. If you need to talk with a doctor after regular hours or on weekends; please call your doctor’s office. The voicemail will give you directions on how to reach the on call doctor for an emergency. Do NOT leave a message on the voice mail. These messages will not be heard until the next business day. Office of Dr. Chapman: (314) 362-2538Diet:Regular Diet as toleratedActivity:You may perform activities as you feel up to it. Do NOT lift anything over 10 pounds for 6 weeks. This includes babies and pets.Do NOT drive while taking narcotic pain medicine. It is very important to stay active. Take several short walks each day.Care Instructions:You may take showers. Pat wounds dry. Do not rub.Keep your incision site dry and clean. Do NOT take tub baths, go swimming or use a hot tub until approved by your doctor. It is normal to feel very tired for several weeks after surgery. It’s ok to rest as needed.Follow Up:You will need to follow up with your Primary Care Doctor in 1-2 weeks. It is VERY important to let your doctor know if any changes were made to your medications while you were in the hospital.Discharge Medications:Current Medications TAKE these medications acetaminophen 500 mg capsuleTake 2 capsules (1,000 mg total) by mouth every 6 (six) hours as needed for painFor: painaspirin 325 mgTake 1 tablet (325 mg total) by mouth every 6 (six) hours as needed for pain or headachesFor: paincyanocobalamin 100 mcg tabletTake 1 tablet (100 mcg total) by mouth early morning before breakfastFor: prevention of vitamin B12 deficiencyCommonly known as: Vitamin B-12docusate sodium 100 mg capsuleTake 1 capsule (100 mg total) by mouth 2 (two) times a day as needed for constipationFor: constipationCommonly known as: COLACEfluticasone propionate 50 mcg/actuation nasal sprayAdminister 1 spray into each nostril daily as needed for rhinitisFor: inflammation of the nose due to an allergyCommonly known as: FLONASEiron bisgly,ps-FA-B-C#12-succ 65 mg-65 mg -1,000 mcg (24) tabletTake 1 tablet by mouth 3 (three) times a weekFor: anemia from inadequate ironlevothyroxine 112 mcg tabletTake 1 tablet (112 mcg total) by mouth early morning before breakfastFor: a condition with low thyroid hormone levelsCommonly known as: SYNTHROIDloperamide 2 mg tabletTake 1 tablet (2 mg total) by mouth 4 (four) times a day as needed for diarrheaFor: diarrhea caused by chemotherapyCommonly known as: IMODIUM A-DLORazepam 0.5 mg tabletTake 1 tablet (0.5 mg total) by mouth every 8 (eight) hours as needed for anxietyFor: anxiousCommonly known as: ATIVANmethocarbamoL 500 mg tabletTake 1 tablet (500 mg total) by mouth 3 (three) times a day as needed for muscle spasmsCommonly known as: ROBAXINmultivitamin with minerals tabletTake 1 tablet by mouth daily with dinnerFor: treatment to prevent mineral deficiency, treatment to prevent vitamin deficiencyomega-3 fatty acids-fish oil 300-1,000 mg capsuleTake 2 capsules (2 g total) by mouth daily with dinnerFor: supplementSUMAtriptan 50 mg tabletTake 1 tablet (50 mg total) by mouth once as needed for migraineFor: a migraine headacheCommonly known as: IMITREXzolpidem 5 mg tabletTake 1 tablet (5 mg total) by mouth nightly as needed for sleepFor: difficulty falling asleepCommonly known as: AMBIENOutpatient Follow-Up:Cosigned by William Chapman, MD at 05/15/2025 12:23 PM CDTElectronically signed by Mallory Hubbard, PA at 05/15/2025 8:56 AM CDTElectronically signed by William Chapman, MD at 05/15/2025 12:23 PM CDTdocumented in this encounter

Discharge Summaries — 2025-12-18

Date: 2025-12-18

Type: Discharge Summaries

Source: epic_ihe_xdm

Michael Bryant, NP - 12/19/2025 9:36 AM CSTFormatting of this note is different from the original.Inpatient Discharge SummaryBRIEF OVERVIEWAdmitting Provider: William Cavanaugh Chapman, MDDischarge Provider: No att. providers foundPrimary Care Physician at Discharge: Beard, Kelsey Michelle, NP 618-258-0485 Admission Date: 12/18/2025 Discharge Date: 12/19/2025Admission Location: Barnes Jewish HospitalHospital Problems/Diagnoses:Principal Problem: Metastatic colon cancer to liverResolved Problems:No resolved hospital problems.DETAILS OF HOSPITAL STAYPresenting Problem/History of Present Illness:Mr. Towell is a 50 y.o. male with a history of sigmoid adenocarcinoma, metastatic terminal ileum adenocarcinoma to the liver s/p segment 2 hepatic resection in 5/2025 with two new lesions concerning for metastasis in segment 8. He returns to discuss repeat hepatic resection. He recovered very well after XI hepatic resection without complications. He continues chemotherapy with Dr. Tan, with last treatment 3 weeks ago. Surveillance MRI 11/9 showed 2 new lesions, 1.2 and 0.6 cm, followed by PET scan with very slight uptake.He feels wells overall, good appetite, no weight loss. Hospital Course:The patient was taken to the OR for a Procedure(s) (LRB):XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED SEGMENT 5 8 and 4B, INTRAOPERATIVE ULTRASOUND and TAP BLOCK (N/A) on 12/18/2025. For details of the operation, please see the OP note in Epic. * Chapman, William Cavanaugh - Primary * Godfrey, Caroline Marie - Fellow>Post operative pain controlled with PO pain mediations.>Foley catheter was removed without incident.>Patient diet was advanced as tolerated on POD 1 passing gas, no BM. >A post-operative visit with the office of Dr. Chapman has been scheduled for 12/29. The patient was discharged to home in stable condition on 12/19, no need for home health skilled services.Scripts: Oxycodone #10, Gabapentin for 14 days, Robaxin for 14 days, OTC; Acetaminophen, Lidocaine patches, senna-docusate, Follow-up:Future Appointments Date Time Provider Department Center 12/29/2025 9:30 AM Martens, Gregory, MD PhD TXP CAM 12B SU Test Results Pending at Discharge:Pending Labs Order Current Status Surgical pathology Collected (12/18/25 1454) Operative Procedures Performed:Procedure(s):XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED SEGMENT 5 8 and 4B, INTRAOPERATIVE ULTRASOUND and TAP BLOCKDischarge DetailsPhysical Exam at Discharge:Discharge Condition: goodPulse: 50Resp: 18BP: 108/59Temp: 36.6 °C (97.8 °F)Weight: 102.1 kg (225 lb)Pertinent Exam Findings at Discharge: Patient discharged with robotic surgical sites approximated with derma bond C/D/I. Implanted Port de-accessed at Discharge. Discharge Disposition:Patient will be discharged to:home Code Status at Discharge: FULL CODEDischarge Instructions:Instructions For Hepatobiliary Surgery Patients: Call 911 or go to your local emergency room if: You have bleeding from your incision that worries you. You have chest pain. You feel like you can’t catch your breath. You faint or pass out. Call Your Doctor If: You have a fever of 101.5 F degrees or higher. It is hard for you to urinate. You have nausea, vomiting or diarrhea. If you have bright red blood or bad smelling drainage from your incision sites. You have any questions about your medications. You have belly pain that is getting worse. Your incision is red or swollen. Your eyes appear yellow; you have clay-colored stool, dark urine, and/or persistent itching. These can be a signs of a problem with your liver. If you are sent home with a drain, call if there is a sudden change in your abdominal drain output or color. If you need to talk with a doctor after regular hours or on weekends; please call your doctor’s office. The voicemail will give you directions on how to reach the on call doctor for an emergency. Do NOT leave a message on the voice mail. These messages will not be heard until the next business day. Office of Dr. Chapman: (314) 362-2538Diet:Regular Diet as toleratedActivity:You may perform activities as you feel up to it. Do NOT lift anything over 10 pounds for 6 weeks. This includes babies and pets.Do NOT drive while taking narcotic pain medicine. It is very important to stay active. Take several short walks each day.Care Instructions:You may take showers. Pat wounds dry. Do not rub.Keep your incision site dry and clean. Do NOT take tub baths, go swimming or use a hot tub until approved by your doctor. It is normal to feel very tired for several weeks after surgery. It’s ok to rest as needed.Follow Up:You will need to follow up with your Primary Care Doctor in 1-2 weeks. It is VERY important to let your doctor know if any changes were made to your medications while you were in the hospital.Discharge Medications:Current Medications PAUSE taking these medications loperamide 2 mg tabletWait to take this until your doctor or other care provider tells you to start again.Take 1 tablet (2 mg total) by mouth 4 (four) times a day as needed for diarrheaFor: diarrhea caused by chemotherapyCommonly known as: IMODIUM A-Dprochlorperazine 10 mg tabletWait to take this until your doctor or other care provider tells you to start again.Defer to prescriber. Take 1 tablet (10 mg total) by mouth 3 (three) times a day as needed for nauseaFor: nausea and vomiting caused by cancer drugsCommonly known as: COMPAZINEzolpidem 5 mg tabletWait to take this until your doctor or other care provider tells you to start again.Do not take while taking narcotic pain medication. Take 1 tablet (5 mg total) by mouth nightly as needed for sleepFor: difficulty falling asleepCommonly known as: AMBIENTAKE these medications acetaminophen 500 mg capsuleTake 2 capsules (1,000 mg total) by mouth every 6 (six) hoursFor: paincetirizine 10 mg tabletTake 1 tablet (10 mg total) by mouth daily as needed for allergies or rhinitisCommonly known as: ZyrTECdocusate sodium 100 mg capsuleTake 1 capsule (100 mg total) by mouth 2 (two) times a day as needed for constipationCommonly known as: COLACEgabapentin 100 mg capsuleTake 1 capsule (100 mg total) by mouth 2 (two) times a dayCommonly known as: NEURONTINlevothyroxine 125 mcg tabletTake 1 tablet (125 mcg total) by mouth early morning before breakfastFor: a condition with low thyroid hormone levelsCommonly known as: SYNTHROIDlidocaine 5 %Place 1 patch on the skin daily for 12 hours Remove & discard patch(es) within 12 hours or as directed by MDCommonly known as: LIDODERMLORazepam 0.5 mg tabletTake 1 tablet (0.5 mg total) by mouth every 8 (eight) hours as needed for anxietyCommonly known as: ATIVANmethocarbamoL 500 mg tabletTake 2 tablets (1,000 mg total) by mouth 3 (three) times a day for 14 daysCommonly known as: ROBAXINmultivitamin with minerals tabletTake 1 tablet by mouth early morning before breakfastoxyCODONE 5 mg immediate release tabletTake 1 tablet (5 mg total) by mouth every 6 (six) hours as needed for painFor: painCommonly known as: ROXICODONEpropranoloL 20 mg tabletTake 1 tablet (20 mg total) by mouth early morning before breakfastCommonly known as: INDERALsenna-docusate 8.6-50 mgTake 1 tablet by mouth daily as needed for constipationCommonly known as: PERICOLACEOutpatient Follow-Up:Future Appointments Date Time Provider Department Center 12/29/2025 9:30 AM Martens, Gregory, MD PhD TXP CAM 12B SU Cosigned by William Chapman, MD at 12/19/2025 3:55 PM CSTElectronically signed by Michael Bryant, NP at 12/19/2025 11:17 AM CSTElectronically signed by William Chapman, MD at 12/19/2025 3:55 PM CSTdocumented in this encounter

Discharge Summary Note — 2024-05-08

Date: 2024-05-08

Type: Discharge Summary Note

Source: meditech_anderson

Author Pei ChungAnderson HealthcareMay 9th, 2024 9:57am

Note Date/Time May 9th, 2024 9:57am

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 Discharge Summary SignedPatient: Towell,Alexander R MR#: M000499848 DOB: 08/04/1975 Acct:V00003663948Age: 48 ADM Date: 05/08/24 Loc: ANH3MEDSUR 327-01 Attending Dr: Pei Chang Chung M.D.cc: Chung, Pei Chang MD; Gaudreault, Rachel N. PA-C; Suthan***, Nanthini MD~DS: Admitting DiagnosisDischarge Date5/9/2024Admitting Diagnosis Small-bowel obstructionDS: Discharge DiagnosisDischarge Diagnosis(1) Small bowel obstruction: Code(s):K56.609 - Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction Status: Acute Assessment and

Plan: resolved, small-bowel series normal, tolerating diet, exam benign, follow-up 2 weeks post discharge(2) History of colon cancer: Code(s):Z85.038 - Personal history of other malignant neoplasm of large intestine Status: Acute Assessment and

Plan: status post sigmoid colectomy and adjuvant chemotherapy, doing well, follow-up with OncologyDS: SummaryHospital CourseReason for hospitalization: small-bowel obstructionHospital Course: The patient is a 48-year-old male presenting from an outside hospital with a small-bowel obstruction. CT from outside hospital was significant for small bowel obstruction with transition point in the right lower quadrant. The patient was transferred to Anderson Hospital and admitted to the surgical service. Upon evaluation, conservative management with bowel rest and NG decompression was initiated. On hospital day 1., a small bowel series was ordered with water-soluble contrast through the NG tube. The small bowel serieswas noted to be unremarkable with noted passage within 15 minutes to the colon. Given these findings, the NG tube was clamped and subsequently removed. The patient was started on a clear liquid diet. On hospital day 2. , the patient was tolerating a clear liquid diet and his abdominal exam was benign. The patient reported multiple bowel movements after the small-bowel series. His diet was then advanced to a regular diet. He was able to tolerate a regular diet without issue and will now be discharged home. He will follow up with me in 2 weeks.Status at DischargeFunctional status at discharge: independent ambulationOverall status at discharge: patient is back to baselineTime Spent with PatientTime attestation: Total time spent providing and/or coordinating discharge services:Time spent: Less than 30 minutesExamConst: General: cooperative, comfortable and no acute distress Resp: Auscultation: clear to auscultation bilaterally Cardio: Rate: regular rate Rhythm: regular rhythm GI: Inspection: normal to inspection and non-distended GI Palp: No abdominal tenderness, Yes Soft to palpation and No Tenderness to palpation present (GI) Discharge PlanDischargeAttending physician on discharge: Chung,Pei Chang Consulting providers: Gaudreault,Rachel N.Discharging Clinician: Chung,Pei Chang Anticipated Discharge Date/Time: 05/09/24 14:00Patient Disposition: Home, Self-CareActivity: as toleratedDiet: as toleratedPatient Instructions: Antibiotic FormStand Alone Forms: General Discharge InformationFollow-up/Referrals:Chung,Pei Chang, MD [Physician] - 2 WeeksDischarge Medications:Continued levothyroxine 100 mcg tablet 100 mcg PO DAILY multivit with min-folic acid [Adult Multivitamin Gummies] 200 mcg Tablet,Chewable 1 tablet PO DAILY cholecalciferol (vitamin D3) [Vitamin D3] 25 mcg (1,000 unit) Tablet 25 mcg PO DAILY Date of admission: 05/08/24 09:11Primary Care Provider: Suthan***,NanthiniAdmitting Provider: Chung,Pei ChangAttending physician on admission: Chung,Pei ChangCondition: StableThis report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical,spelling, and recognition errors present.Report Initialized date/time: Chung, Pei Chang MD 05/09/24 / 0957Electronically signed by: Chung, Pei Chang MD 05/09/24 0957

Discharge Summary Note — 2024-07-01

Date: 2024-07-01

Type: Discharge Summary Note

Source: meditech_anderson

Author Kelsy WasmuthAnderson HealthcareJuly 3rd, 2024 4:37pm

Note Date/Time July 3rd, 2024 4:26pm

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 Discharge Summary SignedPatient: Towell,Alexnder R MR#: M000499848 DOB: 08/04/1975 Acct:V00003676858Age: 48 ADM Date: 07/01/24 Loc: ANH3MEDSUR 303-01 Attending Dr: Pei Chang Chung M.D.cc: Chung, Pei Chang MD; Suthan***, Nanthini MD~DS: Admitting DiagnosisDischarge Date07/03/2024Admitting DiagnosisIleal mass, adenocarcinomaStatus post partial colectomyAnemiaHistory of colon cancerDS: Discharge DiagnosisDischarge Diagnosis(1) Colon cancer: Code(s):C18.9 - Malignant neoplasm of colon, unspecified Status: Acute(2) Status post partial resection of colon: Code(s):Z90.49 - Acquired absence of other specified parts of digestive tract Status: Acute(3) History of colon cancer: Code(s):Z85.038 - Personal history of other malignant neoplasm of large intestine Status: Acute(4) Anemia: Qualifiers: Anemia type: unspecified type Qualified Code(s): D64.9 - Anemia, unspecified Code(s):D64.9 - Anemia, unspecified Status: AcuteDS: SummaryHospital CourseReason for hospitalization: This is a 48-year-old man who has a history of colon cancer status post hand assisted laparoscopic sigmoid colectomy in 2021. He underwent chemotherapy following surgery. Recently, in May of 2024, he was found to have a small-bowel obstruction on a CT scan. He then had a colonoscopy on 05/29/2024 with pathology coming back as moderately differentiated adenocarcinoma from a possible ileal mass. He was seen as an outpatient by Dr. Chung and decision wasmade to proceed with a hand assisted laparoscopic right colectomy. He presentedfor surgery on 07/01/2024.Hospital Course: He underwent hand assisted laparoscopic right colectomy with mobilization of hepatic flexure by Dr. Chung the on 07/01/2024. During surgery he was found to have a palpable mass in the terminal ileum with noted masses in the mesentery consistent with lymph node spread. He was admitted for monitoring and management postoperatively. His diet has slowly been advanced. He is tolerating a solid diet today. No nausea or vomiting. He is tolerating activity. Postoperative pain has been well controlled. Labs monitored postop day 1 and appeared stable. He was voiding independently without any issues. After discussing with Dr. Chung, the patient is stable for discharge postop day 2.Status at DischargeFunctional status at discharge: independent ambulationOverall status at discharge: patient is progressing back to baselineTime Spent with PatientTime attestation: Total time spent providing and/or coordinating discharge services:Time spent: Less than 30 minutesExamConst: General: comfortable and no acute distress Resp: Effort & Inspection: normal respiratory effort Auscultation: clear toauscultation bilaterally Cardio: Rate: regular rate Rhythm: regular rhythm GI: Inspection: non-distended and incision (incisions dry and intact) GI Palp: Yes Soft to palpation, Yes Tenderness to palpation present (GI) (incisional) and No Guarding due to palpation present (GI) Auscultation: normal bowel sounds Neuro: General: moves all extremities and no focal motor deficits Extrem: General: no calf tenderness and no edema Psych: Mental Status: mental status grossly normal Insight: Good insight present (Psych) DS: DataData Completed and PendingCompleted studies during hospitalization: Pending at discharge07/01/24 14:38Surgical [PTH] Routine Procedures/Treatments: Procedures Operation Date: 07/01/24 12:00Actual Procedure Side Surgeonp Hand Assisted Laparoscopic Right Colectomy Right Pei Chang Chung, MDImagingRadiologist’s impression: ITS ImpressionsAbdomen X-Ray 07/01/24 15:32

H&P Notes — 2025-05-14

Date: 2025-05-14

Type: H&P Notes

Source: epic_ihe_xdm

Deshka Foster, MD - 05/14/2025 10:37 AM CDTFormatting of this note might be different from the original.I have reviewed the H&P, examined the patient, and endorse the findings as written. Plan of Care : Based on the above findings, I consider Alexander R Towell to be an acceptable risk for : Procedure(s):XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTEDDeshka Foster, MD, PhDSurgery FellowCosigned by William Chapman, MD at 05/14/2025 11:14 AM CDTElectronically signed by Deshka Foster, MD at 05/14/2025 10:38 AM CDTElectronically signed by William Chapman, MD at 05/14/2025 11:14 AM CDTAssociated attestation - William Chapman, MD - 05/14/2025 11:14 AM CDTFormatting of this note might be different from the original.49 year old man with left lateral segment CRC metastasis, here for robotic liver resection. The patient and his family seem to understand the issues and agree with the plans.Source Note - Mallory Hubbard, PA - 04/30/2025 9:30 AM CDTFormatting of this note might be different from the original.Transplant/ Hepatobiliary Surgery Outpatient Clinic NoteChief Complaint: metastatic colorectal cancer to the liverReferred by: Benjamin R. Tan, MDHPI: Mr. Alexander R Towell is a 49 y.o. male with history of metastatic colorectal cancer the liver. Presenting for surgical consultation accompanied by his girlfriend, Kimberly. He was diagnosed with sigmoid colon cancer status post laparoscopic sigmoid colectomy in 12/29/2021. He was recurrence free until three years later, his recurrence was in the terminal ileum status post right hemicolectomy in 7/1/2024, pathology notable for ileal adenocarcinoma. Last colonoscopy was 2 months ago which was normal. He was first seen in our clinic and reviewed at liver multidisciplinary conference in 10/2024. > Findings: PET (july)- 4 areas of FDG uptake in the liver, very focal. 2 in left hemiliver 1 near segment 7 + 1 near the dome. MRI (aug)- treatment response with smaller lesions, only see 3 lesions. Pelvic disease is treated. >

Plan: Consider left lateral resection versus ablationPast Medical

History: has a past medical history of Anemia, Cancer (HCC), Peripheral neuropathy, and Thyroid disease. Past Surgical

History: has a past surgical history that includes Colon surgery (12/30/2021) and Small Bowel Resection (07/01/2024).Social

H&P Notes — 2025-12-18

Date: 2025-12-18

Type: H&P Notes

Source: epic_ihe_xdm

Caroline Godfrey, MD - 12/18/2025 11:45 AM CSTFormatting of this note might be different from the original.I have reviewed the H&P, examined the patient, and endorse the findings as written. Plan of Care : Based on the above findings, I consider Alexander R Towell to be an acceptable risk for : Procedure(s):XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED– Segment 8Cosigned by William Chapman, MD at 12/18/2025 3:27 PM CSTElectronically signed by Caroline Godfrey, MD at 12/18/2025 11:45 AM CSTElectronically signed by William Chapman, MD at 12/18/2025 3:27 PM CSTAssociated attestation - William Chapman, MD - 12/18/2025 3:27 PM CSTFormatting of this note might be different from the original.50 year old man admitted for planned resection of 2 metastatic sites in the liver. The patient and his family seem to understand the issues and agree with the plans.Source Note - Morgen Rockel, PA - 11/26/2025 9:00 AM CSTFormatting of this note is different from the original.PATIENT NAME: Alexander R TowellDOB: 8/4/197511/26/2025 CHIEF COMPLAINT: Metastatic terminal ileum adenocarcinoma to the liverHISTORY OF PRESENT ILLNESS: Mr. Towell is a 50 y.o. male with a history of sigmoid adenocarcinoma, metastatic terminal ileum adenocarcinoma to the liver s/p segment 2 hepatic resection in 5/2025 with two new lesions concerning for metastasis in segment 8. He returns to discuss repeat hepatic resection. He recovered very well after XI hepatic resection without complications. He continues chemotherapy with Dr. Tan, with last treatment 3 weeks ago. Surveillance MRI 11/9 showed 2 new lesions, 1.2 and 0.6 cm, followed by PET scan with very slight uptake.He feels wells overall, good appetite, no weight loss. CURRENT MEDICATIONS:Current Outpatient Medications: cetirizine (ZyrTEC) 10 mg tablet, Take 1 tablet every day by oral route for 90 days., Disp: , Rfl: cyanocobalamin (Vitamin B-12) 100 mcg tablet, Take 1 tablet (100 mcg total) by mouth early morning before breakfast, Disp: , Rfl: docusate sodium (COLACE) 100 mg capsule, Take 1 capsule (100 mg total) by mouth 2 (two) times a day as needed for constipation, Disp: , Rfl: iron bisgly,ps-FA-B-C#12-succ 65 mg-65 mg -1,000 mcg (24) tablet, Take 1 tablet by mouth 3 (three) times a week, Disp: , Rfl: levothyroxine (SYNTHROID) 112 mcg tablet, Take 1 tablet (112 mcg total) by mouth early morning before breakfast (Patient taking differently: Take 125 mcg by mouth early morning before breakfast), Disp: , Rfl: loperamide (IMODIUM A-D) 2 mg tablet, Take 1 tablet (2 mg total) by mouth 4 (four) times a day as needed for diarrhea, Disp: , Rfl: LORazepam (ATIVAN) 0.5 mg tablet, Take 1 tablet (0.5 mg total) by mouth every 8 (eight) hours as needed for anxiety, Disp: 30 tablet, Rfl: 0 multivitamin with minerals tablet, Take 1 tablet by mouth daily with dinner, Disp: , Rfl: omega-3 fatty acids-fish oil 300-1,000 mg capsule, Take 2 capsules (2 g total) by mouth daily with dinner, Disp: , Rfl: prochlorperazine (COMPAZINE) 10 mg tablet, Take 1 tablet (10 mg total) by mouth 3 (three) times a day as needed for nausea, Disp: 60 tablet, Rfl: 3 propranoloL (INDERAL) 20 mg tablet, Take 1 tablet (20 mg total) by mouth 2 (two) times a day, Disp: , Rfl: zolpidem (AMBIEN) 5 mg tablet, Take 1 tablet (5 mg total) by mouth nightly as needed for sleep, Disp: 30 tablet, Rfl: 0ALLERGIES: No Known AllergiesSOCIAL HISTORY:Social History Tobacco Use Smoking Status Never Smokeless Tobacco Never Alcohol: None reports no history of drug use.The patient is partner and presents to clinic with Kim. Occupation: Researcher. REVIEW OF SYSTEMS:Reports No acute concernsDenies fever/chills, n/v/d/c, or abdominal pain.PHYSICAL EXAM: VitalsBP 125/78 Pulse 61 Temp 36.1 °C (97 °F) Ht 185.4 cm (6’ 1") Wt 105.6 kg (232 lb 12.8 oz) BMI 30.71 kg/m² General Appearance: awake, alert, oriented x3, in no acute distressSkin: there are no suspicious lesions, rashes or jaundiceHead: NCATEyes: EOMI and Sclera nonictericNeck: neck- supple, no massLungs: Chest wall: symmetricHeart: Heart regular rate and rhythmAbdomen: Soft, non-tender, no organomegaly or masses. Hernias: none. Small incisional scars present. Extremities: no edemaNeurologic: negative findings: cranial nerves 2-12 grossly intact, gait normalLABS:Lab Results Component Value Date WBC 4.35 11/20/2025 HGB 15.3 11/20/2025 HCT 43.9 11/20/2025 MCV 93.4 11/20/2025 Lab Results Component Value Date SODIUM 140 11/20/2025 POTASSIUM 4.0 11/20/2025 CHLORIDE 106 11/20/2025 CO2 27 11/20/2025 ANIONGAP 8 11/20/2025 GLUCOSE 105 11/20/2025 BUNSER 23 11/20/2025 CREATININE 1.11 11/20/2025 CALCIUM 9.0 11/20/2025 ALBUMIN 4.3 11/20/2025 ALKPHOS 80 11/20/2025 ALT 46 11/20/2025 AST 28 11/20/2025 BILITOT 0.9 11/20/2025 IMAGING:MRI 11/9/25

History & Physical Note — 2024-05-08

Date: 2024-05-08

Type: History & Physical Note

Source: meditech_anderson

Author Pei ChungAnderson HealthcareMay 8th, 2024 12:20pm

Note Date/Time May 8th, 2024 12:16pm

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 History & Physical Report SignedPatient: Towell,Alexander R MR#: M000499848 DOB: 08/04/1975 Acct:V00003663948Age: 48 ADM Date: 05/08/24 Loc: ANH3MEDSUR 327-01 Attending Dr: Pei Chang Chung M.D.cc: Chung, Pei Chang MD; Gaudreault, Rachel N. PA-C; Suthan***, Nanthini MD~H&P: HPIHistory of Present IllnessDate/Time: 05/08/24 12:12Chief Complaint: abdominal pain

Narrative: The patient is a 48-year-old male well known to my service from previous sigmoidcolectomy secondary to metastatic sigmoid colon cancer. The patient presents complaining of crampy abdominal pain, nausea, constipation over the last month. The patient reports the symptoms have been progressively worsening. Workup, including imaging, is significant for small bowel obstruction. The patient has been admitted to my service and made NPO, NG tube decompression has been initiated. The patient reports he did have some diarrhea yesterday after takingsome laxatives.Review of SystemsReview of Systems: All systems reviewed & are unremarkable except as noted in HPI and below PMFSHPast Medical HistoryMedical History (Reviewed 05/08/24 @ 12:14 by Pei Chang Chung, MD)Colon cancerIron deficiency anemia (Unknown)Mass of colon (~12/2021)ObesitySurgical HistorySurgical History (Reviewed 05/08/24 @ 12:14 by Pei Chang Chung, MD)History of colon resection 12/29/2021 - hand assisted laparoscopic sigmoid colectomy with mobilization of the splenic flexureHistory of partial thyroidectomyFamily HistoryFamily History (Reviewed 05/08/24 @ 12:14 by Pei Chang Chung, MD)Father Hypertension Malignant neoplasm of prostateMother Deceased COPD (chronic obstructive pulmonary disease)Social HistorySocial History (Reviewed 05/08/24 @ 12:14 by Pei Chang Chung, MD)Smoking status: Never smoker Second hand tobacco smoke exposure: No Alcohol intake: never Drinks per week: 1 Alcohol use details: LAST DRINK 2015 Substance use: never Substance use type: does not use Do You Feel Safe in your Home?: Yes Lack of Transportation: No Lack of Food: Never True Current Housing: I Have Housing Concerned About Future Housing: No Difficulty Paying Gas/Electric Bills: No Difficulty Paying for Meds: No Currently Unemployed: No Education: Master’s Degree or Higher Difficulty w/ Childcare or Family Care: No Living arrangements: with family Additional living arrangements comments: LIVES WITH SIGNIFICANT OTHER Spiritual care concerns: No MedsHome Medications and Allergies Home Medications Medication Instructions Recorded Confirmed Typecholecalciferol (vitamin D3) 25 25 mcg PO DAILY 01/12/24 05/08/24 Historymcg (1,000 unit) tablet (Vitamin D3) levothyroxine 100 mcg tablet 100 mcg PO DAILY 01/12/24 05/08/24 Historymultivitamin with minerals-folic 1 tablet PO DAILY 01/12/24 05/08/24 Historyacid 200 mcg chewable tablet (Adult Multivitamin Gummies) AllergiesAllergy/AdvReac Type Severity Reaction Status Date / TimeNo Known Allergies Allergy Verified 05/08/24 02:36Vital Signs Vital Signs - 24 hr 05/07/2420:12 05/07/2420:12 05/07/2422:58Temperature 37.1 C 37.1 C Pulse Rate 72 76 61Respiratory Rate 17 19 18Blood Pressure 143/76 H 143/76 H 123/68Pulse Oximetry 100 100 98Oxygen Delivery Room Air 05/08/2401:00 05/08/2402:26 05/08/2406:00Temperature 36.4 C 36.4 CPulse Rate 66 62 70Respiratory Rate 18 16 16Blood Pressure 137/76 149/80 H 132/72Pulse Oximetry 100 98 100Oxygen Delivery 05/08/2408:25Temperature Pulse Rate Respiratory Rate Blood Pressure Pulse Oximetry Oxygen Delivery Room AirExamConst: General: cooperative, comfortable and no acute distress HENMT: Head: normal to inspection, normocephalic and atraumatic Eyes: General: appearance normal, both eyes and all related structures Neck: Neck: normal visual inspection, full ROM and no lymphadenopathy Resp: Auscultation: clear to auscultation bilaterally Cardio: Rate: regular rate Rhythm: regular rhythm GI: Inspection: normal to inspection, distended and incision GI Palp: No abdominal tenderness, Yes Soft to palpation, No Tenderness to palpation present (GI), No Guarding due to palpation present (GI) and No Rigid due to palpation Skin: General skin exam: normal color and no rashes or lesions noted Neuro: General: patient oriented x3 and CN’s II-XI intact bilaterally Extrem: General: normal to inspection and full ROM Psych: Appearance: grossly normal H&P: ResultsLabsLabs: Short CBC 05/07/24 Range/Units 21:05 WBC 4.9 (4.5-10.0) K/mm3Hgb 11.5 L (14.0-18.0) g/dLHct 35.5 L (42.0-52.0) %Plt Count 240 (150-375) k/mm3 BMP 05/07/24 21:05Sodium 139Potassium 3.6Chloride 107Carbon Dioxide 20 LBUN 25 HCreatinine 1.30Glucose 93Calcium 9.2 Liver Function 05/07/24 Range/Units 21:05 Total Bilirubin 0.5 (0.2-1.3) mg/dLAST 24 (17-59) U/LALT 15 (6-50) U/LAlkaline Phosphatase 85 (38-126) U/LAlbumin 4.7 (3.5-5.1) g/dL Urine 05/07/24 Range/Units 21:05 Urine Color Yellow (Yellow) Urine Appearance Clear (Clear) Urine pH 5.0 (5.0-9.0) Ur Specific Gravity 1.092 H (1.001-1.035) Urine Protein Negative (Negative) mg/dLUrine Glucose (UA) Negative (Negative) mg/dLAssessment and PlanAssessment and plan(1) Small bowel obstruction: Code(s):K56.609 - Unspecified intestinal obstruction, unspecified as to partial versus complete obstruction Status: Acute Assessment and

History & Physical Note — 2024-07-01

Date: 2024-07-01

Type: History & Physical Note

Source: meditech_anderson

Author Pei ChungAnderson HealthcareJuly 1st, 2024 11:33am

Note Date/Time July 1st, 2024 11:33am

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 History & Physical Update SignedPatient: Towell,Alexnder R MR#: M000499848 DOB: 08/04/1975 Acct:V00003676858Age: 48 ADM Date: 07/01/24 Loc: ANHSURGERY Attending Dr: Pei Chang Chung M.D.cc: ~History and Physical UpdateUpdateDate/Time: 07/01/24 11:33History and Physical has been reviewed, including an updated exam of the patient. There are NO changes in the patient’s condition.Risks, benefits, and alternatives have been discussed and questions answered. Patient agrees to proceed with procedure.This report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical,spelling, and recognition errors present.Report Initialized date/time: Chung, Pei Chang MD 07/01/24 / 1133Electronically signed by: Chung, Pei Chang MD 07/01/24 1133

History & Physical Note — 2024-07-22

Date: 2024-07-22

Type: History & Physical Note

Source: meditech_anderson

Author Pei ChungAnderson HealthcareJuly 22nd, 2024 12:21pm

Note Date/Time July 22nd, 2024 12:21pm

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 History & Physical Update SignedPatient: Towell,Alexander R MR#: M000499848 DOB: 08/04/1975 Acct:V00003688837Age: 48 ADM Date: 07/22/24 Loc: ANHSURGERY Attending Dr: Pei Chang Chung M.D.cc: ~History and Physical UpdateUpdateDate/Time: 07/22/24 12:21History and Physical has been reviewed, including an updated exam of the patient. There are NO changes in the patient’s condition.Risks, benefits, and alternatives have been discussed and questions answered. Patient agrees to proceed with procedure.This report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical,spelling, and recognition errors present.Report Initialized date/time: Chung, Pei Chang MD 07/22/24 / 1221Electronically signed by: Chung, Pei Chang MD 07/22/24 1221

Hospital Discharge Instructions

Type: Hospital Discharge Instructions

Source: meditech_anderson

Additional Discharge Instructions DISCHARGE INSTRUCTION SHEET FOR LAPAROSCOPIC SURGERIES DR. JOHNSON/CHUNG

PATIENT TO TAKE HOME

  1. May shower the day after surgery over incisions. Do not submerge in water x 2weeks.

  2. Call office for: Wound increasingly painful or bleeding Vomiting Fever of greater than 101 degrees

  3. Expect some blood on dressing and old blood on skin.

  4. If no bowel movement for two days, take 1 oz. (30 ml) Milk of Magnesia, if no results, take Fleets enema. May take an over the counter stool softener daily.

  5. No heavy lifting > 20-25 pounds x 6 weeks for Hand-assisted laparoscopic colectomy.

  6. No driving for 3 days or while taking narcotic pain medications.

  7. Up walking 10-30 minutes three times per day.

  8. Call the office to schedule a follow-up appointment for 2 weeks after your OR.

  9. Oral pain medications prescription to be sent to pharmacy. May transition to Tylenol 500mg by mouth every 6 hours as needed for pain once your pain becomes mild and is not requiring the narcotics.

  10. NUTRITION: Start out by drinking fluids and increase your diet as tolerated. If you experience nausea, try dry toast, crackers, and 7-UP. If nausea or vomiting persists, contact your surgeon�s office.

Instruction/Education Provided Antibiotic Form Hydrocodone/Acetaminophen (By mouth) Colectomy (DC)

Hospital Discharge Instructions — 2022-02-09

Date: 2022-02-09

Type: Hospital Discharge Instructions

Source: meditech_anderson

Additional Instructions Discharge Instruction Sheet for Portacath Placement Dr. Lane, Dr. Wikiera, Dr. Johnson, Dr. Chung General and Laparoscopic Surgical Associates 6812 State Route 162 Suite 121 Maryville, IL. 62062 618-288-3616 1.) May shower in 24 hours. 2.) Rest today, then may resume normal light activity tomorrow. 3.) No strenuous activity with upper extremity on the side of the port for 1 week. 4.) Tylenol or ibuprofen over the counter as needed for pain. 5.) Call office for any wound concerns or increasing pain. 6.) Follow up with oncologist as scheduled. You were given TORADOL 15MG (IBUPROFEN) today at 1:00 PM. Do not repeat this medication for 3 hours from time given.

Hospital Discharge Instructions — 2024-07-01

Date: 2024-07-01

Type: Hospital Discharge Instructions

Source: meditech_anderson

Additional Instructions DISCHARGE INSTRUCTION SHEET FOR DR. CHUNG

  1. May shower in 24 hours, no soaking in bath x 2weeks.
  2. Call office for: Wound increasingly painful or bleeding Vomiting Fever of greater than 101 degrees
  3. No heavy lifting > 10-15 pounds x 6 weeks
  4. No driving for 1 week
  5. Up walking 10-30 minutes three times per day.
  6. Follow-up 10-14 days in office for wound check or as previously scheduled. (288-3616)
  7. Oral pain medications prescription has been sent electronically to the pharmacy. Take Tylenol 500mg every 6 hours and Ibuprofen 600mg every 6 hours for the first 2 days, then as needed.
Hospital Discharge Instructions — 2024-07-22

Date: 2024-07-22

Type: Hospital Discharge Instructions

Source: meditech_anderson

Additional Instructions Discharge Instruction Sheet for Portacath Placement Dr. Lane, Dr. Wikiera, Dr. Johnson, Dr. Chung General and Laparoscopic Surgical Associates 6812 State Route 162 Suite 121 Maryville, IL. 62062 618-288-3616 1.) May shower in 24 hours. 2.) Rest today, then may resume normal light activity tomorrow. 3.) No strenuous activity with upper extremity on the side of the port for 1 week. 4.) Tylenol or ibuprofen over the counter as needed for pain. 5.) Call office for any wound concerns or increasing pain. 6.) Follow up with oncologist as scheduled.

Miscellaneous Notes — 2023-08-09

Date: 2023-08-09

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Brittni C - 08/09/2023 10:49 AM CDTFormatting of this note might be different from the original.Received a referral for patient to be seen for right wrist, I tried to call both numbers and left a voicemail for her to give us a call back and schedule.Electronically signed by Brittni C at 08/09/2023 10:50 AM CDTdocumented in this encounter

Miscellaneous Notes — 2024-08-12

Date: 2024-08-12

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Nurse Kimberly B - 08/12/2024 4:17 PM CDTFormatting of this note might be different from the original.Called pt about amb referral placed on 8/1. No appt has been scheduled with mws onx. Gave phone number to department and asked pt to call at convenient time.Electronically signed by Nurse Kimberly B at 08/12/2024 4:22 PM CDTdocumented in this encounter

Miscellaneous Notes — 2024-09-06

Date: 2024-09-06

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Benjamin Tan, MD - 09/06/2024 11:35 AM CDTFormatting of this note might be different from the original.Left Vm for him to call back to discuss tumor board consensus.Left VM also with Dr. Arshad, pt’s local oncologist.and left VM about possible candidacy for resection. Electronically signed by Benjamin Tan, MD at 09/06/2024 11:45 AM CDTdocumented in this encounter

Miscellaneous Notes — 2024-09-11

Date: 2024-09-11

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Ciaran M - 09/11/2024 2:53 PM CDTFormatting of this note is different from the original.Patient Query:Was an attempt to transfer to the assigned clinical staff or backline? “Yes”, Reason for call?: Ellen Sweatt is calling from Dr.Tan’s office requesting scheduling for patient. The referral has not been fully reviewed yet and informed Ellen of this and informed her that I would notify Dr. Field’s office.Who is the caller: Ellen SweattWhat is the best number for them to contact for a call back: 3143624113 Electronically signed by Ciaran M at 09/11/2024 2:59 PM CDTdocumented in this encounter

Miscellaneous Notes — 2024-09-17

Date: 2024-09-17

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Benjamin Tan, MD - 09/17/2024 11:58 AM CDTFormatting of this note might be different from the original.Called paeint about his scan results as well as tumor board recommendations. Will need a sooner appt than what was given for the patient to discuss suitability of resection vs transplnation vs systemic therapy alone vs HAIP. As such will refer the patient to see Dr. Chapman/Doyle/Khan for discussion.Electronically signed by Benjamin Tan, MD at 09/17/2024 12:00 PM CDTdocumented in this encounter

Miscellaneous Notes — 2024-10-03

Date: 2024-10-03

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Matthew H - 10/03/2024 11:24 AM CDTFormatting of this note might be different from the original.Called to schedule. Pt will need to callback to set up visit d/t infusion conflict. Electronically signed by Matthew H at 10/03/2024 11:25 AM CDTdocumented in this encounter

Miscellaneous Notes — 2024-11-01

Date: 2024-11-01

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Matthew H - 11/01/2024 1:23 PM CDTFormatting of this note might be different from the original.Images from the original note were not included.Pt girlfriend called to inquire about treatment process. She stated that MRI that was scheduled by Dr. Fields office was canceled, then rescheudled; however, she is unsure if this MRI is valid. MA is going to place new orders for MRI and schedule. Pt girlfriend would like to know what the plan is for after MRI if any. Electronically signed by Matthew H at 11/01/2024 1:25 PM CDTdocumented in this encounter

Miscellaneous Notes — 2024-11-14

Date: 2024-11-14

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Matthew H - 11/14/2024 8:30 AM CSTFormatting of this note might be different from the original.—– Message from Stephanie S sent at 11/13/2024 3:29 PM CST —–Hi,This has been approved by insurance. The referral has been updated to reflect this. They should be good to go.Thanks!Stephanie S—– Message —–From: Hunter, Matthew, EMTSent: 11/12/2024 2:34 PM CSTTo: Wu Su Abd Transplant Precert PoolI am not sure if I have requested a Pre-Auth for this patient or not. If not can we start one.Electronically signed by Matthew H at 11/14/2024 8:30 AM CSTdocumented in this encounter

Miscellaneous Notes — 2025-01-06

Date: 2025-01-06

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Elizabeth N - 01/06/2025 2:11 PM CSTFormatting of this note might be different from the original.Patient’s wife, Kim, called. She said Dr. Chapman Jr called them recently and they have not been able to connect with him. They are aware that Dr. Chapman Sr will be reaching out to them with regards to further treatment for Mr. Towell. They would like a general idea of what the test results ordered by Dr Chapman Jr indicated. I gave the message to Dr Chapman Jr and he reached out to the patient.Electronically signed by Elizabeth N at 01/06/2025 2:14 PM CSTdocumented in this encounter

Miscellaneous Notes — 2025-05-14

Date: 2025-05-14

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Initial Assessments - Nurse Kelli M - 05/15/2025 7:31 AM CDTFormatting of this note might be different from the original.CM Initial Assessment Interview NoteInformation Obtained From: Patient(05/14/25 1630)Admission Source: Non Health Care Facility Point of OriginImpression: Patient admitted for robotic liver resection s/p colorectal cancer and hepatic metastasis. Patient lives at home with his significant other, Kimberly and is IADL’s at baseline.Plan Includes: Patient anticipated discharge home when medically stable. Patient may have home health care needs pending PT/OT recs. Patient does not have a preference for a home health agency and a list of agencies can/will be provided if needed. Patient has family for home support and transportation. Case Management will continue to follow for anticipated discharge needs. Additional Information: Role of CM explained to patient. CM verified address, phone number, insurance and emergency contact from facesheet with patient/family. Primary Source of Transportation: KimberlyDoes the patient need discharge transport arranged?: No(05/14/25 1630)Health Insurance Coverage: MolinaPrescription Coverage: yesPharmacy:Walmart Pharmacy 1071 - Wood River, IL - 610 WESLEY DRIVE610 WESLEY DRIVEWood River IL 62095Phone: 618-259-0293 Fax: 618-259-8757Primary Care Provider: Kelsey Beard, NPSuthan, Nanthini, MDPrior to Admission:Functional Status: Independent with ADLsPrimary Caregiver: SelfSupport System: Spouse/Significant OtherHome Care Services: NoOutpatient Services: NoDurable Medical Equipment: NoneLiving Arrangements: Spouse/significant otherType of Residence: Private residenceSteps in home?: Yes, Outside of home, Yes, Inside homeNumber of steps inside: 10 stepsNumber of steps outside: 4 stepsMedication management: Independent(05/14/25 1630)SDOH:Transportation:Financial Resource:Housing:Utilities:Social Connections:Food Insecurity:Behavioral Health Services:Behavioral Health Services: No(05/14/25 1630)Anticipated Level of Care:Anticipated discharge level of care: Private residencePt/Family agrees with Anticipated Level of Care: Yes(05/14/25 1630)Patient expects to be Discharged to:Private residence, (05/14/25 1630)Patient’s Identified Problem/GoalProblem: Ensure acute medical needs are met and that patient has a safe discharge plan.Goal: Secure a discharge plan that patient/family are agreeable with and ensure patient has continuum of care.Case management will follow for discharge planning and send referrals as needed. Kelli Marie Macomber, RNElectronically signed by Nurse Kelli M at 05/15/2025 7:37 AM CDTPlan of Care - Nurse Caden C - 05/14/2025 9:34 PM CDTFormatting of this note might be different from the original.Goals: monitor I&Os, monitor vital signs, pain management, foley catheter discontinued, fall preventionSummary: Problem: Discharge PlanningGoal: Understanding discharge needs will improveOutcome: ProgressingProblem: ActivityGoal: Risk for activity intolerance and fatigue will decreaseOutcome: ProgressingGoal: Ability to tolerate increased activity will improveOutcome: ProgressingGoal: Ability to avoid complications of mobility impairment will improveOutcome: ProgressingProblem: Communication ImpairmentGoal: Ability to express needs and understand communicationOutcome: ProgressingProblem: General Patient EducationGoal: Knowledge of disease process, condition or treatment will be improvedOutcome: ProgressingProblem: Health BehaviorGoal: Ability to state signs and symptoms to report to health care provider will improveOutcome: ProgressingGoal: Ability to identify and alter actions that are detrimental to health will improveOutcome: ProgressingGoal: Ability to identify and utilize available resources and services will improveOutcome: ProgressingGoal: Compliance with prescribed regimen will improveOutcome: ProgressingProblem: Physical RegulationGoal: Will remain free from infectionOutcome: ProgressingGoal: Ability to maintain clinical measurements within normal limits will improveOutcome: ProgressingGoal: Ability to maintain body temperature in the normal range will improveOutcome: ProgressingProblem: SafetyGoal: Free from injury or harmOutcome: ProgressingGoal: Ability to maintain safety and efficiency with swallowing without signs of aspiration will improveOutcome: ProgressingElectronically signed by Nurse Caden C at 05/14/2025 9:36 PM CDTPlan of Care - Nurse Amber T - 05/14/2025 3:34 PM CDTFormatting of this note might be different from the original.Goals: Monitor vital signs, intake and output, pain management, comfort, admission questionsSummary: Problem: Discharge PlanningGoal: Understanding discharge needs will improveOutcome: ProgressingElectronically signed by Nurse Amber T at 05/14/2025 3:35 PM CDTBrief Op Note - William Chapman, MD - 05/14/2025 1:08 PM CDTFormatting of this note is different from the original.Operative Progress NoteSurgical Team: Surgeons and Role: * Chapman, William Cavanaugh, MD - PrimaryAnesthesiologist: Zoller, Jonathan Kramer, MDAnesthesia Resident: Lewis, Bradley Mitchell, DOCirculator: St. Pierre, Grace Marguerite, RNScrub: Sullivan, Ryan W., STRNFA: Scherer, Meranda Della, RNFLOAT: Berlage, Julia Newman, RN; Boehmer, Natalie Nicole, RNDATE OF SURGERY :5/14/2025Preoperative

Miscellaneous Notes — 2025-11-21

Date: 2025-11-21

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Telephone Encounter - Jeannette K - 11/21/2025 9:55 AM CSTFormatting of this note might be different from the original.Per Mallory, schedule pt to be seen by Dr. Chapman next Wed, 11/26. Also schedule pt for CPAP for the same day. Procedure should be robotic liver resection.Spoke with pt and he is scheduled for 11/26 at 9 AM. I also put a prep for case in and spoke to CPAP. Pt is scheduled for CPAP on 11/26 at 10AM. Pt is aware of all of the above and voiced understanding. Electronically signed by Jeannette K at 11/21/2025 9:59 AM CSTdocumented in this encounter

Miscellaneous Notes — 2025-12-18

Date: 2025-12-18

Type: Miscellaneous Notes

Source: epic_ihe_xdm

Plan of Care - Nurse Jayla W - 12/19/2025 9:09 AM CSTFormatting of this note might be different from the original.Goals: Clinical Goals for the Shift: ambulation, vital signsSummary: Problem: ActivityGoal: Patient’s tolerance of increased activity will improveOutcome: ProgressingGoal: Patient will maintain or regain ADL functionOutcome: ProgressingProblem: NutritionGoal: Patient’s nutritional status will improveOutcome: ProgressingGoal: Patient’s ability to achieve adequate nutrition will improveOutcome: ProgressingElectronically signed by Nurse Jayla W at 12/19/2025 9:09 AM CSTPlan of Care - Nurse Danee C - 12/19/2025 6:11 AM CSTFormatting of this note might be different from the original.Shift Summary: Pain controlled with current regimen. Patient ambulated independently in hallway. Problem: NutritionGoal: Patient’s nutritional status will improveOutcome: OngoingFlowsheets (Taken 12/19/2025 0610)Patient’s nutritional status will improve: Provide postoperative nutritional progressionProblem: Physical RegulationGoal: Gastrointestinal status for postoperative course will improveOutcome: OngoingFlowsheets (Taken 12/19/2025 0610)Gastrointestinal status for postoperative course will improve: Monitor gastrointestinal status Perform actions to prevent or reduce the incidence of constipationProblem: ActivityGoal: Patient’s tolerance of increased activity will improveOutcome: ProgressingFlowsheets (Taken 12/19/2025 0610)Patient’s tolerance of increased activity will improve: Implement and manage activity progression plan Encourage out of bed for meals Encourage energy conservation techniquesProblem: Lack of KnowledgeGoal: Ability to develop a pain control plan will improveOutcome: ProgressingFlowsheets (Taken 12/19/2025 0609)Ability to develop a pain control plan will improve: Explain causes of pain and how long pain can be expected to last Teach information regarding pain management Educate pain scale for assessing level of painProblem: MedicationGoal: Satisfaction with pain management medication regimen will improveOutcome: ProgressingFlowsheets (Taken 12/19/2025 0609)Satisfaction with pain management medication regimen will improve: Assess satisfaction with pain management regimenElectronically signed by Nurse Danee C at 12/19/2025 6:12 AM CSTBrief Op Note - William Chapman, MD - 12/18/2025 2:05 PM CSTFormatting of this note is different from the original.Operative Progress NoteSurgical Team: * Chapman, William Cavanaugh - Primary * Godfrey, Caroline Marie - FellowAnesthesiologist: King, Christopher R., MD PhDCRNA: Maxey, Lucas Aaron, CRNACirculator: Boehmer, Natalie Nicole, RNScrub: Sullivan, Ryan W., STSurgical Assistant: Matson, Sarah Christine, PAOrientee Circulator: Thomason, Andy Keith, RNDATE OF SURGERY :12/18/2025Preoperative

Diagnosis: Pre-op Diagnosis * Metastatic colon cancer to liver [C18.9, C78.7]Postoperative

Notes

Type: Notes

Source: athena_sihf

Date Note Type Note Provider Name and Address Organization Details Recorded Time

09/27/2021

text/html

Rash/Skin Lesion Reported by Patient HPI For quality, patient reports multiple (two) but reports not painful . For location, patient reports chest (two lumps) . For duration, patient reports has noted for >3 months (5 yrs) . For associated symptoms, patient reports no fever .

New pt is here to establish pcp. pt said he had on and off episodes of lightheadedness , denied chest pain or palpitations . Pt admits he has anxiety with some panic symptoms , declined med , he could manage without med per pt

Nanthini Suthan, MD

Attn: Accounting,2041 GOOSE LAKE RD, East Saint Louis, IL, 62206-2822, US

IL - SIHF 09/27/2021 15:15:47

10/12/2021

text/html

Anemia Reported by Patient HPI For context, patient reports previous hemoglobin: (7.1) and low iron . For associated symptoms, patient reports blood in stool but reports no shortness of breath and no chest pain . For severity, patient reports microcytic (mcv<80) . For modifying factors, patient reports otc medication (nsaid) .

Rash/Skin Lesion Reported by Patient HPI For quality, patient reports multiple (two) but reports not painful . For location, patient reports chest (two lumps) . For duration, patient reports has noted for >3 months (5 yrs) . For associated symptoms, patient reports no fever .

Us showed lipoma .

pt is here for f/u and labs pt said he had on and off episodes of lightheadedness , denied chest pain or palpitations . Pt admits he has anxiety with some panic symptoms , declined med , he could manage without med per pt

Nanthini Suthan, MD

Attn: Accounting,2041 GOOSE LAKE RD, East Saint Louis, IL, 62206-2822, US

IL - SIHF 10/12/2021 15:51:44

11/12/2021

text/html

Rash/Skin Lesion Reported by Patient HPI For quality, patient reports multiple (two) but reports not painful . For location, patient reports chest (two lumps) . For duration, patient reports has noted for >3 months (5 yrs) . For associated symptoms, patient reports no fever .

Us showed lipoma .

Anemia Reported by Patient HPI For context, patient reports previous hemoglobin: (8.0) and low iron . For associated symptoms, patient reports blood in stool but reports no shortness of breath and no chest pain . For severity, patient reports microcytic (mcv<80) . For modifying factors, patient reports otc medication (nsaid) .

OR Notes — 2025-05-14

Date: 2025-05-14

Type: OR Notes

Source: epic_ihe_xdm

Anesthesia Postprocedure Evaluation - Archana Bharadwaj, MD - 05/14/2025 3:06 PM CDTFormatting of this note is different from the original.Patient: Alexander R TowellProcedure Summary Date: 05/14/25 Room / Location: BJH OR POD 5 ROOM 230 / BJH OR POD 5 Anesthesia Start: 1221 Anesthesia Stop: 1439 Procedure: XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED, TAP Block (Abdomen)

Diagnosis: Metastatic colon cancer to liver (HCC) (Metastatic colon cancer to liver (HCC) [C18.9, C78.7]) Surgeons: Chapman, William Cavanaugh, MD Responsible Provider: Zoller, Jonathan Kramer, MD Anesthesia Type: general ASA Status: 2 Anesthesia Type: generalLast vitalsBP 137/89 (BP Location: Left arm, Patient Position: HOB 30 degrees) | Pulse 84 | Temp 36.2 °C (97.2 °F) (Temporal) | Resp 14 | SpO2 94% Anesthesia Post EvaluationPatient location during evaluation: PACUPatient participation: complete - patient participatedLevel of consciousness: fully awakePain score: 4Pain management: adequateAirway patency: patentEvidence of recall: noCardiovascular status: acceptableRespiratory status: acceptableHydration status: stablePt is: normothermicNausea/Vomiting status: noneNo notable events documented.Cosigned by Ahmet Bermede, MD at 05/14/2025 3:08 PM CDTElectronically signed by Archana Bharadwaj, MD at 05/14/2025 3:07 PM CDTElectronically signed by Ahmet Bermede, MD at 05/14/2025 3:08 PM CDTAnesthesia Procedure Notes - Bradley Lewis, DO - 05/14/2025 12:54 PM CDTAssociated Order(s): Peripheral IV CatheterFormatting of this note might be different from the original.Peripheral IV CatheterPatient location: ORStaff:Placed by:Resident: Lewis, Bradley Mitchell, DOPreprocedure prep:Prep solution: chlorhexadinePPE: gloves and provider hat/maskPIV line:Laterality: leftSite: wristCatheter size: 18 gTechnique: direct visualizationProcedure details: good blood returnNumber of attempts: 1

Assessment:Events: patient tolerated procedure well with no complicationsElectronically signed by Bradley Lewis, DO at 05/14/2025 12:54 PM CDTAnesthesia Procedure Notes - Bradley Lewis, DO - 05/14/2025 12:54 PM CDTAssociated Order(s): Arterial LineFormatting of this note might be different from the original.Arterial LinePatient location: ORIndication: continuous blood pressure monitoring and blood sampling neededUltrasound assisted: yesStaff:Supervising provider: Zoller, Jonathan Kramer, MDPlaced by:Resident: Lewis, Bradley Mitchell, DOProcedure prep:Prep solution: chlorhexadine/alcoholPrep: provider hat/mask and sterile glovesArterial line:Catheter size: 20 gaugeCatheter type: wire-guided catheterLaterality: leftSite: radial arteryLine secured: tapeResults: good waveform and good blood returnNumber of attempts: 1

Assessment:Events: patient tolerated procedure well with no complicationsElectronically signed by Bradley Lewis, DO at 05/14/2025 12:54 PM CDTAnesthesia Procedure Notes - Bradley Lewis, DO - 05/14/2025 12:48 PM CDTAssociated Order(s): AirwayFormatting of this note might be different from the original.AirwayPatient location: ORIndications for airway management: anesthesia and airway protectionDifficult airway: noStaff: Placed by:Anesthesiologist: Zoller, Jonathan Kramer, MDResident: Lewis, Bradley Mitchell, DOEmergent airway documentation: Risks and benefits discussed: yesConsent obtained: yesConsent given by: patientAirway prep:Preoxygenated: yesPatient position: sniffingMask difficulty assessment: 1 - vent by maskSpontaneous ventilation during airway: absentSedation level during airway: GAFinal airway details: Final airway type: endotracheal airwayTube type: ETTETT size: 8.0 mmCuffed: yesTechnique used for successful ETT placement: direct laryngoscopyBlade type: MacintoshBlade size: 4Cormack-Lehane (direct): grade I - full view of glottisETT to lips: 24 cmPlacement verified by: auscultation and CO2 detectionAirway secured with: silk tapeNumber of attempts: 1Electronically signed by Bradley Lewis, DO at 05/14/2025 12:49 PM CDTAnesthesia Preprocedure Evaluation - Jonathan Zoller, MD - 05/01/2025 7:36 AM CDTFormatting of this note is different from the original.Images from the original note were not included.Center for Preoperative Assessment and PlanningPreoperative Evaluation RecordEvaluation type/location: CPAP BJHPlanned procedure site: Not ScheduledDate: 05/01/25_____________________________________________________________Anesthesia EvaluationAlexander R Towell is a 49 y.o. maleXI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED (Abdomen)Pre-Op Diagnosis Codes: * Metastatic colon cancer to liver (HCC) [C18.9, C78.7]HISTORYHPIAlexander Towell is a 49 yo male who presents for evaluation prior to undergoing a laparoscopic liver resection VS ablation for colon cancer with mets to the liver. He was diagnosed with T4 N1 M0 stage IIIB moderately differentiated adenocarcinoma sigmoid colon s/p laparoscopic sigmoid colectomy done on 12/29/2021 with subsequent right sided hemicolectomy done on 7/1/2024. Other PMH of hypothyroid, anemia, neuropathy, OSA. Past Medical HistoryInformation obtained from: patient and chart.Information obtained during: In PersonNeurological Pertinent negatives: seizures; neuromuscular disease; CVA/stroke; TIA; CEA; ICA stenosis; dementia/mild cognitive impairment and carotid artery stentCardiovascular Pertinent negatives: hypertension ; CAD ; MI ; CABG ; valvular heart disease; valve replacement; atrial fibrillation; arrhythmia; pacemaker/ICD; PVD; DVT/PE; negative for CHF; drug-eluting stent(s); bare metal stent(s) and coronary angioplastyRespiratory + Sleep apnea (OSA) (Per sleep study 2023: Mild sleep disordered breathing without clinically significant obstructive sleep apnea)Pertinent negatives: COPD; asthma; pulmonary hypertension; no O2 use outside the hospital; non-smoker and no tracheostomyHepatic / Heme + Liver disease (Colon cancer with mets to the liver)+ History of anemia - in neoplastic diseasePertinent negatives: history of thrombocytopenia and history of Coombs positiveComments: F/b Dr. Syed M Arshad Mercy Hem/Onc LOV 4/16/2025 and Dr. Tan WU oncology LOV 8/15/2024 Gastrointestinal Pertinent negatives: GERD and hiatal herniaComments: Colon cancer s/p hemicolectomy; SBO s/t cancerRenal / GU Pertinent negatives: renal disease; dialysis and nephrolithiasisMusculoskeletal/Pain + Chronic pain - neuropathic pain.+ Headaches (throughout chemo therapy)Pertinent negatives: chronic opioid use and previous treatment for opioid use disorderEndocrine / Other + Thyroid disease (s/p right thyroidectomy 2022) - hypothyroidism+ Cancer history (Maintenance chemotherapy with 5-FU leucovorin and Avastin started on February 12, 2025.)- current cancer and metastatic cancer. Cancer type: Colon s/p hemicolectomy.Pertinent negatives: diabetes mellitus; obesity (BMI >30); rheumatological disease and transplanted organComments: F/b Dr. Wonil Tae OSF endocrinology 4/3/2025.Functional Capacity Functional capacity: 4-6 METsComments: Able to perform ADLs independently. Able to walk 2 city blocks and climb 2 flights of stairs. Denies CP or SOB. Review of Systems + previous transfusion (iron infusions only; last 4 years ago)+ muscle weakness (generalized s/t chemo)+ chronic pain+ numbness/tingling (neuropathy s/t chemo)+ vision loss (glasses)+ nausea/vomiting (after chemo for 24 hours)+ dentures/partials (upper partial)+ diarrhea (s/t chemo; no recent changes)Pertinent negatives: productive cough; wheezing; SOB; recent cold/flu; fever; chest pain; palpitations; orthopnea; pedal edema; PND; Sickle Cell disease/trait; transfusion reaction; melena/hematochezia; easy bruising; bleeding problems; syncope; dizziness; hard of hearing; heartburn; dysphagia; chipped/loose teeth; abdominal pain; diaphoresis and no unexpected weight changeComments: Denies UTI symptoms. PAT Summary and Plans Cardiac risk classification of planned procedure: intermediate cardiac risk.Preoperative assessment status: lab tests ordered.Initial preoperative evaluation discussed with: Song, Ziyan, MDAdditional comments: Alexander R Towell is a 49 y.o. male who is being evaluated prior to undergoing an intermediate cardiac risk surgery. Revised Cardiac Risk Index factors are (none) for a total RCRI of 0 out of 6. Functional capacity is 4-6 METs.Obstructive sleep apnea (OSA) screening status is HIGH RISK due to known OSABlood bank needs for day of procedure: T&C 2 unit pRBCsPending labs/tests include: CBC CMP T&S PT PTT-right chest wall port-Patient reports taking 325 mg of aspirin for headaches only and was educated to stop taking 1 week prior to procedure. Preoperative evaluation performed by Mccalle Erin Wilkey, NP on 05/01/25 at 7:39 AM..Follow up noteLabs reviewed and are without significant findings.Surgeon’s office reviews laboratory results independently, including final results of surgeon ordered labs.CPAP process complete. Follow-up completed by: Renee Michelle Figura, NP on 05/02/25 at 10:18 AMPatient Active Problem List Diagnosis Date Noted Metastatic colon cancer to liver (HCC) 04/30/2025 Adenocarcinoma of ileum (HCC) 08/23/2024 Malignant neoplasm metastatic to liver (HCC) 08/16/2024 Past Medical

OR Notes — 2025-12-18

Date: 2025-12-18

Type: OR Notes

Source: epic_ihe_xdm

Anesthesia Postprocedure Evaluation - Samuel Erlinger, MD - 12/18/2025 4:41 PM CSTFormatting of this note is different from the original.Patient: Alexander R TowellProcedure Summary Date: 12/18/25 Room / Location: BJH OR POD 5 ROOM 230 / BJH OR POD 5 Anesthesia Start: 1309 Anesthesia Stop: 1608 Procedure: XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED SEGMENT 5 8 and 4B, INTRAOPERATIVE ULTRASOUND and TAP BLOCK (Abdomen)

Diagnosis: Metastatic colon cancer to liver (Metastatic colon cancer to liver [C18.9, C78.7]) Surgeons: Chapman, William Cavanaugh, MD Responsible Provider: King, Christopher R., MD PhD Anesthesia Type: general ASA Status: 3 Anesthesia Type: generalLast vitalsVitals Value Taken Time BP 143/94 12/18/25 16:40 Temp 36.7 °C (98.1 °F) 12/18/25 16:00 Pulse 70 12/18/25 16:40 Resp 18 12/18/25 16:40 SpO2 93 % 12/18/25 16:40 Vitals shown include unfiled device data. Anesthesia Post EvaluationPatient location during evaluation: PACUPatient participation: complete - patient participatedLevel of consciousness: follows simple commands and fully awakePain management: adequateAirway patency: adequateCardiovascular status: acceptable and hemodynamically stableRespiratory status: acceptableHydration status: acceptablePt is: normothermicNausea/Vomiting status: noneElectronically signed by Samuel Erlinger, MD at 12/18/2025 4:42 PM CSTAnesthesia Procedure Notes - Lucas Maxey, CRNA - 12/18/2025 2:05 PM CSTAssociated Order(s): Peripheral IV CatheterFormatting of this note might be different from the original.Peripheral IV CatheterPatient location: ORStaff:Placed by:CRNA: Maxey, Lucas Aaron, CRNAPreprocedure prep:Prep solution: alcoholPPE: glovesPIV line:Laterality: rightSite: forearmCatheter size: 14 gTechnique: anatomical landmarks and direct visualizationProcedure details: good blood return and occlusive dressing appliedNumber of attempts: 1

Assessment:Events: patient tolerated procedure well with no complicationsElectronically signed by Lucas Maxey, CRNA at 12/18/2025 2:05 PM CSTAnesthesia Procedure Notes - Lucas Maxey, CRNA - 12/18/2025 2:05 PM CSTAssociated Order(s): Arterial LineFormatting of this note might be different from the original.Arterial LinePatient location: ORIndication: continuous blood pressure monitoring and blood sampling neededUltrasound assisted: yesStaff:Placed by:CRNA: Maxey, Lucas Aaron, CRNAProcedure prep:Prep solution: chlorhexadine/alcoholPrep: provider hat/mask, sterile gloves and sterile probe coverArterial line:Catheter size: 20 gaugeCatheter length: 1 and 3/4 inchCatheter type: wire-guided catheterSeldinger technique: yesLaterality: leftSite: radial arteryLine secured: tape and TegadermResults: good waveform and good blood returnNumber of attempts: 1

Assessment:Events: patient tolerated procedure well with no complicationsElectronically signed by Lucas Maxey, CRNA at 12/18/2025 2:05 PM CSTAnesthesia Procedure Notes - Lucas Maxey, CRNA - 12/18/2025 2:04 PM CSTAssociated Order(s): AirwayFormatting of this note might be different from the original.AirwayPatient location: ORUrgency: electiveIndications for airway management: anesthesiaDifficult airway: noStaff: Placed by:CRNA: Maxey, Lucas Aaron, CRNAEmergent airway documentation: Risks and benefits discussed: yesConsent obtained: yesConsent given by: patientAirway prep:Preoxygenated: yesPatient position: sniffingMask difficulty assessment: 1 - vent by maskSpontaneous ventilation during airway: absentSedation level during airway: GAFinal airway details: Final airway type: endotracheal airwayTube type: ETTETT size: 7.5 mmCuffed: yesTechnique used for successful ETT placement: video laryngoscopyDevices/Methods used in placement: styletInsertion site: oralBlade type: MacintoshVideo blade type: McGrathBlade size: 4Cormack-Lehane (video): grade I - full view of glottisInitial cuff pressure: 25 cm H2OCuff volume: 7 mLCuff inflated with: airETT to lips: 22 cmPlacement verified by: auscultationAirway secured with: silk tapeNumber of attempts: 1Electronically signed by Lucas Maxey, CRNA at 12/18/2025 2:05 PM CSTAnesthesia Preprocedure Evaluation - Christopher King, MD PhD - 11/26/2025 10:03 AM CSTFormatting of this note is different from the original.Images from the original note were not included.Center for Preoperative Assessment and PlanningPreoperative Evaluation RecordEvaluation type/location: CPAP BJHPlanned procedure site: BJH South OR (Pods 2/3/5/CPC)Date: 11/26/25_____________________________________________________________Anesthesia EvaluationXI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED (Abdomen)Pre-Op Diagnosis Codes: * Metastatic colon cancer to liver [C18.9, C78.7]HISTORYHPIAlexander R Towell is a 50 y.o. male w/ notable PMHx of anemia, thrombocytopenia, hypothyroidism, metastatic colon cancer s/p laparoscopic sigmoid colectomy (12/29/2021) with subsequent right sided hemicolectomy (7/1/2024) and liver resection (5/2025) who is being evaluated preoperatively prior to planned robotic-assisted laparoscopic liver resection for metastatic colon cancer to liverPast Medical HistoryInformation obtained from: patient and chart.Information obtained during: In PersonNeurological + Neuromuscular disease (peripheral neuropathy)Pertinent negatives: seizures; CVA/stroke; TIA; CEA; ICA stenosis; dementia/mild cognitive impairment and carotid artery stentCardiovascular Pertinent negatives: hypertension ; CAD ; MI ; CABG ; systolic/diastolic dysfunction w/o CHF ; valvular heart disease; valve replacement; atrial fibrillation; arrhythmia; pacemaker/ICD; PVD; DVT/PE; negative for CHF; drug-eluting stent(s); bare metal stent(s) and coronary angioplastyRespiratory Pertinent negatives: COPD; asthma; sleep apnea (OSA); pulmonary hypertension; no O2 use outside the hospital; non-smoker and no tracheostomyHepatic / Heme + Liver disease (liver mets)+ History of anemia (normal H&H on 11/20/2025)+ History of thrombocytopenia (Plts= 131k on 11/20/25)Pertinent negatives: history of Coombs positiveGastrointestinal Pertinent negatives: GERD and hiatal herniaRenal / GU Pertinent negatives: renal disease; dialysis and nephrolithiasisMusculoskeletal/Pain Pertinent negatives: chronic pain; chronic opioid use and previous treatment for opioid use disorderEndocrine / Other + Thyroid disease - hypothyroidism+ Cancer history- metastatic cancer and s/p chemo. Cancer type: colon cancer w/ mets to liver.Pertinent negatives: diabetes mellitus; obesity (BMI >30); rheumatological disease; transplanted organ and infectious diseaseFunctional Capacity Functional capacity: 6-10 METsComments: Jogs short distances for exercise with no CP/SOB.Able to lie supine with no dyspneaReview of Systems + previous transfusion (“years ago”)+ numbness/tingling (peripheral neuropathy)+ vision loss (glasses)+ heartburn (occasional sx’s)+ nausea/vomiting (from chemo)+ dentures/partials (upper partial)Pertinent negatives: productive cough; wheezing; SOB; recent cold/flu; fever; chest pain; palpitations; orthopnea; pedal edema; PND; Sickle Cell disease/trait; transfusion reaction; melena/hematochezia; easy bruising; bleeding problems; syncope; dizziness; muscle weakness; chronic pain; hard of hearing; dysphagia; diarrhea; chipped/loose teeth; abdominal pain; diaphoresis and no unexpected weight changeComments: Denies URI/UTI symptomsPAT Summary and Plans Cardiac risk classification of planned procedure: intermediate cardiac risk.Preoperative assessment status: lab tests ordered.Additional comments: Alexander R Towell is a 50 y.o. male who is being evaluated prior to undergoing an intermediate cardiac risk surgery. Revised Cardiac Risk Index factors are (none) for a total RCRI of 0 out of 6. Functional capacity is 6-10 METs.Obstructive sleep apnea (OSA) screening status is LOW risk; STOP-BANG is 1. Pt denies h/o OSA. Blood bank needs for day of procedure: T&C 2 unit pRBCsMay need updated T&S depending on DOS: TBDPending labs/tests include: CBC T&SCBC and CMP reviewed from 11/20/25 and notable for: (otherwise unremarkable from an anesthesia perspective)Plts= 131kPreoperative evaluation performed by Kelly Ann Wilkens, NP on 11/26/25 at 10:35 AM. .Follow up noteLabs reviewed and are without significant findings.Surgeon’s office reviews laboratory results independently, including final results of surgeon ordered labs.CPAP process complete. Follow-up completed by: Barbara E. Brake, NP on 12/01/25 at 8:50 AMPatient Active Problem List Diagnosis Date Noted H/O resection of liver 08/01/2025 Metastasis to liver 05/14/2025 Metastatic colon cancer to liver 04/30/2025 Adenocarcinoma of ileum (HCC) 08/23/2024 Malignant neoplasm metastatic to liver (HCC) 08/16/2024 Past Medical

Plan of Care

Type: Plan of Care

Source: meditech_anderson

Instructions

Antibiotic Form Hydrocodone/Acetaminophen (By mouth) Colectomy (DC)

Plan of Treatment

Type: Plan of Treatment

Source: athena_sihf

Reminders

Order Date Submit Date Provider Name Organization Details Last Modified By Last Modified Time Details

Appointments

PHONE VISIT 15

03/30/2026 10:45AM

Nicole Bennett, NP Not available Not available Not available

ANY 15

04/09/2026 01:30PM

KELSEY BEARD, FNP-BC Not available Not available Not available

Lab

drug screen, urine

10/28/2025 12:45:49

10/28/2025

Nicole Bennett, NP

Bethalto HC (BH)

2 Terminal Dr Ste 8, EAST ALTON, IL, 62024-2294, Ph (618) 259-0365

Nicole Bennett, NP 10/28/2025 12:45:51

TSH + free T4, serum

04/01/2025 11:29:25

04/01/2025

KELSEY BEARD, FNP-BC

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Darla Turner, MA 04/22/2025 17:07:37

CBC w/ auto diff

04/01/2025 11:29:25

04/01/2025

KELSEY BEARD, FNP-BC

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 05/02/2025 09:14:39

CMP, serum or plasma

04/01/2025 11:29:25

04/01/2025

KELSEY BEARD, FNP-BC

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 05/02/2025 09:14:36

HbA1c (hemoglobin A1c), blood

04/01/2025 11:29:25

04/01/2025

KELSEY BEARD, FNP-BC

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 05/02/2025 09:14:37

lipid panel, serum

04/01/2025 11:29:25

04/01/2025

KELSEY BEARD, FNP-BC

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 05/02/2025 09:14:34

influenza virus A + B + SARS-CoV-2 (COVID19) Ag panel, rapid IA, upper respiratory specimen

02/10/2025 13:10:29

02/10/2025

KELSEY BEARD, FNP-BC

Bethalto HC (Adult Med)

2 Terminal Dr Ste 8, EAST ALTON, IL, 62024-2294, Ph (618) 258-0485

Not Available 02/10/2025 16:13:43

lipid panel, serum

11/30/2023 09:42:49

11/30/2023

Nanthini Suthan, MD

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 12/13/2023 03:08:26

CMP, serum or plasma

11/30/2023 09:42:49

11/30/2023

Nanthini Suthan, MD

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 12/13/2023 03:08:27

albumin/creatinine, mass ratio, urine

11/30/2023 09:42:48

11/30/2023

Nanthini Suthan, MD

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 12/13/2023 07:15:15

CBC w/ auto diff

11/30/2023 09:42:48

11/30/2023

Nanthini Suthan, MD

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Not Available 12/13/2023 03:08:28

CMP, serum or plasma

01/18/2023 14:59:46

01/18/2023

Nanthini Suthan, MD

LABCORP

102 Rottingham,Ste 2, Edwardsville, IL, 62025, Ph (618) 659-8692

Plan of Treatment

Type: Plan of Treatment

Source: meditech_anderson

I have reviewed Dr. Arshad’s office note, colonoscopy report and pathology prior to today’s visit. I discussed the pathology finding with the patient. I have recommended proceeding with HAL right colectomy under general anesthesia as an AM admit. Procedure risks, benefits, and expected outcomes were discussed in detail. Explained this is a hand assisted technique. Discussed the usual length of operation time, need for bowel prep with antibiotics, usual placement of incision and trocars, typical 6-8 week recovery, as well as the length of time spent in the hospital. Potential complications were also discussed in detail which includes conversion to open surgery, bleeding, infection, anastomotic leak, and return to surgery. All questions were answered. Patient would like to proceed. Follow-up 2 weeks postoperatively.

  1. Personal Hx of colon cancer/ SBO/ ileum ulcer/chronic constipation/weight loss/appetite loss: Patient had an outpatient CT at St. Anthony’s which showed SBO and patient then presented to Anderson ER 5/07/2024 at which time he was seen by surgery ( Dr. Chung) and NG decompression recommended and there was no indication for surgery at that time. S/P partial sigmoid bowel resection for adenocarcinoma in the sigmoid colon on 12/29/2021, patient completed chemotherapy but did not require radiation. Colonoscopy performed by Dr. Rodriguez 05/29/2024 which revealed a ulcer at the ileum. Unfortunately, bx were consistent with moderately differentiated adenocarcinoma. patient has been taking Dulcolax daily to avoid any slowing of his bowels. Following his hospitalization beginning of May he was doing well until about 12 days ago when he started to experience abdominal cramping and nausea. At that time he may dietary adjustments and switch to more of a liquid based diet that has been slowly advancing his diet and yesterday was able to tolerate solid foods. Today in the office he denied any GI complaints other than appetite loss and weight loss. Patient advised to contact his oncologist Dr. Arshad to discuss his treatment/surgical options He will continue to adjust his diet based on symptoms and ok to continue laxatives at this time as he feels he is dependent on them Patient advised to avoid hard to digest foods such as meats recommended supplemental nutrition such as boost or Ensure to help increase caloric intake
  2. IDA: Labs earlier this month showed Hgb 12, Hct 36, MCV 81, platelets 240, iron 35, TIBC 451, iron sat 8% and ferritin 5. patient denies any signs of active GI bleeding at this time. Patient to follow up with Hematology/Oncology for management The patient will follow up in the office on an as-needed basis. This report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical, spelling, and recognition errors present. Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Plan of Treatment — 2021-12-29

Date: 2021-12-29

Type: Plan of Treatment

Source: meditech_anderson

? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3, TIBC of 13 and ferritin <1. continue oral iron Will schedule EGD and colonoscopy. Never had EGD. last colonoscopy was over 20 years ago. He believes his father was dx with colon cancer in his 70’s. Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Future Visits Future appointment information is unavailable

Referrals to Other ProvidersReason for ReferralReferral Start DateProviderProvider Contact InformationProvider AddressK63.89 - Other specified diseases of intestine,D50.9 - Iron deficiency anemia, unspecifiedNovember 22nd, 2021Richard H. Wikiera , DOWork Phone: +1(618)288-36166810 State Route 100Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Future Procedures Future procedure information is unavailable

Future Medications Future medication information is unavailable

Patient InstructionsAnemia (AC)Anemia (AC)Antibiotic FormHydrocodone/Acetaminophen (By mouth)Colectomy (DC)

Plan of Treatment — 2022-02-01

Date: 2022-02-01

Type: Plan of Treatment

Source: meditech_anderson

? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3, TIBC of 13 and ferritin <1. continue oral iron Will schedule EGD and colonoscopy. Never had EGD. last colonoscopy was over 20 years ago. He believes his father was dx with colon cancer in his 70’s. Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Future Visits Future appointment information is unavailable

Referrals to Other ProvidersReason for ReferralReferral Start DateProviderProvider Contact InformationProvider AddressK63.89 - Other specified diseases of intestine,D50.9 - Iron deficiency anemia, unspecifiedNovember 22nd, 2021Richard H. Wikiera , DOWork Phone: +1(618)288-36166810 State Route 100Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Future Procedures Future procedure information is unavailable

Future Medications Future medication information is unavailable

Patient InstructionsAnemia (AC)Anemia (AC)Antibiotic FormHydrocodone/Acetaminophen (By mouth)Colectomy (DC)

Plan of Treatment — 2022-02-08

Date: 2022-02-08

Type: Plan of Treatment

Source: meditech_anderson

? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3, TIBC of 13 and ferritin <1. continue oral iron Will schedule EGD and colonoscopy. Never had EGD. last colonoscopy was over 20 years ago. He believes his father was dx with colon cancer in his 70’s. Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Future Visits Future appointment information is unavailable

Referrals to Other ProvidersReason for ReferralReferral Start DateProviderProvider Contact InformationProvider AddressK63.89 - Other specified diseases of intestine,D50.9 - Iron deficiency anemia, unspecifiedNovember 22nd, 2021Richard H. Wikiera , DOWork Phone: +1(618)288-36166810 State Route 100Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Future Procedures Future procedure information is unavailable

Future Medications Future medication information is unavailable

Patient InstructionsAnemia (AC)Anemia (AC)Antibiotic FormHydrocodone/Acetaminophen (By mouth)Colectomy (DC)

Plan of Treatment — 2022-02-09

Date: 2022-02-09

Type: Plan of Treatment

Source: meditech_anderson

? etiology. denies any overt blood. Recent H&H 7.1/27.3, iron saturation of 3, TIBC of 13 and ferritin <1. continue oral iron Will schedule EGD and colonoscopy. Never had EGD. last colonoscopy was over 20 years ago. He believes his father was dx with colon cancer in his 70’s. Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Future Visits Future appointment information is unavailable

Referrals to Other ProvidersReason for ReferralReferral Start DateProviderProvider Contact InformationProvider AddressK63.89 - Other specified diseases of intestine,D50.9 - Iron deficiency anemia, unspecifiedNovember 22nd, 2021Richard H. Wikiera , DOWork Phone: +1(618)288-36166810 State Route 100Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Future Procedures Future procedure information is unavailable

Future Medications Future medication information is unavailable

Patient InstructionsAnemia (AC)Anemia (AC)Antibiotic FormHydrocodone/Acetaminophen (By mouth)Colectomy (DC)

Plan of Treatment — 2022-03-16

Date: 2022-03-16

Type: Plan of Treatment

Source: meditech_anderson

Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Future Visits Future appointment information is unavailable

Referrals to Other ProvidersReason for ReferralReferral Start DateProviderProvider Contact InformationProvider AddressK63.89 - Other specified diseases of intestine,D50.9 - Iron deficiency anemia, unspecifiedNovember 22nd, 2021Richard H. Wikiera , DOWork Phone: +1(618)288-36166810 State Route 100Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Future Procedures Future procedure information is unavailable

Future Medications Future medication information is unavailable

Patient InstructionsAnemia (AC)Anemia (AC)Antibiotic FormHydrocodone/Acetaminophen (By mouth)Colectomy (DC)

Plan of Treatment — 2022-05-16

Date: 2022-05-16

Type: Plan of Treatment

Source: meditech_anderson

Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Future Visits Future appointment information is unavailable

Referrals to Other ProvidersReason for ReferralReferral Start DateProviderProvider Contact InformationProvider AddressK63.89 - Other specified diseases of intestine,D50.9 - Iron deficiency anemia, unspecifiedNovember 22nd, 2021Richard H. Wikiera , DOWork Phone: +1(618)288-36166810 State Route 100Suite 100MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Syed M. Arshad , MDWork Phone: +1(618)288-11402227 Vadalabene Dr.Suite 200MARYVILLE IL 62062Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Future Procedures Future procedure information is unavailable

Future Medications Future medication information is unavailable

Patient InstructionsAnemia (AC)Antibiotic FormHydrocodone/Acetaminophen (By mouth)Colectomy (DC)Acute Diarrhea (ED)

Plan of Treatment — 2024-05-08

Date: 2024-05-08

Type: Plan of Treatment

Source: meditech_anderson

Future Tests Future scheduled test information is unavailable

Pending Tests Pending diagnostic test information is unavailable

Future Visits Future appointment information is unavailable

Referrals to Other ProvidersReason for ReferralReferral Start DateProviderProvider Contact InformationProvider AddressAs needed.Nanthini Suthan*** , MDWork Phone: +1(618)258-0485TWO TERMINAL DRIVESUITE 8EAST ALTON IL 62024Primary Care Physician SuthanWork Phone: +1(618)258-0485Pei Chang Chung , MDWork Phone: +1(618)288-36166810 State Route 162Suite 100MARYVILLE IL 62062Future ProceduresProcedure NameOrdered DateScheduled DateOutpatient Surgery DischargeJanuary 17th, 2024 1:01pmJanuary 17th, 2024 1:00amOutside images CTMay 7th, 2024 10:15pmMay 7th, 2024 12:00amDischarge OrderMay 9th, 2024 9:50amMay 9th, 2024 9:50amPlacement to ObservationMay 7th, 2024 11:56pmMay 7th, 2024 11:56pmChange Status to InpatientMay 8th, 2024 9:11amMay 8th, 2024 9:11amFuture Medications Future medication information is unavailable

Patient InstructionsAntibiotic Form

Plan of Treatment — 2024-07-01

Date: 2024-07-01

Type: Plan of Treatment

Source: meditech_anderson

AuthorHannah MorrisonAnderson HealthcareAuthoredJune 12th, 2024 10:08amI have reviewed Dr. Arshad’s office note, colonoscopy report and pathology prior to today’s visit. I discussed the pathology finding with the patient. I have recommended proceeding with HAL right colectomy under general anesthesia as an AM admit. Procedure risks, benefits, and expected outcomes were discussed in detail. Explained this is a hand assisted technique. Discussed the usual length of operation time, need for bowel prep with antibiotics, usual placement of incision and trocars, typical 6-8 week recovery, as well as the length of time spent in the hospital. Potential complications were also discussed in detail which includes conversion to open surgery, bleeding, infection, anastomotic leak, and return to surgery. All questions were answered. Patient would like to proceed. Follow-up 2 weeks postoperatively.AuthorSheena EslingerAnderson HealthcareAuthoredMay 31st, 2024 12:52pm1) Personal Hx of colon cancer/ SBO/ ileum ulcer/chronic constipation/weight loss/appetite loss: Patient had an outpatient CT at St. Anthony’s which showed SBO and patient then presented to Anderson ER 5/07/2024 at which time he was seen by surgery ( Dr. Chung) and NG decompression recommended and there was no indication for surgery at that time. S/P partial sigmoid bowel resection for adenocarcinoma in the sigmoid colon on 12/29/2021, patient completed chemotherapy but did not require radiation. Colonoscopy performed by Dr. Rodriguez 05/29/2024 which revealed a ulcer at the ileum. Unfortunately, bx were consistent with moderately differentiated adenocarcinoma. patient has been taking Dulcolax daily to avoid any slowing of his bowels. Following his hospitalization beginning of May he was doing well until about 12 days ago when he started to experience abdominal cramping and nausea. At that time he may dietary adjustments and switch to more of a liquid based diet that has been slowly advancing his diet and yesterday was able to tolerate solid foods. Today in the office he denied any GI complaints other than appetite loss and weight loss. Patient advised to contact his oncologist Dr. Arshad to discuss his treatment/surgical options He will continue to adjust his diet based on symptoms and ok to continue laxatives at this time as he feels he is dependent on them Patient advised to avoid hard to digest foods such as meats recommended supplemental nutrition such as boost or Ensure to help increase caloric intake 2) IDA: Labs earlier this month showed Hgb 12, Hct 36, MCV 81, platelets 240, iron 35, TIBC 451, iron sat 8% and ferritin 5. patient denies any signs of active GI bleeding at this time. Patient to follow up with Hematology/Oncology for management The patient will follow up in the office on an as-needed basis. This report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical, spelling, and recognition errors present.Future Tests Future scheduled test information is unavailable

Plan of Treatment — 2024-07-22

Date: 2024-07-22

Type: Plan of Treatment

Source: meditech_anderson

AuthorHannah MorrisonAnderson HealthcareAuthoredJune 12th, 2024 10:08amI have reviewed Dr. Arshad’s office note, colonoscopy report and pathology prior to today’s visit. I discussed the pathology finding with the patient. I have recommended proceeding with HAL right colectomy under general anesthesia as an AM admit. Procedure risks, benefits, and expected outcomes were discussed in detail. Explained this is a hand assisted technique. Discussed the usual length of operation time, need for bowel prep with antibiotics, usual placement of incision and trocars, typical 6-8 week recovery, as well as the length of time spent in the hospital. Potential complications were also discussed in detail which includes conversion to open surgery, bleeding, infection, anastomotic leak, and return to surgery. All questions were answered. Patient would like to proceed. Follow-up 2 weeks postoperatively.AuthorSheena EslingerAnderson HealthcareAuthoredMay 31st, 2024 12:52pm1) Personal Hx of colon cancer/ SBO/ ileum ulcer/chronic constipation/weight loss/appetite loss: Patient had an outpatient CT at St. Anthony’s which showed SBO and patient then presented to Anderson ER 5/07/2024 at which time he was seen by surgery ( Dr. Chung) and NG decompression recommended and there was no indication for surgery at that time. S/P partial sigmoid bowel resection for adenocarcinoma in the sigmoid colon on 12/29/2021, patient completed chemotherapy but did not require radiation. Colonoscopy performed by Dr. Rodriguez 05/29/2024 which revealed a ulcer at the ileum. Unfortunately, bx were consistent with moderately differentiated adenocarcinoma. patient has been taking Dulcolax daily to avoid any slowing of his bowels. Following his hospitalization beginning of May he was doing well until about 12 days ago when he started to experience abdominal cramping and nausea. At that time he may dietary adjustments and switch to more of a liquid based diet that has been slowly advancing his diet and yesterday was able to tolerate solid foods. Today in the office he denied any GI complaints other than appetite loss and weight loss. Patient advised to contact his oncologist Dr. Arshad to discuss his treatment/surgical options He will continue to adjust his diet based on symptoms and ok to continue laxatives at this time as he feels he is dependent on them Patient advised to avoid hard to digest foods such as meats recommended supplemental nutrition such as boost or Ensure to help increase caloric intake 2) IDA: Labs earlier this month showed Hgb 12, Hct 36, MCV 81, platelets 240, iron 35, TIBC 451, iron sat 8% and ferritin 5. patient denies any signs of active GI bleeding at this time. Patient to follow up with Hematology/Oncology for management The patient will follow up in the office on an as-needed basis. This report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical, spelling, and recognition errors present.Future Tests Future scheduled test information is unavailable

Progress Note — 2024-05-08

Date: 2024-05-08

Type: Progress Note

Source: meditech_anderson

Author Anthony ZychAnderson HealthcareMay 8th, 2024 7:04pm

Note Date/Time May 7th, 2024 9:04pm

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 Emergency Room Visit Note SignedPatient: Towell,Alexander R MR#: M000499848 DOB: 08/04/1975 Acct:V00003663948Age: 48 ADM Date: 05/08/24 Loc: ANH3MEDSUR 327-01 Attending Dr: Pei Chang Chung M.D.cc: Gaudreault, Rachel N. PA-C; Suthan***, Nanthini MD; Zych, Anthony H. MD~HPI - Abdominal PainGeneralChief Complaint: Abdominal PainStated Complaint: bowel obstruction; CT scan earlier todayTime Seen by Provider: 05/07/24 20:19Source: patient and old records reviewedMode of arrival: ambulatoryLimitations: no limitationsHistory of Present IllnessHPI narrative: Patient is a 48-year-old male who presents the ED with report of bowel obstruction. Patient has history of partial colectomy in 2019 for colon cancer,performed by Dr. Chung. He has since underwent chemotherapy under Dr. Arshad. He states a history of chronic constipation, but states over the last 1 month, he has had increased difficulty with constipation. He has required taking laxatives frequently to have a bowel movement. He does note his stools have been dark in color over the last few weeks. He had blood work done recently andwas noted to be newly anemic. Following with Dr. Arshad for this. He is not onany blood thinners. Denies BRBPR. Has been having intermittent abdominal pain,mostly throughout his upper abdomen over the last 1 week, with intermittent nausea and vomiting. He underwent outpatient CT scan today at Saint Anthony’s Hospital in Alton which showed a partial small-bowel obstruction. He was then sent to the ED for further evaluation. Patient denies fevers.Related Data Home Medications Medication Instructions Recorded Confirmedcholecalciferol (vitamin D3) 25 25 mcg PO DAILY 01/12/24 01/12/24mcg (1,000 unit) tablet (Vitamin D3) levothyroxine 100 mcg tablet 100 mcg PO DAILY 01/12/24 01/12/24multivitamin with minerals-folic 1 tablet PO DAILY 01/12/24 01/12/24acid 200 mcg chewable tablet (Adult Multivitamin Gummies) AllergiesAllergy/AdvReac Type Severity Reaction Status Date / TimeNo Known Allergies Allergy Verified 05/07/24 20:16Review of SystemsReview of Systems: CONSTITUTIONAL: Denies fever, chills, or sweats.GASTROINTESTINAL: See HPI.GENITOURINARY: Denies dysuria or hematuria.MUSCULOSKELETAL: Denies back pain, extremity pain, myalgia.NEUROLOGIC: Denies headache, dizziness, numbness, or weakness. All systems reviewed & are unremarkable except as noted in HPI and below PMFSHPast Medical HistoryMedical History (Reviewed 05/07/24 @ 21:08 by Rachel N. Gaudreault, PA-C)Colon cancerIron deficiency anemia (Unknown)Mass of colon (~12/2021)ObesitySurgical HistorySurgical History (Reviewed 05/07/24 @ 21:08 by Rachel N. Gaudreault, PA-C)History of colon resection 12/29/2021 - hand assisted laparoscopic sigmoid colectomy with mobilization of the splenic flexureHistory of partial thyroidectomyFamily HistoryFamily History (Reviewed 05/07/24 @ 21:08 by Rachel N. Gaudreault, PA-C)Father Carcinoma of colon HypertensionMother Deceased COPD (chronic obstructive pulmonary disease)Social HistorySocial History (Reviewed 05/07/24 @ 21:08 by Rachel N. Gaudreault, PA-C)Smoking status: Never smoker Second hand tobacco smoke exposure: No Alcohol intake: former Drinks per week: 1 Alcohol use details: LAST DRINK 2015 Substance use: never Substance use type: does not use Living arrangements: with family Additional living arrangements comments: LIVES WITH SIGNIFICANT OTHER Spiritual care concerns: No Exam

Progress Note — 2024-07-01

Date: 2024-07-01

Type: Progress Note

Source: meditech_anderson

Author Pei ChungAnderson HealthcareJuly 2nd, 2024 2:47pm

Note Date/Time July 2nd, 2024 2:47pm

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 General Surgery Progress Note SignedPatient: Towell,Alexnder R MR#: M000499848 DOB: 08/04/1975 Acct:V00003676858Age: 48 ADM Date: 07/01/24 Loc: ANH3MEDSUR 303-01 Attending Dr: Pei Chang Chung M.D.cc: ~Progress Note: A&PAssessment and Plan(1) Adenocarcinoma of small bowel: Code(s):C17.9 - Malignant neoplasm of small intestine, unspecified Status: Acute Assessment and

Plan: doing well, await path, ADAT, cont encourage OOB/ISSubjectiveSubjectiveDate/Time Seen: 07/02/24 14:46Interval history: feels pretty good, up and ambulating s issue, no bowel fxn, tol clearsReview of SystemsReview of Systems: All systems reviewed & are unremarkable except as noted in HPI and below ExamConst: General: cooperative, comfortable and no acute distress GI: Inspection: normal to inspection, non-distended and incision GI Palp: Yes abdominal tenderness, Yes Soft to palpation, Yes Tenderness to palpation present (GI), No Guarding due to palpation present (GI) and No Rigid due to palpation Objective DataVital SignsVital Signs: Vital Signs - 24 hr 07/01/2415:49 07/01/2416:00 07/01/2416:15Temperature 36.5 C Pulse Rate 55 L 61 56 LRespiratory Rate 14 18 16Blood Pressure 117/62 113/58 L 126/66Pulse Oximetry 100 100 98Oxygen Delivery Simple FaceMask Simple FaceMask Room AirOxygen Flow Rate 8 8 07/01/2416:30 07/01/2416:45 07/01/2417:00Temperature Pulse Rate 66 70 77Respiratory Rate 18 16 18Blood Pressure 119/60 123/74 123/70Pulse Oximetry 96 100 100Oxygen Delivery Room Air Room Air Room AirOxygen Flow Rate 07/01/2417:20 07/01/2417:35 07/01/2418:05Temperature 36.0 C L 36.0 C L 36.0 C LPulse Rate 71 74 60Respiratory Rate 18 16 18Blood Pressure 139/56 L 150/58 H 141/58 HPulse Oximetry 97 99 98Oxygen Delivery Oxygen Flow Rate 07/01/2419:07 07/01/2420:00 07/01/2420:00Temperature 36.3 C L 36.3 C LPulse Rate 57 L 68Respiratory Rate 18 17Blood Pressure 132/55 L 122/64Pulse Oximetry 98 100 100Oxygen Delivery Room Air Oxygen Flow Rate 07/01/2423:57 07/02/2404:00 07/02/2408:00Temperature 36.9 C 36.6 C 36.0 C LPulse Rate 63 72 50 LRespiratory Rate 18 16 16Blood Pressure 113/62 123/63 125/65Pulse Oximetry 99 99 100Oxygen Delivery Oxygen Flow Rate 07/02/2408:00 07/02/2411:48Temperature 36.1 C LPulse Rate 58 LRespiratory Rate 16Blood Pressure 127/70Pulse Oximetry 99Oxygen Delivery Room Air Oxygen Flow Rate Intake/OutputIntake/Output: Intake & Output 06/29/24 06/30/24 07/01/24 07/02/24 23:59 23:59 23:59 23:59Intake Total 300 1050Output Total 550Balance 300 500Meds/ResultsMedications: Active MedicationsGeneric Name Dose Route Start Last Admin Trade Name Freq PRN Reason Stop Dose AdminHydrocodone Bitart/Acetaminophen 1 tab 07/01/24 15:35 07/02/24 06:21 Hydrocodone/Acetaminophen (*Crx) 5-325 Mg Tablet PO 1 tab Q4H PRN Administration Pain Rated 4-6 Enoxaparin Sodium 40 mg 07/02/24 09:00 07/02/24 08:05 Enoxaparin 40 Mg/0.4 Ml Syringe SUB-Q 40 mg DAILY SCH AdministrationFamotidine 20 mg 07/01/24 21:00 07/02/24 08:05 Famotidine 20 Mg/2 Ml Vial IV PUSH 20 mg Q12HR SCH AdministrationFentanyl Citrate 25 mcg 07/01/24 16:00 Fentanyl Citrate Inj (*Crx) 100 Mcg/2 Ml Vial IV PUSH Q2M PRN Pain Hydromorphone HCl 1 mg 07/01/24 17:16 Hydromorphone Hcl Inj (*Crx) 1 Mg/Ml Syr IV PUSH Q2H PRN Breakthrough Pain Rated 7-10 or NPO Hydromorphone HCl 0.5 mg 07/01/24 15:35 Hydromorphone Hcl Inj (*Crx) 1 Mg/Ml Syr IV PUSH Q2H PRN Breakthrough Pain Rated 4-6 or NPO Lactated Ringer’s 1,000 mls @ 100 mls/hr 07/01/24 15:35 07/02/24 10:18 Lr - Lactated Ringers Iv IV CONT 100 mls/hr .Q10H SCH AdministrationIbuprofen 800 mg in 200 mls @ 400 mls/hr 07/01/24 15:35 Caldolor 800 Mg/200 Ml IVPB Q6H PRN Breakthrough Pain Rated 1-3 or NPO Levothyroxine Sodium 100 mcg 07/02/24 06:30 07/02/24 05:17 Levothyroxine Sodium 100 Mcg Tablet PO 100 mcg DAILY@0630 SCH AdministrationNaloxone HCl 0.1 mg 07/01/24 15:35 Naloxone Hcl 0.4 Mg/Ml Vial IV PUSH Q2M PRN Opiate Reversal Ondansetron HCl 4 mg 07/01/24 15:35 Ondansetron Inj 4 Mg/2 Ml Vial IV PUSH Q4H PRN Nausea And Vomiting Radiology Results: ITS ImpressionsAbdomen X-Ray 07/01/24 15:32

Progress Note — 2024-07-22

Date: 2024-07-22

Type: Progress Note

Source: meditech_anderson

Author James PowellAnderson HealthcareJuly 22nd, 2024 1:23pm

Note Date/Time July 22nd, 2024 1:23pm

Anderson Hospital 6800 State Route 162 Maryville, IL 62062 Anesthesiology Progress Note SignedPatient: Towell,Alexander R MR#: M000499848 DOB: 08/04/1975 Acct:V00003688837Age: 48 ADM Date: 07/22/24 Loc: ANHSURGERY Attending Dr: Pei Chang Chung M.D.cc: ~Anes - Initial Pre Proc EvalProcedure: Operation Date: 07/22/24 14:00Proposed Proceduresp Insertion Porta Cath - Pei Chang Chung, MDDate/Time: 07/22/24 13:23Surgeon: Pei Chang Chung, MDPre Op

Diagnosis: malig neoplasm of colonPatient DataAge: 48Gender: MHeight: 1.85 mWeight: 90.5 kg Last Vital SignsTemp 36.6 C 07/22/24 12:42Pulse 57 L 07/22/24 12:42Resp 16 07/22/24 12:42BP 121/73 07/22/24 12:42Pulse Ox 100 07/22/24 12:42O2 Del Method Room Air 07/22/24 12:42 AllergiesAllergy/AdvReac Type Severity Reaction Status Date / TimeNo Known Allergies Allergy Verified 07/22/24 12:21 Home Medications Medication Instructions Recorded Confirmed Typecholecalciferol (vitamin D3) 25 25 mcg PO DAILY 01/12/24 07/22/24 Historymcg (1,000 unit) tablet (Vitamin D3) levothyroxine 100 mcg tablet 100 mcg PO DAILY 01/12/24 07/22/24 Historymultivitamin with minerals-folic 1 tablet PO DAILY 01/12/24 07/22/24 Historyacid 200 mcg chewable tablet (Adult Multivitamin Gummies) ferrous sulfate 325 mg (65 mg 650 mg PO DAILY 06/26/24 07/22/24 Historyiron) tablet omega-3 fatty acids 1,000 mg PO DAILY 06/26/24 07/22/24 HistoryPatient hx anesthesia problems: noneFamily hx anesthesia problems: noneResults Review: All pre-operative results and documents have been reviewed as part of the pre-operative evaluation.PMFSHPast Medical HistoryMedical History (Reviewed 07/22/24 @ 13:23 by James S. Powell, MD)Colon cancerIron deficiency anemia (Unknown)Mass of colon (~12/2021)Surgical HistorySurgical History (Reviewed 07/22/24 @ 13:23 by James S. Powell, MD)History of colon resection 12/29/2021 - hand assisted laparoscopic sigmoid colectomy with mobilization of the splenic flexureHistory of partial thyroidectomyFamily HistoryFamily History (Reviewed 07/22/24 @ 13:23 by James S. Powell, MD)Father Hypertension Malignant neoplasm of prostateMother Deceased COPD (chronic obstructive pulmonary disease)Social HistorySocial History (Reviewed 07/22/24 @ 13:23 by James S. Powell, MD)Smoking status: Never smoker Second hand tobacco smoke exposure: No Alcohol intake: never Drinks per week: 1 Alcohol use details: LAST DRINK 2015 Substance use: never Substance use type: does not use Do You Feel Safe in your Home?: Yes Lack of Transportation: No Lack of Food: Never True Current Housing: I Have Housing Concerned About Future Housing: No Difficulty Paying Gas/Electric Bills: No Difficulty Paying for Meds: No Currently Unemployed: No Education: Master’s Degree or Higher Difficulty w/ Childcare or Family Care: No Living arrangements: with family Additional living arrangements comments: with sp Spiritual care concerns: No Anes - Eval Final PreProcedureDay of Procedure07/22/24 13:23Patient weight: overweightHeart: regular rate and rhythmLungs: clear to auscultationAirway: Mallampati scale class IINeurological: alert and orientedLast oral intake: >/= 8 hoursASA classification: IIIEmergent: noAnesthetic plan: proceedAnesthesia type and monitoring: general GIVS and standard monitoringResults Review: All pre-operative results and documents have been reviewed as part of the pre-operative evaluation.Informed Consent: The patient’s anesthetic plan and its attendant risks and benefits were discussed with the patient/family/POA. Questions were solicited and answers provided to the satisfaction of the patient/family/POA.This report may have been done utilizing a voice recognition system. Attempts have been made to correct errors. However, there may be uncorrected grammatical,spelling, and recognition errors present.Report Initialized date/time: Powell, James S. II MD 07/22/24 / 1323Electronically signed by: Powell, James S. II MD 07/22/24 1323

Progress Notes — 2023-08-23

Date: 2023-08-23

Type: Progress Notes

Source: epic_ihe_xdm

Mary Stuart, PA - 08/23/2023 9:00 AM CDTFormatting of this note is different from the original.Images from the original note were not included.NEW PATIENT VISITSubjective CHIEF COMPLAINTHe had concerns including Pain of the Right Wrist.HISTORY OF PRESENT ILLINESSPatient here with complaints of right wrist pain. He reports a fall 8 months ago. He was playing with his niece and this was an accidental fall. Symptoms initially got better slowly with time, however he is continued to experience ongoing ulnar-sided pain. It limits him with rotation and extension type activities. Symptoms are exacerbated by use. They improve with rest. A constant dull aching sensation. He states history of chemo induced neuropathy of the right wrist and hand, which is stablePain AssessmentPain

Assessment: 0-10Pain Score: 2PAST MEDICAL HISTORYHe has a past medical history of Anemia, Cancer (CMS/HCC) (HCC), and Peripheral neuropathy.PAST SURGICAL HISTORYHe has a past surgical history that includes Colon surgery.MEDICATIONSHe has a current medication list which includes the following prescription(s): levothyroxine.ALLERGIESHe has No Known Allergies.SOCIAL HISTORYHe No alcohol history on file.FAMILY HISTORYHistory reviewed. No pertinent family history.REVIEW OF SYSTEMSReview of Systems Constitutional: Negative for chills, fatigue and fever. Eyes: Negative for pain and visual disturbance. Respiratory: Negative for chest tightness and shortness of breath. Cardiovascular: Negative for chest pain and leg swelling. Gastrointestinal: Negative for abdominal pain, constipation, diarrhea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for myalgias. Skin: Negative for rash and wound. Neurological: Negative for dizziness, weakness and light-headedness. Hematological: Does not bruise/bleed easily. Psychiatric/Behavioral: Negative for confusion and hallucinations. Objective PHYSICAL EXAMBP 141/89 | Pulse 62 | Ht 182.9 cm (6’) | Wt 100.2 kg (221 lb) | BMI 29.97 kg/m² Right hand/wristInspectionErythema: absentEffusion: absentEdema: presentSurgical scar/wound: absent. PalpationTenderness: present. The tenderness is located in the ulnar forveal, ulnar triquetral and DRUJ.Range of motionThe patient has reduced range of motion of the right wrist.The patient has pain with range of motion of the right wrist.Strength Thumb extension: 5/5Thumb flexion: 5/5Thumb opposition: 5/5Wrist extension: 4/5Wrist flexion: 5/5Interossei: 3/5Grip: 4/5NeurovascularThe patient has normal vascular on the right side of their body.The patient has normal sensation with exceptions as noted below.Median: paresthesiasRadial: paresthesiasUlnar: paresthesiasTestTinel’s sign: negativeUlnar Impaction sign: positiveLeft hand/wristThe patient has normal inspection, palpation, range of motion, strength, and stability of the left hand and wrist.REVIEW OF X-RAYS/STUDIES/LABSXR Wrist Right 3 or More Views Radiographs of the right wrist reviewed, interpreted, and compared with earlier views obtained at an outside facility. No acute fractures are seen. On tunnel view, there subacute changes at the trapezial process, likely reflective of prior injury or subacute fracture. No bony entrapment is present upon carpal tunnel. Positive ulnar variance appreciatedFriedman, Michael, MD - 07/28/2023Formatting of this note might be different from the original.EXAM DESCRIPTION: XR WRIST LIMITED 2 VIEW RIGHTREASON FOR STUDY: Two views submitted without comparison.

Progress Notes — 2024-08-15

Date: 2024-08-15

Type: Progress Notes

Source: epic_ihe_xdm

Benjamin Tan, MD - 08/15/2024 3:15 PM CDTFormatting of this note is different from the original.Images from the original note were not included.Oncology Medicine History and PhysicalAlexander R TowellDOB:8/4/1975 DATE OF VISIT:8/15/2024Referring Provider: Syed M. Arshad, MD Cancer Staging No matching staging information was found for the patient.Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XF- ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparsocopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/BevacizumabMalignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R Towell, Alexander R does not have any active plans of the following types: Oncology Chemotherapy Treatment, Oncology Treatment (2), Oncology Treatment (3), Oncology Supportive Care, Specialty Infusion Treatment, Blood Products, BMT, HematologySubjective Mr. Alexander R Towell is a 49 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for second opinion for his metastatic colon cancer.In brief, Mr. Alexander R Towell presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyToday, he comes and noted :- feeling well- mild loose stools- no fever, chills- no nausea, vomiting- no abdominal pain- no chest pain, SOBPast Medical

Progress Notes — 2024-09-11

Date: 2024-09-11

Type: Progress Notes

Source: epic_ihe_xdm

Ellen S - 09/11/2024 3:06 PM CDTFormatting of this note might be different from the original.Called Dr.Field’s office to attempt to get this pt scheduled and was unsuccessful after a 20 minute call that was not helpful. Called Dr.Field’s office back because of concerns this appt will not get scheduled and was told Megan the NP will get back with me.Electronically signed by Ellen S at 09/11/2024 3:14 PM CDTdocumented in this encounter

Progress Notes — 2024-09-12

Date: 2024-09-12

Type: Progress Notes

Source: epic_ihe_xdm

Ellen S - 09/12/2024 10:47 AM CDTFormatting of this note might be different from the original.Tried calling Megan@Dr.Field’s office back @314-125-7507 but no answer.Electronically signed by Ellen S at 09/12/2024 10:50 AM CDTdocumented in this encounter

Progress Notes — 2024-10-23

Date: 2024-10-23

Type: Progress Notes

Source: epic_ihe_xdm

Lauren Lutz, NP - 10/23/2024 10:30 AM CDTFormatting of this note is different from the original.Transplant/ Hepatobiliary Surgery Outpatient Clinic NoteChief Complaint: mCRC to the liverReferred by: Nanthini Suthan, MDHPI: Mr. Alexander R Towell is a 49 y.o. male with a history of metastatic CRC diagnosed via colonoscopy done for constipation in 2021. Pt then underwent laparoscopic sigmoid colectomy 12/29/21 (1/23 lymph nodes +; negative for K-ras mutation). Complete chemotherapy with FOLFOX 2/16-12/22/22. Per patient report, things were stable for ~1 year, when he began experiencing constipation again. Pt underwent repeat colonoscopy 5/29/24 which demonstrated a large ulcerated lesion with bleeding in the terminal ileum. He is now s/p R sided hemicolectomy 7/1/24 (small bowel +invasive adenocarcinoma, perineural invasion present, 4/14 lymph nodes +; no lymphovascular invasion; K-ras negative). Pt started back on chemotherapy with FOLFIRI/Avastin 7/25/24 with Dr. Arshad (Mercy), and has also been seen by Dr. Tan at WashU for a second opinion. Per patient report he underwent a CT scan last week at Anderson hospital, those results are not available at the time of this visit. Of note, pt initially planned to be seen by Dr. Fields who scheduled a repeat MRI 11/1/24, pt was able to get into see Dr. Chapman sooner. Advised pt to keep appointment for repeat MRI. Past Medical

History: has a past medical history of Anemia, Cancer (CMS/HCC) (HCC), Peripheral neuropathy, and Thyroid disease. Past Surgical

History: has a past surgical history that includes Colon surgery (12/30/2021) and Small Bowel Resection (07/01/2024).Social

History: Alcohol: deniesTobacco: deniesMarijuana: deniesOccupation: not currently, previous research assistant at SIUEPresents to clinic with partner. Allergies: No Known AllergiesFamily

History:family history includes Prostate cancer (age of onset: 69) in his father.Medications: HOME MEDICATIONS : cyanocobalamin (Vitamin B-12) 100 mcg tablet iron bisgly,ps-FA-B-C#12-succ 65 mg-65 mg -1,000 mcg (24) tablet levothyroxine (SYNTHROID) 100 mcg tablet multivitamin with minerals tablet omega-3 fatty acids-fish oil 300-1,000 mg capsuleReview of Systems: Reports: overall tolerating chemo ok, some fatigue, N better managed on current regimenDenies any abdominal pain, vomiting, constipation, diarrhea, dark urine, light stools, fevers, chills, loss of appetite, weight loss, jaundice or pruritis. Physical Exam: Blood pressure 143/79, pulse 85, temperature 36.6 °C (97.8 °F), height 182.9 cm (6’), weight 89.5 kg (197 lb 6.4 oz).Constitutional: AmbulatoryHead: Normocephalic, non traumaticEyes:Bilateral sclera anicteric ENT: Normal hearing, no obvious deformitiesLungs: Non- labored breathing, on room airCV: Well perfused, no JVDAbdomen: Soft, not distended, non tenderSkin: No rashes or jaundiceExtremities: Warm, no pitting pedal edemaNeuro: No gross neurological deficitsPysch: Mood appropriate, A+Ox3Labs: No results found for: “WBC”, “HGB”, “HCT”, “MCV"Lab Results Component Value Date CREATININE 1.4 (H) 08/28/2024 Pathology: Taken: 8/20/2024 Received: 8/20/2024 Accessioned: 8/20/2024 Reported: 8/22/2024 Physician(s): Benjamin Tan, M.D. Anderson Hospital Department of Pathology 6800 State Route 162 Maryville, IL 62062 P: 618-391-6765 F: 618-288-6541 Histology: 618-391-6774

Progress Notes — 2024-11-14

Date: 2024-11-14

Type: Progress Notes

Source: epic_ihe_xdm

William Chapman, MD - 11/14/2024 1:00 PM CSTFormatting of this note is different from the original.Images from the original note were not included.WASHINGTON UNIVERSITY SCHOOL OF MEDICINE SECTION OF COLON RECTAL SURGERY HISTORY AND PHYSICALName: Alexander R TowellMRN: 104670153Date of birth: 8/4/1975Date of visit: 11/14/2024 Referring Provider: Benjamin R. Tan, MDPCP: Suthan, Nanthini, MDOncologist:Tan, Benjamin R., MD Reason for visit: Evaluate question of peritoneal metastasis from small bowel adenocarcinoma. HPI: Mr. Towell is a 49 y.o. male who presents for evaluation of a questionable peritoneal metastasis from his known primary small bowel adenocarcinoma. In brief, this is a 49-year-old male who in 2021 was diagnosed with a sigmoid colon cancer and underwent primary resection with anastomosis. He subsequently received a complete course of adjuvant therapy and was otherwise without evidence of residual disease until July 20, 2024. At that time, he presented with symptoms and underwent axial imaging which showed bowel obstruction with a presumed mass in the terminal ileum. He then underwent laparoscopic right hemicolectomy, with an operative note that reports no evidence of peritoneal disease. His pathology returned with a primary diagnosis of ileal adenocarcinoma with positive lymph nodes. There was no mention of exploration of the pelvis, but notably the surgeon did not see any evidence of peritoneal metastasis at that time. In August, 2024, he then underwent PET imaging prior to initiating adjuvant chemotherapy and was found to have evidence of disease within the liver as well as several foci of PET avidity in the pelvis in the retrovesical pouch. At that time, he was initiated on medical treatment and referred to the hepatobiliary Surgical Service as well as myself for further evaluation. He has since seen the liver surgery team, and they have ordered an MRI of the abdomen to better characterize his amount of residual liver disease after adjuvant therapy.Today, he presents to me for evaluation of this questionable pelvic metastasis. He has no abdominal pain at this time and is otherwise without symptoms. He is having regular bowel function and tolerating a diet. His weight is stable. He continues on chemotherapy, with approximately 8 weeks left prior to completing his course of FOLFIRI. He is up-to-date with his colonoscopy, having undergone 1 earlier this year which was unremarkable. He has also had genetic testing, which he notes showed no evidence of any germline mutations.His past surgical history is notable for a laparoscopic anterior resection in 2021 and a laparoscopic right hemicolectomy in 2024. He has no notable family history of colon or rectal cancer.Pertinent Past Medical

Progress Notes — 2024-12-10

Date: 2024-12-10

Type: Progress Notes

Source: epic_ihe_xdm

Maureen Mercier, NP - 12/10/2024 10:25 AM CSTFormatting of this note might be different from the original.To call patient regarding MRI findings and plan for interval imaging.Electronically signed by Maureen Mercier, NP at 12/10/2024 10:27 AM CSTdocumented in this encounter

Progress Notes — 2024-12-30

Date: 2024-12-30

Type: Progress Notes

Source: epic_ihe_xdm

Maureen Mercier, NP - 12/30/2024 1:04 PM CSTFormatting of this note might be different from the original.Attempted to call wife regarding questions regarding MRI. No answer. VM left.Electronically signed by Maureen Mercier, NP at 12/30/2024 1:04 PM CSTdocumented in this encounter

Progress Notes — 2025-04-30

Date: 2025-04-30

Type: Progress Notes

Source: epic_ihe_xdm

Mallory Hubbard, PA - 04/30/2025 9:30 AM CDTFormatting of this note might be different from the original.Transplant/ Hepatobiliary Surgery Outpatient Clinic NoteChief Complaint: metastatic colorectal cancer to the liverReferred by: Benjamin R. Tan, MDHPI: Mr. Alexander R Towell is a 49 y.o. male with history of metastatic colorectal cancer the liver. Presenting for surgical consultation accompanied by his girlfriend, Kimberly. He was diagnosed with sigmoid colon cancer status post laparoscopic sigmoid colectomy in 12/29/2021. He was recurrence free until three years later, his recurrence was in the terminal ileum status post right hemicolectomy in 7/1/2024, pathology notable for ileal adenocarcinoma. Last colonoscopy was 2 months ago which was normal. He was first seen in our clinic and reviewed at liver multidisciplinary conference in 10/2024. > Findings: PET (july)- 4 areas of FDG uptake in the liver, very focal. 2 in left hemiliver 1 near segment 7 + 1 near the dome. MRI (aug)- treatment response with smaller lesions, only see 3 lesions. Pelvic disease is treated. >

Plan: Consider left lateral resection versus ablationPast Medical

History: has a past medical history of Anemia, Cancer (HCC), Peripheral neuropathy, and Thyroid disease. Past Surgical

History: has a past surgical history that includes Colon surgery (12/30/2021) and Small Bowel Resection (07/01/2024).Social

History: Alcohol use: none Tobacco use: noneOccupation: previous research assistant at SIUEECOG status: ECOG: 0 - Fully active, able to carry on all pre-disease performance without restrictionAllergies: No Known AllergiesFamily

History:family history includes Prostate cancer (age of onset: 69) in his father.Medications: HOME MEDICATIONS : cyanocobalamin (Vitamin B-12) 100 mcg tablet iron bisgly,ps-FA-B-C#12-succ 65 mg-65 mg -1,000 mcg (24) tablet levothyroxine (SYNTHROID) 100 mcg tablet multivitamin with minerals tablet omega-3 fatty acids-fish oil 300-1,000 mg capsuleReview of Systems: Reports: noneDenies any abdominal pain, nausea, vomiting, constipation, diarrhea, dark urine, light stools, fevers, chills, loss of appetite, weight loss, jaundice or pruritis. Physical Exam: Blood pressure 130/84, pulse 54, temperature 36.3 °C (97.3 °F), height 182.9 cm (6’), weight 96.6 kg (213 lb).Constitutional: Ambulatory, No acute distressHead: Normocephalic, non traumaticEyes:Bilateral sclera anicteric ENT: Normal hearing, no obvious deformitiesLungs: Non- labored breathing, on room airCV: Well perfused, no JVDAbdomen: Soft, not distended, non tender. No hernia. Well healed incision. Skin: No rashes or jaundiceExtremities: Warm, no pitting pedal edemaNeuro: No gross neurological deficitsPysch: Mood appropriate, A+Ox3Labs: > none to review Pathology: Consult material received from Anderson Hospital, Maryville, IL (OSC: AS21-7173; 11/22/2021) A. Stomach, biopsy - Normal oxyntic mucosa - No H. pylori organisms are identified by H&E examination B. Small bowel, biopsy - Normal duodenal mucosa C. Large bowel, descending colon mass, biopsy - Ulcerated invasive adenocarcinoma Consult material received from Anderson Hospital, Maryville, IL (OSC: AS21-7988; 12/29/2021) A. Large bowel, sigmoid, left hemicolectomy - Moderately differentiated colonic adenocarcinoma invading the visceral peritoneum (pT4a) - Tumor arises in the sigmoid colon and measures 6.0 cm in greatest dimension, per report - Surgical margins are negative for tumor - Negative for perineural or lymphovascular invasion - Metastatic adenocarcinoma in one of twenty-three lymph nodes(1/23; pN1a) Consult material received from Anderson Hospital, Maryville, IL (OSC: AS24-3099; 05/29/2024) A. Small bowel, terminal ileum ulcerated lesion, biopsy - Invasive adenocarcinoma, moderately-differentiated - Intact nuclear expression of mismatch repair proteins (MLH1, PMS2, MSH2, and MSH6) by immunostains Consult material received from Anderson Hospital, Maryville, IL (OSC: AS24-3810; 07/01/2024) A. Large bowel, right colon and ileum, right hemicolectomy - Moderately differentiated adenocarcinoma involving the perienteric soft tissue, muscularis propria, submucosa, and mucosa (see comment) - No precursor lesion identified in the ileal mucosa - Per report, deep/radial margin positive for tumor - Distal and proximal margins negative for tumor - Positive for perineural invasion - Negative for definitive lymphovascular invasion - Five tumor deposits identified - Metastatic adenocarcinoma in four of fourteen lymph nodes (4/14) - Normal appendix Imaging: MRI 4/30/2025: 1. Unchanged hepatic segment 2 lesion consistent with continuedtreatment response. No evidence of progressive or new metastaticdisease in the abdomen.2. Near complete resolution of the wedge shaped lesion in hepaticsegment 8, which was previously thought to represent focal hepatictoxicity related to oxaliplatin.

Progress Notes — 2025-05-14

Date: 2025-05-14

Type: Progress Notes

Source: epic_ihe_xdm

Nurse Kelli M - 05/15/2025 9:18 AM CDTFormatting of this note is different from the original. 05/14/25 1630 Discharge Summary Discharge Disposition Private residence Recommended Discharge Level of Care Private residence Actual Discharge Level of Care Private residence Does Actual Level of Care Match Care Team Recommendation? Yes Post Acute Care Plan Post Acute Care Needs Identified No Discharge Additional Assistance Does the patient need discharge transport arranged? No Post Discharge Care Provider Post Discharge Care Plan DC Summary has been faxed to next level of care provider (see Follow Up Providers) Per medical team, patient is medically stable for discharge at this time. Follow up appointment has been scheduled by current medical team for May 28th. Transportation will be provided by significant other. Patient and/or family are agreeable with the plan. If any further discharge needs arise, please contact the covering case manager. Electronically signed by Nurse Kelli M at 05/15/2025 9:39 AM CDTElectronically signed by Nurse Kelli M at 05/15/2025 9:39 AM CDTMaggie Algya, RD - 05/15/2025 9:18 AM CDTFormatting of this note is different from the original.NUTRITION ASSESSMENTNutrition Status: Patient appears adequately nourished at this time.REASON FOR ASSESSMENT: Consult/Referral - Post-Op Nutrition Assessment Encounter Date: 05/15/25 9:58 AM Admission Date: 5/14/2025 LOS: 1 daysHPI: Patient is a 49 y.o. male with history of metastatic colorectal cancer the liver. He was diagnosed with sigmoid colon cancer status post laparoscopic sigmoid colectomy in 12/29/2021. He was recurrence free until three years later, his recurrence was in the terminal ileum status post right hemicolectomy in 7/1/2024, pathology notable for ileal adenocarcinoma. 5/24: OR for robotic segment 2 resectionObjective Past Medical

History: Diagnosis Date Anemia Cancer (HCC) Peripheral neuropathy Sleep apnea Thyroid disease Past Surgical

History: Procedure Laterality Date COLON SURGERY 12/30/2021 SMALL BOWEL RESECTION 07/01/2024 THYROIDECTOMY, PARTIAL Right 2022 Social History Tobacco Use Smoking status: Never Smokeless tobacco: Never Substance and Sexual Activity Drug use: Never Sexual activity: Defer Alcohol Use: Not At Risk (5/14/2025) AUDIT-C Frequency of Alcohol Consumption: Never Average Number of Drinks: Patient does not drink Frequency of Binge Drinking: Never MEDICATION/LAB REVIEW:Scheduled Meds: acetaminophen, 1,000 mg, oral, Q6H SCHheparin, 5,000 Units, subcutaneous, Q8H SCHketorolac, 15 mg, intravenous, Q6H SCHlevothyroxine, 112 mcg, oral, Daily - 0600lidocaine, 1 patch, transdermal, Q24Hlidocaine, 1 patch, transdermal, Q24HmethocarbamoL, 500 mg, oral, TIDContinuous Infusions: PRN Meds: LORazepam ondansetron oxyCODONERecent Labs Lab Units 05/15/250538 05/14/251438 SODIUM mmol/L 141 142 POTASSIUM PLASMA mmol/L 4.3 4.1 CHLORIDE mmol/L 105 105 CO2 mmol/L 25 25 BUN SERUM mg/dL 12 20 CREATININE mg/dL 1.03 1.16 GFR-NON-AFRICAN AMERICAN mL/min/1.73 m2 89 77 CALCIUM mg/dL 9.4 8.9 ALBUMIN g/dL 4.1 3.9 PHOSPHORUS PLASMA mg/dL 4.7* 4.5 MAGNESIUM mg/dL 2.3 2.7* Recent Labs Lab Units 05/15/250538 05/14/251438 GLUCOSE mg/dL 132 118 ALT Date Value Ref Range Status 05/15/2025 78 (H) 7 - 55 Units/L Final AST Date Value Ref Range Status 05/15/2025 67 (H) 10 - 50 Units/L Final Alk phos Date Value Ref Range Status 05/15/2025 61 40 - 130 Units/L Final No results found for: “HGBA1C”, “HDL”, “LDLCALC”, “CHOL”, “TRIG"NURSING ASSESSMENT:Last BM Date: (PTA)Bowel Sounds (All Quadrants): ActiveBraden Scale Score: 20Skin Integrity: Surgical incision Vital Signs@FLOW(5)Temp: 36.5 °C (97.7 °F)Pulse: 60Resp: 17SpO2: 100 %Intake/Output Summary (Last 24 hours) at 5/15/2025 0958Last data filed at 5/15/2025 0325Gross per 24 hour Intake 743.75 ml Output 1480 ml Net -736.25 ml Adult Malnutrition Scoring Tool (MST)Have You Recently Lost Weight Without Trying?: NoHave you been eating poorly because of a decreased appetite?: NoMalnutrition Screening Tool (MST) Score: 0AnthropometricsWeight: 97.9 kg (215 lb 14.4 oz)Admission Weight : 93 kgWeight Change: 4.94 kg (10.90 lbs)IBW/kg (Calculated) : 83.5 kgHeight: 185.4 cm (6’ 1”)Weight in (lb) to have BMI = 25: 189.1BMI (Calculated): 28.5Wt Readings from Last 10 Encounters: 05/15/25 97.9 kg (215 lb 14.4 oz) 05/01/25 96.8 kg (213 lb 6.5 oz) 04/30/25 96.6 kg (213 lb) 04/30/25 102.1 kg (225 lb) 11/14/24 87.9 kg (193 lb 12.8 oz) 11/29/24 86.2 kg (190 lb) 10/23/24 89.5 kg (197 lb 6.4 oz) 08/28/24 90.7 kg (200 lb) 08/15/24 88.2 kg (194 lb 6.4 oz) 08/23/23 100.2 kg (221 lb) ESTIMATED NEEDS: Weight Used for Equation Calculations (RD Determined): 97.5 kg (215 lb)Total Kcal/kg Estimated Needs : 1958.64 Kcal/kg: 20. Type of Weight Used for Estimated Kcals: CurrentTotal Protein Estimated Needs (gm): 108.55 Protein Needs Based on g/kg: 1.3 Type of Weight Used for Estimated Protein : IdealTotal Fluid Estimated Needs: 1958.64 Fluid Needs Based on : 1 ml/kcal Type of Weight Used for Estimated Fluid Needs: Current Dietary Orders (From admission, onward) Start Ordered 05/15/25 0651 Adult Diet Regular Diet effective now Question: (BJH) Diet type Answer: Regular 05/15/25 0650 Allergies: Reviewed. Pt does not have any cultural or religious food preferences.

Progress Notes — 2025-05-28

Date: 2025-05-28

Type: Progress Notes

Source: epic_ihe_xdm

Maureen Mercier, NP - 05/28/2025 9:15 AM CDTFormatting of this note is different from the original.Abdominal Transplant/HPB Post-Op Clinic NoteChief Complaint: Postoperative visit.HPI: Mr. Alexander R Towell is a 49 y.o. male with a history of metastatic colorectal cancer to the liver s/p XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED, TAP Block on 05/14/2025 with Dr. Chapman. The postoperative course was unremarkable. Doing well today. Minimal complaints upon Ros. Feeling well. He denies abdominal pain, nausea, vomiting, constipation, diarrhea, fevers or chills. He reports a healthy appetite. Past Medical

History: has a past medical history of Anemia, Cancer (HCC), Peripheral neuropathy, Sleep apnea, and Thyroid disease.He has no past medical history of Acute respiratory failure requiring reintubation (HCC), Awareness under anesthesia, Delayed emergence from general anesthesia, Hard to intubate, Malignant hyperthermia, Motion sickness, PONV (postoperative nausea and vomiting), Postoperative delirium, or Pseudocholinesterase deficiency. Past Surgical

History: has a past surgical history that includes Colon surgery (12/30/2021); Small Bowel Resection (07/01/2024); and Thyroidectomy, partial (Right, 2022).Social

History: reports that he has never smoked. He has never used smokeless tobacco. He reports that he does not use drugs. Patient denies consuming alcoholic drinks. Allergies: No Known AllergiesFamily

History: family history includes Prostate cancer (age of onset: 69) in his father.Medications: HOME MEDICATIONS : cyanocobalamin (Vitamin B-12) 100 mcg tablet docusate sodium (COLACE) 100 mg capsule iron bisgly,ps-FA-B-C#12-succ 65 mg-65 mg -1,000 mcg (24) tablet levothyroxine (SYNTHROID) 112 mcg tablet loperamide (IMODIUM A-D) 2 mg tablet LORazepam (ATIVAN) 0.5 mg tablet multivitamin with minerals tablet omega-3 fatty acids-fish oil 300-1,000 mg capsule prochlorperazine (COMPAZINE) 10 mg tablet propranoloL (INDERAL) 20 mg tablet zolpidem (AMBIEN) 5 mg tabletVitalsBP 132/86 Pulse 93 Temp 36.4 °C (97.6 °F) Ht 182.9 cm (6’) Wt 98.7 kg (217 lb 9.6 oz) SpO2 97% BMI 29.51 kg/m² Review of Systems: Review of Systems All other systems reviewed and are negative.Physical Exam: Physical ExamConstitutional: General: He is not in acute distress. Appearance: Normal appearance. He is not ill-appearing, toxic-appearing or diaphoretic. HENT: Head: Normocephalic and atraumatic. Right Ear: External ear normal. Left Ear: External ear normal. Eyes: Conjunctiva/sclera: Conjunctivae normal. Cardiovascular: Rate and Rhythm: Normal rate. Pulses: Normal pulses. Pulmonary: Effort: Pulmonary effort is normal. No respiratory distress. Abdominal: General: Abdomen is flat. There is no distension. Palpations: Abdomen is soft. There is no mass. Tenderness: There is no abdominal tenderness. There is no guarding. Hernia: No hernia is present. Comments: Incision healing well Musculoskeletal: Comments: Independently moves extremities Skin: General: Skin is warm and dry. Coloration: Skin is not pale. Findings: No erythema or rash. Neurological: Mental Status: He is alert and oriented to person, place, and time. Psychiatric: Mood and Affect: Mood normal. Behavior: Behavior normal. Thought Content: Thought content normal. Judgment: Judgment normal. Surgical Pathology:URGICAL PATHOLOGY REPORT FINAL WITH ADDENDUM Patient Name: TOWELL, ALEXANDER R. Accession #: S25-23061 Gender: M DOB: 8/4/1975 (Age: 49) Address: 304 PICKER AVE, WOOD RIVER, IL 62095-1144 MRN: 104670153 Hospital #: 2272813559 Taken:5/14/2025 Received:5/14/2025 Accessioned:5/14/2025 Reported: 5/19/2025 Patient Type: BJH Inpatient Service: Surgery Location: BJH 0164 Physician(s): William C. Chapman, M.D. Nanthini Suthan, MD Benjamin Tan, M.D.

Progress Notes — 2025-07-08

Date: 2025-07-08

Type: Progress Notes

Source: epic_ihe_xdm

Benjamin Tan, MD - 07/08/2025 11:45 AM CDTFormatting of this note is different from the original.Images from the original note were not included. Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:7/8/2025 Cancer Staging No matching staging information was found for the patient.Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XF- ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparsocopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/2025Malignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R Towell, Alexander R does not have any active plans of the following types: Oncology Chemotherapy Treatment, Oncology Treatment (2), Oncology Treatment (3), Oncology Supportive Care Therapy Plan, Specialty Infusion Treatment, Blood Products, BMT, Hematology, Radiopharmaceutical Treatment, Pediatric Infusion Treatment, Pediatric Infusion Treatment #3, Pediatric Infusion Treatment #2, Transplant Therapy Plan, PHERESIS, DIALYSIS, Interventional Psychiatry, Line Care , Dialysis Therapy Plan 2, BMT/ONC IP BLOOD PRODUCTS, Specialty Infusion Treatment 2, Specialty Infusion Treatment 3, Specialty Infusion Treatment 4, Oncology Supportive Care Treatment Plan, Oncology Treatment (4)Subjective Mr. Alexander R Towell is a 49 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.Since his last visit with us, he continued with his treatments locally. His last scans done 4/30/2025 showed He then underwent a robotic segment 2 resection by Dr. Chapman on 5/14/2025. Operative findings notes no other metasattic site except for the segment 2 lesion which was small. Pathology showed metatatic adenocarcinoma but also at the cauterized margin with PNI.Today, he comes with his wife and notes- feeling well- surgical scars well healed- no diarrhea- no fever, chills- no nausea, vomiting- no abdominal pain- no chest pain, SOBPast Medical

Progress Notes — 2025-07-31

Date: 2025-07-31

Type: Progress Notes

Source: epic_ihe_xdm

Crystal Wolf, PA - 07/31/2025 10:20 AM CDTFormatting of this note is different from the original.Images from the original note were not included. Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:7/31/2025 Cancer Staging No matching staging information was found for the patient.Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XF- ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparsocopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/2025Malignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment Plans for Towell, Alexander R Oncology Chemotherapy Treatment: FOLFIRI+Bev: (Fluorouracil / Leucovorin / Irinotecan / Bevacizumab) 14 Day Cycles - Colon/Rectum Current day: Day 1, Cycle 1 (Planned for 7/31/2025) Following planned day: Day 1, Cycle 2 (Planned for 8/14/2025) Subjective Mr. Alexander R Towell is a 49 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.He was last seen here on 7/8/2025. His pathology from his liver resection 5/14/2025 was discussed and planned to continue FOLFIRI/Bev. Patient wanted to transfer his treatments to SOCO. Today is cycle 1 of FOLFIRI/Bev. He presents to clinic today accompanied by his wife. He has been tolerating treatment well and his only complaints are fatigue and nausea. His nausea is well controlled with Compazine. Since hepatic resection in May, he has been on maintenance therapy. He uses Propranolol for migraines. He is eating well with a healthy appetite. He has normal bowel and urinary function. He denies abdominal pain, vomiting, diarrhea, constipation, fevers, chills,or chest pain. Past Medical

Progress Notes — 2025-08-14

Date: 2025-08-14

Type: Progress Notes

Source: epic_ihe_xdm

Benjamin Tan, MD - 08/14/2025 11:00 AM CDTFormatting of this note is different from the original.Images from the original note were not included. Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:8/14/2025 Cancer Staging No matching staging information was found for the patient.Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:- DYPD normal1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XT on Liver specimen 5/14/20253. TEMPUS XF- 07/08/2025ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparoscopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/20255. Resumption of 5FU +/- bev- 07/31/2025 Cycle 1 5FU 2400 CIVI- MRI/PET no evidence of recurrenceMalignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R Oncology Chemotherapy Treatment: FOLFIRI+Bev: (Fluorouracil / Leucovorin / Irinotecan / Bevacizumab) 14 Day Cycles - Colon/Rectum Current day: Day 1, Cycle 1 (Started on 7/31/2025; Originally planned for 7/31/2025) Following planned day: Day 1, Cycle 2 (Planned for 8/14/2025) Line Care : IV Maintenance Therapy Plan Current treatment: Treatment 1 (Planned for 8/14/2025) Subjective Mr. Alexander R Towell is a 50 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.He resumed 5FU alone 7/31/2025.He had restaging scans done with MRI and PET 8/13/2025 which showed no evidence of disease. His CTDNA was negative and his CEA 4.6 7/31/2025He comes today and notes:- feeling well- no abdominal pain- no nausea, vomiting- no fever, chills- no diarrhea, constipationPast Medical

Progress Notes — 2025-09-11

Date: 2025-09-11

Type: Progress Notes

Source: epic_ihe_xdm

Amy Ngo, NP - 09/11/2025 8:15 AM CDTFormatting of this note is different from the original.Images from the original note were not included.Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:9/11/2025 Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:- DYPD normal1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XT on Liver specimen 5/14/20253. TEMPUS XF- 07/08/2025ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparoscopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/20255. Resumption of 5FU +/- bev- 07/31/2025 Cycle 1 5FU 2400 CIVI- MRI/PET no evidence of recurrence- 08/14/2025 Cycle 2 5FU 2400 CIVI- 08/28/2025 Cycle 3 5FU 2400 CIVIMalignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R “Alex” Oncology Chemotherapy Treatment: FOLFIRI+Bev: (Fluorouracil / Leucovorin / Irinotecan / Bevacizumab) 14 Day Cycles - Colon/Rectum Current day: Day 1, Cycle 4 (Planned for 9/11/2025) Following planned day: Day 1, Cycle 5 (Planned for 9/25/2025) Line Care : IV Maintenance Therapy Plan Current treatment: Treatment 1 (Planned for 8/14/2025) Subjective Mr. Alexander R Towell is a 50 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.He resumed 5FU alone 7/31/2025. His CTDNA was negative and his CEA 4.6 7/31/2025. He had restaging scans done with MRI and PET 8/13/2025 which showed no evidence of disease.He comes today with his SO and notes:- feeling well with no complaints- tolerating 5FU pump well- eating and drinking well- bowels are moving without issues or change, at baselinePast Medical

Progress Notes — 2025-10-09

Date: 2025-10-09

Type: Progress Notes

Source: epic_ihe_xdm

Benjamin Tan, MD - 10/09/2025 8:15 AM CDTFormatting of this note is different from the original.Images from the original note were not included.Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:10/9/2025 Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:- DYPD normal1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XT on Liver specimen 5/14/20253. TEMPUS XF- 07/08/2025ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparoscopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/20255. Resumption of 5FU +/- bev- 07/31/2025 Cycle 1 5FU 2400 CIVI- MRI/PET no evidence of recurrence- 08/14/2025 Cycle 2 5FU 2400 CIVI- 08/28/2025 Cycle 3 5FU 2400 CIVIMalignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R “Alex” Oncology Chemotherapy Treatment: FOLFIRI+Bev: (Fluorouracil / Leucovorin / Irinotecan / Bevacizumab) 14 Day Cycles - Colon/Rectum Current day: Day 1, Cycle 6 (Planned for 10/9/2025) Following planned day: Day 1, Cycle 7 (Planned for 10/23/2025) Line Care : IV Maintenance Therapy Plan Current treatment: Treatment 1 (Planned for 8/14/2025) Subjective Mr. Alexander R Towell is a 50 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.He had his last treatment with 5FU on 9/25/2025 and tolerated this well.He comes today with his SO and notes:- feeling well with no complaints- tolerating 5FU pump well- no abdominal pain, nausea, vomiting, mucositis- bleeding, jaundice, painPast Medical

Progress Notes — 2025-11-06

Date: 2025-11-06

Type: Progress Notes

Source: epic_ihe_xdm

Amy Ngo, NP - 11/06/2025 11:20 AM CSTFormatting of this note is different from the original.Images from the original note were not included.Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:11/6/2025 Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:- DYPD normal1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XT on Liver specimen 5/14/20253. TEMPUS XF- 07/08/2025ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparoscopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/20255. Resumption of 5FU +/- bev- 07/31/2025 Cycle 1 5FU 2400 CIVI- 08/13/2025 MRI/PET no evidence of recurrence- 08/14/2025 Cycle 2 5FU 2400 CIVI- 08/28/2025 Cycle 3 5FU 2400 CIVI- 09/11/2025 Cycle 4 5FU 2400 CIVI- 09/25/2025 Cycle 5 5FU 2400 CIVI- 10/09/2025 Cycle 6 5FU 2400 CIVI- 10/23/2025 Cycle 7 5FU 2400 CIVI- 11/16/2025 Cycle 8 5FU 2400 CIVIMalignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R “Alex” Oncology Chemotherapy Treatment: FOLFIRI+Bev: (Fluorouracil / Leucovorin / Irinotecan / Bevacizumab) 14 Day Cycles - Colon/Rectum Current day: Day 1, Cycle 8 (Planned for 11/6/2025) Following planned day: Day 1, Cycle 9 (Planned for 11/20/2025) Line Care : IV Maintenance Therapy Plan Current treatment: Treatment 1 (Planned for 8/14/2025) Subjective Mr. Alexander R Towell is a 50 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.He was last seen 10/9/2025 and continued on 5FU. He last received 5FU on 10/23/2025. He underwent CT today which showed stable lung nodules. His MRI is still pending insurance approval. He comes today with his SO and notes:- may have had a 24h bug, felt drained, HA, vomited. Feeling better now. - no fevers, chills- no other complaints including abdominal pain, SOB, cough, chest painPast Medical

Progress Notes — 2025-11-12

Date: 2025-11-12

Type: Progress Notes

Source: epic_ihe_xdm

Amy Ngo, NP - 11/12/2025 5:20 PM CSTFormatting of this note might be different from the original.Called patient and informed him of MRI results showing two new liver lesions concerning for metastatic disease. Will plan for PET/CT, tumor board review and possible referral to HPB surgery.Pt voiced understanding and agreement. Electronically signed by Amy Ngo, NP at 11/12/2025 5:21 PM CSTdocumented in this encounter

Progress Notes — 2025-11-20

Date: 2025-11-20

Type: Progress Notes

Source: epic_ihe_xdm

Benjamin Tan, MD - 11/20/2025 8:15 AM CSTFormatting of this note is different from the original.Images from the original note were not included.Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:11/20/2025 Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:- DYPD normal1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XT on Liver specimen 5/14/20253. TEMPUS XF- 07/08/2025ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparoscopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/20255. Resumption of 5FU +/- bev- 07/31/2025 Cycle 1 5FU 2400 CIVI- 08/13/2025 MRI/PET no evidence of recurrence- 08/14/2025 Cycle 2 5FU 2400 CIVI- 08/28/2025 Cycle 3 5FU 2400 CIVI- 09/11/2025 Cycle 4 5FU 2400 CIVI- 09/25/2025 Cycle 5 5FU 2400 CIVI- 10/09/2025 Cycle 6 5FU 2400 CIVI- 10/23/2025 Cycle 7 5FU 2400 CIVI- 11/06/2025 Cycle 8 5FU 2400 CIVI (CEA 2.9)- 11/06/2025 CT Chest stable lung lesions- 11/09/2025 MRI abdomen with 2 new liver lesions- 11/19/2025 PET/FDGMalignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R “Alex” Oncology Chemotherapy Treatment: FOLFIRI+Bev: (Fluorouracil / Leucovorin / Irinotecan / Bevacizumab) 14 Day Cycles - Colon/Rectum Current day: Day 1, Cycle 9 (Planned for 11/20/2025) Following planned day: Day 1, Cycle 10 (Planned for 12/4/2025) Line Care : IV Maintenance Therapy Plan Current treatment: Treatment 1 (Planned for 8/14/2025) Subjective Mr. Alexander R Towell is a 50 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.He was last seen 11/6/2025 and continued on 5FU. He last received cycle 8 5FU on 11/6/2025. He underwent CT chest 11/6/2025 which showed stable lung nodules. His MRI done 11/9/2025 showed development of 2 liver lesions suspicious for metastatic disease. He had a PET/FDG done 11/19/2025 which showed minimal uptake in one of the liver lesions but could not differentiate between recurrence vs physiologic change.His case was reviewed at Tumor board this morning and consensus is to refer back to dr. Chapman to discussed possible wedge resections for these two peripheral liver lesions and confirm if indeed recurrent vs benign. He comes today with his SO and notes:- feeling well- no abdominal pain- no jaundice- no nausea, vomitingPast Medical

Progress Notes — 2025-11-26

Date: 2025-11-26

Type: Progress Notes

Source: epic_ihe_xdm

Morgen Rockel, PA - 11/26/2025 9:00 AM CSTFormatting of this note is different from the original.PATIENT NAME: Alexander R TowellDOB: 8/4/197511/26/2025 CHIEF COMPLAINT: Metastatic terminal ileum adenocarcinoma to the liverHISTORY OF PRESENT ILLNESS: Mr. Towell is a 50 y.o. male with a history of sigmoid adenocarcinoma, metastatic terminal ileum adenocarcinoma to the liver s/p segment 2 hepatic resection in 5/2025 with two new lesions concerning for metastasis in segment 8. He returns to discuss repeat hepatic resection. He recovered very well after XI hepatic resection without complications. He continues chemotherapy with Dr. Tan, with last treatment 3 weeks ago. Surveillance MRI 11/9 showed 2 new lesions, 1.2 and 0.6 cm, followed by PET scan with very slight uptake.He feels wells overall, good appetite, no weight loss. CURRENT MEDICATIONS:Current Outpatient Medications: cetirizine (ZyrTEC) 10 mg tablet, Take 1 tablet every day by oral route for 90 days., Disp: , Rfl: cyanocobalamin (Vitamin B-12) 100 mcg tablet, Take 1 tablet (100 mcg total) by mouth early morning before breakfast, Disp: , Rfl: docusate sodium (COLACE) 100 mg capsule, Take 1 capsule (100 mg total) by mouth 2 (two) times a day as needed for constipation, Disp: , Rfl: iron bisgly,ps-FA-B-C#12-succ 65 mg-65 mg -1,000 mcg (24) tablet, Take 1 tablet by mouth 3 (three) times a week, Disp: , Rfl: levothyroxine (SYNTHROID) 112 mcg tablet, Take 1 tablet (112 mcg total) by mouth early morning before breakfast (Patient taking differently: Take 125 mcg by mouth early morning before breakfast), Disp: , Rfl: loperamide (IMODIUM A-D) 2 mg tablet, Take 1 tablet (2 mg total) by mouth 4 (four) times a day as needed for diarrhea, Disp: , Rfl: LORazepam (ATIVAN) 0.5 mg tablet, Take 1 tablet (0.5 mg total) by mouth every 8 (eight) hours as needed for anxiety, Disp: 30 tablet, Rfl: 0 multivitamin with minerals tablet, Take 1 tablet by mouth daily with dinner, Disp: , Rfl: omega-3 fatty acids-fish oil 300-1,000 mg capsule, Take 2 capsules (2 g total) by mouth daily with dinner, Disp: , Rfl: prochlorperazine (COMPAZINE) 10 mg tablet, Take 1 tablet (10 mg total) by mouth 3 (three) times a day as needed for nausea, Disp: 60 tablet, Rfl: 3 propranoloL (INDERAL) 20 mg tablet, Take 1 tablet (20 mg total) by mouth 2 (two) times a day, Disp: , Rfl: zolpidem (AMBIEN) 5 mg tablet, Take 1 tablet (5 mg total) by mouth nightly as needed for sleep, Disp: 30 tablet, Rfl: 0ALLERGIES: No Known AllergiesSOCIAL HISTORY:Social History Tobacco Use Smoking Status Never Smokeless Tobacco Never Alcohol: None reports no history of drug use.The patient is partner and presents to clinic with Kim. Occupation: Researcher. REVIEW OF SYSTEMS:Reports No acute concernsDenies fever/chills, n/v/d/c, or abdominal pain.PHYSICAL EXAM: VitalsBP 125/78 Pulse 61 Temp 36.1 °C (97 °F) Ht 185.4 cm (6’ 1") Wt 105.6 kg (232 lb 12.8 oz) BMI 30.71 kg/m² General Appearance: awake, alert, oriented x3, in no acute distressSkin: there are no suspicious lesions, rashes or jaundiceHead: NCATEyes: EOMI and Sclera nonictericNeck: neck- supple, no massLungs: Chest wall: symmetricHeart: Heart regular rate and rhythmAbdomen: Soft, non-tender, no organomegaly or masses. Hernias: none. Small incisional scars present. Extremities: no edemaNeurologic: negative findings: cranial nerves 2-12 grossly intact, gait normalLABS:Lab Results Component Value Date WBC 4.35 11/20/2025 HGB 15.3 11/20/2025 HCT 43.9 11/20/2025 MCV 93.4 11/20/2025 Lab Results Component Value Date SODIUM 140 11/20/2025 POTASSIUM 4.0 11/20/2025 CHLORIDE 106 11/20/2025 CO2 27 11/20/2025 ANIONGAP 8 11/20/2025 GLUCOSE 105 11/20/2025 BUNSER 23 11/20/2025 CREATININE 1.11 11/20/2025 CALCIUM 9.0 11/20/2025 ALBUMIN 4.3 11/20/2025 ALKPHOS 80 11/20/2025 ALT 46 11/20/2025 AST 28 11/20/2025 BILITOT 0.9 11/20/2025 IMAGING:MRI 11/9/25

Progress Notes — 2025-12-01

Date: 2025-12-01

Type: Progress Notes

Source: epic_ihe_xdm

Jeannette K - 12/01/2025 4:07 PM CSTFormatting of this note might be different from the original.Pt scheduled for surgery on 12/18/25 at 11:30 AM. Him and his partner, Kim are aware of date, time, arrival time, instructions, and location. MyChart message also sent. Electronically signed by Jeannette K at 12/01/2025 4:07 PM CSTdocumented in this encounter

Progress Notes — 2025-12-16

Date: 2025-12-16

Type: Progress Notes

Source: epic_ihe_xdm

Jeannette K - 12/16/2025 7:43 AM CSTFormatting of this note might be different from the original.Confirmed pts upcoming surgery for 12/18/25 at 11:30 AM. Arrival time 9:30 AM. Location discussed. Pt and his spouse voiced understanding.Electronically signed by Jeannette K at 12/16/2025 8:11 AM CSTdocumented in this encounter

Progress Notes — 2025-12-18

Date: 2025-12-18

Type: Progress Notes

Source: epic_ihe_xdm

Reshma Mulla, MD - 12/19/2025 6:25 AM CSTFormatting of this note is different from the original.Images from the original note were not included.Hepatobiliary Surgery Daily Progress HPI:Mr. Alexander R Towell is a 50 y.o. year old admitted for Metastatic colon cancer to liverLength of Hospitalization: 1Post Procedure Day: 12/18/2025 Procedure(s):XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED SEGMENT 5 8 and 4B, INTRAOPERATIVE ULTRASOUND and TAP BLOCK SUBJECTIVE/ INTERVAL HISTORY-Patient denies uncontrolled pain, nausea, fever, shortness of breath. -No AEON-Voided urine around 500 ml-denies any nausea or vomiting-pain well controlled Objective Physical Exam Constitutional: Appears comfortable. Lying in bed. No distress. HENT: No nasal cannula nor NGT Eyes: Conjunctivae are normal. Pulmonary/Chest: Effort normal No respiratory distress. No grossly audible wheezes nor ralesAbdominal: Soft. No distension. Appropriately tender. Incision closed with dermabond no warmth, erythema, fluctuance, drainage. No drain . There is no rebound and no guarding. Musculoskeletal: Normal range of motion. No edema or deformity. Neurological: Alert and oriented to person, place, and time. Skin: Skin is warm and dry. No rash noted. Not diaphoretic. No erythema. Psychiatric: Normal mood and affect. Current Facility-Administered Medications: acetaminophen (TYLENOL) tablet 1,000 mg, 1,000 mg, oral, Q6H SCH, 1,000 mg at 12/19/25 0538 Carrier Fluids for Secondary Infusion - 0.9% Sodium Chloride, 30 mL, intravenous, PRN enoxaparin (LOVENOX) syringe 40 mg, 40 mg, subcutaneous, Daily-2100, 40 mg at 12/18/25 2042 gabapentin (NEURONTIN) capsule 100 mg, 100 mg, oral, BID, 100 mg at 12/18/25 2042 levothyroxine (SYNTHROID) tablet 125 mcg, 125 mcg, oral, Daily - 0600, 125 mcg at 12/19/25 0538 lidocaine (LIDODERM) 5 % patch 1 patch, 1 patch, transdermal, Q24H methocarbamoL (ROBAXIN) tablet 1,000 mg, 1,000 mg, oral, TID, 1,000 mg at 12/18/25 2042 ondansetron (ZOFRAN) injection 4 mg, 4 mg, intravenous, Q6H PRN oxyCODONE (ROXICODONE) tablet 5 mg, 5 mg, oral, Q4H PRN, 5 mg at 12/18/25 1831 propranoloL (INDERAL) tablet 20 mg, 20 mg, oral, Daily - 0600, 20 mg at 12/19/25 0538 senna-docusate (PERICOLACE) 8.6-50 mg per tablet 1 tablet, 1 tablet, oral, BID, 1 tablet at 12/18/25 2042 sodium chloride 0.9% flush 0.5-20 mL, 0.5-20 mL, intra-catheter, Q8H SCH (ALT), 10 mL at 12/18/25 2042 sodium chloride 0.9% flush 0.5-20 mL, 0.5-20 mL, intra-catheter, PRNLab/Radiology/Diagnostic Review:Laboratory studies from the past 24 hours were reviewed and significant forHematology Lab History Latest Ref Rng & Units 11/6/2025 09:13 11/20/2025 07:58 11/26/2025 10:50 12/19/2025 04:12 Labs - Hematology WBC 3.80 - 9.90 K/cumm 5.69 4.35 5.39 9.25 Total Hb, POC 13.0 - 17.5 g/dL 15.5 15.3 15.3 14.3 Hct 38.9 - 50.3 % 44.5 43.9 45.8 41.4 Plt 150 - 400 K/cumm 160 131 204 164 Neutrophil abs 1.50 - 6.50 K/cumm 3.35 2.66 Lymphocytes, abs 0.80 - 3.30 K/cumm 1.56 0.95 Chem/LFT Lab History Latest Ref Rng & Units 10/23/2025 12:31 11/6/2025 09:13 11/20/2025 07:58 12/19/2025 04:12 Labs-Chem/LFT Sodium 135 - 145 mmol/L 141 137 140 137 Creatinine 0.80 - 1.30 mg/dL 1.05 1.07 1.11 1.12 Bilirubin, total 0.1 - 1.2 mg/dL 0.6 0.7 0.9 1.1 AST 10 - 50 Units/L 24 23 28 105 ALT 7 - 55 Units/L 36 29 46 101 Alk phos 40 - 130 Units/L 68 71 80 71 CrCl- Actual Body Weight (Cockcroft-Gault) 123.1 121.7 117 113.9 No results found for: “AMYLASEFL"Recent Radiology studies were reviewed and significant for: PET/CT imaging(11/19/2025)Suggestion of subtle uptake in the area of queriedhepatic segment 4A enhancing lesion on recent MRI, which mayrepresent metastasis versus physiologic artifact. No evidence ofhypermetabolic disease elsewhere.MRI Abdomen and Pelvis(11/11/2025)-Interval development of two hepatic segment 4A/8 lesions, suspiciousfor metastatic disease.Vitals:24hr Min/Max:Temp Min: 36.3 °C (97.4 °F) Max: 36.9 °C (98.4 °F)Pulse Min: 50 Max: 78BP Min: 102/68 Max: 166/100Resp Min: 12 Max: 25SpO2 Min: 92 % Max: 98 %Most Recent:Vitals: 12/19/25 0538 BP: 110/64 Pulse: 67 Resp: Temp: SpO2: I/O last 2 completed shifts:In: 1313.7 [I.V.:1313.7]Out: 820 [Urine:800; Blood:20]I/O this shift:In: 273.2 [P.O.:50; I.V.:223.2]Out: 350 [Urine:350]Recent Interventions: Assessment/Plan 1. Metastatic colon cancer to liver2.Advance diet as tolerated3.OOBC4. DischargeReshma Mulla, MD12/19/20256:26 AM Cosigned by William Chapman, MD at 12/19/2025 9:10 PM CSTElectronically signed by Reshma Mulla, MD at 12/19/2025 12:22 PM CSTElectronically signed by William Chapman, MD at 12/19/2025 9:10 PM CSTRiadh Cheddadi, MD - 12/18/2025 7:20 PM CSTFormatting of this note is different from the original.Surgery Post Op Check NoteAlexander R Towell8/4/1975104670153Pt returns from the OR 12/18/2025 s/p XI LIVER RESECTION - LAPAROSCOPIC ROBOTIC ASSISTED SEGMENT 5 8 and 4B, INTRAOPERATIVE ULTRASOUND and TAP BLOCK by Chapman, William Cavanaugh, MD for Pre-op Diagnosis * Metastatic colon cancer to liver [C18.9, C78.7]Patient transferred from PACU to floor in stable condition. Patient is resting comfortably in bed. Pain controlled with scheduled and PRN medication. Denies nausea, emesis, chest pain, or SOB. Vital signs have been reviewed and are stable.Diet: Dietary Orders (From admission, onward) Start Ordered 12/18/25 1808 Adult Diet Clear Liquid Diet effective now Question: (BJH) Diet type Answer: Clear Liquid 12/18/25 1807 Physical Exam:Vitals: 12/18/25 1905 BP: 141/88 Pulse: 57 Resp: 18 Temp: 36.3 °C (97.4 °F) SpO2: 98% Constitutional: Alert and oriented x4 and no acute distressCV: Regular rate.Pulm: Unlabored respirations. Equal and symmetric chest rise.Abdomen: Soft, appropriately tender, nondistended. Incisions c/d/i with no active drainage or bleeding. No hematoma noted. No rebound tenderness or involuntary guarding. Neuro: Grossly nonfocal.Extremities: Warm and well perfused.Assessment and PlanThe patient is doing well in the immediate postop period following- CLD- mIVF- Multimodal pain control regimen- Follow up PM labs- DVT ppx- Encourage OOB and IS use Riadh Cheddadi, MDGeneral Surgery ResidentElectronically signed by Riadh Cheddadi, MD at 12/18/2025 7:20 PM CSTdocumented in this encounter

Progress Notes — 2025-12-29

Date: 2025-12-29

Type: Progress Notes

Source: epic_ihe_xdm

Sarah Matson, PA - 12/29/2025 9:30 AM CSTFormatting of this note is different from the original.PATIENT NAME: Alexander R TowellDOB: 8/4/197512/29/25CHIEF COMPLAINT: Postoperative evaluation after robotic resection of 2 metastatic colorectal cancer sites to the liverHISTORY OF PRESENT ILLNESS: Mr. Towell is a 50 y.o. male s/p robotic resection of 2 metastatic colorectal cancer sites to the liver approximately 11 days ago, who presents for postoperative visit today. He denies complaintsCURRENT MEDICATIONS: Current Outpatient Medications: acetaminophen 500 mg capsule, Take 2 capsules (1,000 mg total) by mouth every 6 (six) hours, Disp: , Rfl: cetirizine (ZyrTEC) 10 mg tablet, Take 1 tablet (10 mg total) by mouth daily as needed for allergies or rhinitis, Disp: , Rfl: docusate sodium (COLACE) 100 mg capsule, Take 1 capsule (100 mg total) by mouth 2 (two) times a day as needed for constipation, Disp: , Rfl: gabapentin (NEURONTIN) 100 mg capsule, Take 1 capsule (100 mg total) by mouth 2 (two) times a day, Disp: 60 capsule, Rfl: 11 levothyroxine (SYNTHROID) 125 mcg tablet, Take 1 tablet (125 mcg total) by mouth early morning before breakfast, Disp: , Rfl: lidocaine (LIDODERM) 5 %, Place 1 patch on the skin daily for 12 hours Remove & discard patch(es) within 12 hours or as directed by MD, Disp: , Rfl: [Paused] loperamide (IMODIUM A-D) 2 mg tablet, Take 1 tablet (2 mg total) by mouth 4 (four) times a day as needed for diarrhea, Disp: , Rfl: LORazepam (ATIVAN) 0.5 mg tablet, Take 1 tablet (0.5 mg total) by mouth every 8 (eight) hours as needed for anxiety, Disp: 30 tablet, Rfl: 0 multivitamin with minerals tablet, Take 1 tablet by mouth early morning before breakfast, Disp: , Rfl: oxyCODONE (ROXICODONE) 5 mg immediate release tablet, Take 1 tablet (5 mg total) by mouth every 6 (six) hours as needed for pain, Disp: 10 tablet, Rfl: 0 [Paused] prochlorperazine (COMPAZINE) 10 mg tablet, Take 1 tablet (10 mg total) by mouth 3 (three) times a day as needed for nausea, Disp: 60 tablet, Rfl: 3 propranoloL (INDERAL) 20 mg tablet, Take 1 tablet (20 mg total) by mouth early morning before breakfast, Disp: , Rfl: senna-docusate (PERICOLACE) 8.6-50 mg, Take 1 tablet by mouth daily as needed for constipation, Disp: , Rfl: [Paused] zolpidem (AMBIEN) 5 mg tablet, Take 1 tablet (5 mg total) by mouth nightly as needed for sleep, Disp: 30 tablet, Rfl: 0ALLERGIES: No Known AllergiesREVIEW OF SYSTEMS: Denies fever/chills, weight loss, abdominal pain. PHYSICAL EXAM: VitalsBP 133/77 Pulse 51 Temp 36.4 °C (97.5 °F) Ht 185.4 cm (6’ 1") Wt 107.7 kg (237 lb 6.4 oz) BMI 31.32 kg/m² General Appearance: awake, alert, oriented x3, in no acute distress Skin: there are no suspicious lesions or rashes or jaundiceHead: NCAT, Eyes: EOMI and Sclera nonictericNeck: neck- suppleLungs: Chest wall: symmetricAbdomen: Soft, non-tender, no hernia, mass, or fluid collection appreciated. Incisions healing wellExtremities: no lower extremity edema bilaterallyASSESSMENT:50 y.o. male s/p robotic resection of 2 metastatic colorectal cancer sites to the liver LABS: Lab Results Component Value Date WBC 9.25 12/19/2025 HGB 14.3 12/19/2025 HCT 41.4 12/19/2025 Lab Results Component Value Date SODIUM 137 12/19/2025 POTASSIUM 4.2 12/19/2025 GLUCOSE 110 12/19/2025 BUNSER 13 12/19/2025 CREATININE 1.12 12/19/2025 SURGICAL PATHOLOGY:

Progress Notes — 2026-01-15

Date: 2026-01-15

Type: Progress Notes

Source: epic_ihe_xdm

Ellen S - 01/15/2026 9:42 AM CSTFormatting of this note might be different from the original.Dr.Tan changed his mind from Tempus to Guardant.Electronically signed by Ellen S at 01/15/2026 12:26 PM CSTdocumented in this encounter

Progress Notes — 2026-01-15

Date: 2026-01-15

Type: Progress Notes

Source: epic_ihe_xdm

Benjamin Tan, MD - 01/15/2026 11:30 AM CSTFormatting of this note is different from the original.Images from the original note were not included.Oncology Return/Follow Up VisitAlexander R TowellDOB:8/4/1975 DATE OF VISIT:1/15/2026 Oncology History Overview Note DIAGNOSIS:Sigmoid Adenocarcinoma Stage IIIMetastaticTerminal Ileum Adenocarcinoma, MSS, RAS WT, with liver metastasesGENOMIC DATA:- DYPD normal1. TEMPUS XT for small bowel adenocarcinoma2. TEMPUS XT on Liver specimen 5/14/20253. TEMPUS XF- 07/08/2025ONCOLOGIC HISTORY:presented with anemia with tiredness, constipation, abdominal pain and fatigue back in 2021. He required blood transfusions- 11/22/2021 Colonoscopy showed malignant appearing mas in descending colon with ulceration and partial obstruction- 11/23/2021 labs notes wbc 3.8, Hb 9.4, platelets 310K, creatinine 1.8, bilirubin 0.3, CEA 1.4- 12/09/2021 CT scan showed exophytic sigmoid colon mass (2.6 cm) with Lymph nodes suspicious for metastatic disease and sclerotic focus in the left iliac bone.- 12/10/2021 Consultation with Dr. Syed (Oncology)- 12/29/2021 laparsocopic sigmoid colectomy pathology showed moderately differentiated colon adenocarcinoma 1 of 23 LN +, MSS, RAS WT- stage IIIB pT4N1M0- 02/16/2022 to 08/29/2022 adjuvant FOLFOX x 12 cycles with dose reduction. Toxicities include neuropathy and diarrhea, fatigue- 01/01/2023 CT scans showed no recurrence- 01/09/2023 Colonoscopy showed normal findings- 12/29/2023 CT showed no metastases- 05/29/2024 Colonoscopy showed large ulcerated mass in the terminal ileum, biopsy confirmed moderately differentiated adenocarcinoma- 07/01/2024 right hemicolectomy - showed 4 of 14 LN +, PNI+, no LVI, RAS WT, MSS- 07/11/2024 Tempus XF - 07/25/2024 PET scan done showed liver lesions. Started chemotherapy with Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/bevacizumab: has diarrhea treated with immodium- 08/15/2024 Consultation with medical oncology (tan) to discuss HAI pump therapyTREATMENT HISTORY: laparoscopic sigmoid colectomy 12/29/2021Adjuvant FOLFOX x 12 cycles 2/16/2022- 8/2022Right hemicolectomy 7/1/2024FRONTLINE FOLFIRI/Bevacizumab- 07/25/2024 Cycle 1 FOLFIRI- 08/12/2024 Cycle 2 FOLFIRI/Bevacizumab- 02/12/2025 Maintenance 5FU/bevacizumab- 04/16/2025 Maintenance 5FU/Bev (last dose prior to surgery)5. Robotic Segment 2 resection (Chapman) 5/14/20255. Resumption of 5FU +/- bev- 07/31/2025 Cycle 1 5FU 2400 CIVI- 08/13/2025 MRI/PET no evidence of recurrence- 08/14/2025 Cycle 2 5FU 2400 CIVI- 08/28/2025 Cycle 3 5FU 2400 CIVI- 09/11/2025 Cycle 4 5FU 2400 CIVI- 09/25/2025 Cycle 5 5FU 2400 CIVI- 10/09/2025 Cycle 6 5FU 2400 CIVI- 10/23/2025 Cycle 7 5FU 2400 CIVI- 11/06/2025 Cycle 8 5FU 2400 CIVI (CEA 2.9)- 11/06/2025 CT Chest stable lung lesions- 11/09/2025 MRI abdomen with 2 new liver lesions- 11/19/2025 PET/FDG suggestion of subtle uptake in segment 4A- 01/15/2026 CT/MRI stable pulmonary nodules, Malignant neoplasm metastatic to liver (HCC) 8/16/2024 Initial Diagnosis Malignant neoplasm metastatic to liver (HCC)Active Treatment & Therapy Plans for Towell, Alexander R “Alex” Oncology Chemotherapy Treatment: FOLFIRI+Bev: (Fluorouracil / Leucovorin / Irinotecan / Bevacizumab) 14 Day Cycles - Colon/Rectum (On Hold) Current day: Day 1, Cycle 9 (Planned for 11/20/2025) Following planned day: Day 1, Cycle 10 (Planned for 12/4/2025) Line Care : IV Maintenance Therapy Plan Current treatment: Treatment 1 (Planned for 8/14/2025) Subjective Mr. Alexander R Towell is a 50 y.o. Non-Hispanic male who comes to the Gastrointestinal Oncology Clinic at Washington University for a follow up oncology visit.He was last seen 11/6/2025 and continued on 5FU. He last received cycle 8 5FU on 11/6/2025. He underwent resection of the 2 liver lesions on 12/18/2025. Operative findings noted normal looking liver and 2 surface based tumors in segment 4 and 5/8. A non-anatomic excisional resection was performed by Dr. Chapman. His case was reviewed at Tumor board this morning and consensus is to refer back to dr. Chapman to discussed possible wedge resections for these two peripheral liver lesions and confirm if indeed recurrent vs benign. He was discharged 12/19/2025. He had repeat scans today which showed post operative changes with no suspicious lesionsHe comes today with his SO and notes:- feeling well- no abdominal pain- no jaundice- no nausea, vomiting- his surgical scars are well healed with no bleeding or suppuration, there is an area of healing wound with granulation in the abdomen- no fever, chillsPast Medical

Reason for Referral

Type: Reason for Referral

Source: athena_sihf

Sleep Medicine Referral for Sleep apnea

Referring Physician: Nathini Suthan, Internal Medicine, (618) 258-0485

Encounter Date: 07/25/2023

Gastroenterologist Referral for Occult blood detected in feces

iron deficiency

Please contact patient to schedule appointment. Thank you

Referring Physician: Nathini Suthan, Internal Medicine, (618) 258-0485

Encounter Date: 10/12/2021

Sleep Medicine Referral for Sleep apnea

Please contact patient to schedule appointment. Thank you

Referring Physician: Nathini Suthan, Internal Medicine, (618) 258-0485

Encounter Date: 09/27/2021

Reason for Referral

Type: Reason for Referral

Source: meditech_anderson

Reason for Referral Date Referral was Provided

Provider Office Contact Location

November 22, 2021 Edmundo A. Rodriguez-Frias 618-391-5070 6812 STATE ROUTE 162 SUITE 204 MARYVILLE,IL 62062